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Thesis Abstract 
 Mild Traumatic Brain Injury (TBI) is a major health concern due to its high 
incidence and lasting cognitive consequences for the patient. Diffuse Axonal Injury 
(DAI); diffuse damage to axons caused by inertial forces during the TBI, is hypothesised 
to be a leading cause for these impairments. MRI-based research which has examined 
mild, acute cases has produced findings which indicate that the mechanisms and 
progression of mild TBI may be unique and not simply a less pronounced version of 
severe TBI. This thesis describes a set of experiments which used a variety of advanced 
MRI techniques to examine the physiological presentation and progression of mild TBI, 
and how this related to cognitive outcome. 
 Forty-four mild and 9 moderate TBI patients were recruited an average of 6 
days post-injury, scanned using a variety MRI techniques and administered a 
neuropsychological test battery. Twenty-three of these patients (18 mild and 5 
moderate) returned one year later and repeated all testing. Thirty-three matched 
controls were also recruited and given the same set of tests. 
 At the acute time-point patients underperformed on a variety of cognitive 
tests, although performance at the chronic time-point had normalised compared to 
controls. The distribution of visible lesions (as identified on quantitative T1 / T2 and T1W 
scans) was found to be similar to patterns previously reported in severe patients. 
Results also indicated more lesions to be related to greater acute cognitive deficit. 
Diffusion Tensor Imaging experimentation revealed a number of unexpected, 
cognitively-relevant metric changes at the acute and chronic time-points. Magnetic 
Resonance Spectroscopy investigation also showed a number of unusual metabolite 
concentration changes and also found these to relate to cognitive functioning. Novel 
hypotheses were formed from these findings.  
 This work has demonstrated a number of cognitively-relevant physiological 
changes following TBI which appear unique to mild injury. 
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Chapter 1. Traumatic Brain Injury 
1.1 Traumatic Brain Injury 
A Traumatic Brain Injury (TBI) refers to any physically-induced head injury 
which results in altered neural physiology (Menon et al., 2010). TBI has been reported 
to be the leading cause of death from all trauma admissions to hospitals (Caldwell and 
McGovern, 1993). A TBI can result from closed or penetrating head injuries, the most 
commonly reported being road traffic accidents with falls being second in frequency 
(Tagliaferri et al., 2006), and assault also being relatively common (Thornhill et al., 
2000). In America firearms are cited as a major cause of TBI (Sosin et al., 1995), 
although the mechanisms and impact of a bullet-injury differ from other TBI’s which 
are typically characterised by a forceful, yet blunt impact to the head. Likewise, blast-
injuries are also frequently investigated under the umbrella term of TBI (DePalma et 
al., 2005), although as these are characterised by various factors such as shockwaves 
from the explosion and burns, they are also not directly comparable. As this thesis 
focuses on the more traditional type of injury, it should therefore be considered that 
any following discussion of the mechanisms and implications of TBI may not always be 
relevant to firearm or blast injury.  
A systematic review of European-based literature (Tagliaferri et al., 2006) 
estimates that (within Europe) 775,500 people sustain a TBI every year, leading to an 
average hospitalisation of 235 per 100,000. UK-based research has reported 
approximately 150 per 100,000 annual admissions (Thornhill et al., 2000). The number 
of deaths as a direct result from a TBI is estimated at 11 per 100 cases although this 
drops to 3 in 100 when considering only those who survive long enough to be admitted 
to hospital. Patients are usually male and within the “young adult” age bracket 
(variably defined, although usually around 16-25 years of age (Bruns and Hauser, 
2003)). Combining the high incidence of acquired disability with the youth of the 
population means TBI is a major healthcare burden, warranting research to improve 
our understanding of the mechanisms involved so that patient treatment may become 
more effective. 
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1.2 Defining the Severity of a TBI 
Healthcare systems and research frequently label individual patients with an 
injury severity rating based on a variety of factors. The most common method of doing 
this is through use of Glasgow Coma Scale (GCS (Teasdale and Jennett, 1974), Table 
1.1); an assessment of responsiveness administered at the scene of injury. In this 
assessment patients are given a separate score for their eye opening, and verbal and 
motor responses, with a higher number indicating a greater degree of responsiveness. 
These individual scores are then added together for a maximum possible score of 15 
(essentially indicating full awareness and ability) and a minimum of 3 (indicating a 
complete lack of any response). Using this total score, patients may then be classified 
as “mild” (typically a score of 13-15), “moderate” (9-12) or “severe” (8 or below; this 
scoring system is common throughout research, as will be discussed over the following 
pages). 
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While the UK NICE guidelines (2014) and a substantial amount of research uses 
GCS score alone to grade patient severity (e.g. (Arfanakis et al., 2002, Chu et al., 2010, 
Sidaros et al., 2008, Rutgers et al., 2008)) other scales and means of defining severity 
exist. The Mayo classification system (Malec et al., 2007) is a scale which uses only 
“mild” and “severe” labels, and incorporates imaging findings together with the GCS 
wherein any patient who would otherwise be defined as “mild” (i.e. a GCS of 13-15) 
becomes “moderate” if there is also visible injury on standard anatomical scans. This 
scale is sometimes used within research (e.g. (Sharp et al., 2011, Kinnunen et al., 
2011)). Information regarding if the patient experienced loss of consciousness (LoC) 
and / or post-traumatic amnesia (PTA), and if so for how long, is also sometimes 
utilised (Rao and Lyketsos, 2000). LoC describes a period of time immediately after the 
injury where the patient is completely unconscious while PTA describes a period of 
Eye Opening 
Spontaneous 4 
To verbal stimuli 3 
To pain 2 
No response 1 
Verbal Response 
Oriented to time, place and person; uses appropriate words and 
phrases 
5 
Confused 4 
Inappropriate words or verbal response 3 
Incomprehensible words  2 
No response 1 
Motor Response 
Spontaneous movement 6 
Withdraws to touch 5 
Withdraws to pain 4 
Abnormal flexion 3 
Abnormal extension 2 
No response 1 
(Add the score from each category to get the total. The maximum score is 15, indicating the best level of 
neurologic functioning. The minimum is 3, indicating total neurologic unresponsiveness) 
Table 1.1. The Glasgow Coma Scale. At the scene of injury, the patient is given a score for each 
category based on their responsiveness. 
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time after injury where a patient is conscious but is unable to store memories and 
therefore does not later recall (Rao and Lyketsos, 2000, Russell and Smith, 1961). 
These are each described in more detail in 1.8.  
Thus, LoC and PTA may be used as further indicators of the patient’s state of 
health (as is recommended in the NICE guidelines (2014) and variably found across 
previous studies (Asikainen et al., 1998, Sherer et al., 2008)) or, within research, may 
be combined with the GCS as additional factors which the authors use to define the 
severity label which a patient is given. This is often done in cases of defining mild 
injury, in line with the Mild Traumatic Brain Injury Interdisciplinary Special Interest 
Group of the American Congress of Rehabilitation Medicine guidelines (Esselman and 
Uomoto, 1995), (e.g. (Inglese et al., 2005, Messe et al., 2011, Miles et al., 2008)). This 
variably classifies mild injury as either involving a LoC of less than 30 minutes and a 
GCS of 13-15 (regardless of PTA) or simply PTA of less than 24 hours (regardless of LoC 
or GCS). It also defines head injuries as mild in cases where the patient is simply dazed 
/ confused / in a transient mental state, but without any information regarding GCS, 
PTA or LoC. Other research may not consider GCS at all in the definition of injury 
severity, such as one investigation which instead used a combination of LoC, PTA and 
imaging findings to define "mild" injury (Little et al., 2010).  
As outlined above, “mild” head injury does not have a single working definition 
within research, although most means of using the term still principally revolve around 
the idea of the patient needing a GCS of between 13 and 15. As such, further 
references to “mild”, “moderate” and “severe” injury will refer only to the standard 
GCS definitions (i.e. a GCS of 13-15 for mild, 8-13 for moderate and 3-7 for severe). 
Estimates for the incidence of mild TBI claim it accounts for approximately 80% of all 
TBI cases, with moderate and severe injury then accounting for around 10% each 
(Tagliaferri et al., 2006). Although mild injury is often clinically presented without any 
imaging changes, thus increasing the likelihood of being discharged from hospital 
early, a substantial proportion of these patients suffer on-going symptoms. Although 
the severity of this disability is typically greater in “severe” patients (Tagliaferri et al., 
2006), it is reported (Thornhill et al., 2000) that 83% of TBI cases are discharged within 
48 hours despite approximately half of each severity group going on to experience 
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some form of chronic disability. Within the literature there is a relative paucity of 
studies which focus on mild TBI patients compared to those examining severe TBI. 
These considerations present a need for a shift in focus within the research to the 
nature and outcome of mild TBI.  
1.3 Predicting a Patient’s Outcome 
In order to examine the outcome of a patient, it is helpful to first have a set 
method of defining how “well” a patient is at a given point in time. The Glasgow 
Outcome Scale (GOS (Jennett and Bond, 1975)) is widely used as a means of doing this. 
Using this scale, patients may be categorised into five groups, starting with “Death” 
and moving through “Persistent Vegetative State”, “Severe Disability (conscious but 
disabled)”, “Moderate Disability (disabled but independent)”, and finally “Good 
recovery”, which as the authors state implies a resumption of normal life albeit with 
some potential minor psychological complications. The scale may be used at any point 
following injury, although the authors highlight the strong possibility of a patient's 
condition significantly improving or worsening during the first year of recovery.   
Severity of injury is arguably the single strongest predictor of patient outcome 
with research showing that lower GCS score is associated with a worse GOS score 
(Mosenthal et al., 2002) and higher mortality (Chi et al., 2006). Greater severity of 
injury (as measured by the GCS and a number of other scales) has also been shown to 
predict worse re-integration into the community (Wagner et al., 2000). However there 
are numerous other measurable factors which have been shown to affect and / or 
relate the patient’s prognosis. While some of the following factors are closely tied to 
severity definitions they have also been shown to hold strong predictive power 
regarding prognosis when considered on their own. 
Younger age predicts both increased chance of survival upon hospital 
admission (Klauber et al., 1989) and also better outcome as measured both by 
functional status (Oh et al., 2006) and also the GOS (Mushkudiani et al., 2007). Higher 
levels of education also predict better functional status (i.e. the degree of acquired 
disability, (Wagner et al., 2000)) and GOS (Mushkudiani et al., 2007). TBI’s obtained 
through a motor vehicle accident (Morrison et al., 2004) and the existence of a prior 
TBI (Wagner et al., 2000) are both associated with worse functional status.  
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Systolic blood pressure on admission greater than or equal to 135mmHG is a 
strong predictor of surviving the first 3 days post-injury (White et al., 2001) while low 
systolic pressure and heart rate are also associated with worse functional status (Oh et 
al., 2006). Greater length of coma is related to worse GOS (Temkin et al., 1995). Both 
midline shift (where the brain is shifted left or right in the skull) and the presence of 
intracranial lesions on CT scan are also associated with increased mortality and worse 
functional status (Schreiber et al., 2002, Maas et al., 2007, Bahloul et al., 2004, Oh et 
al., 2006). Unsurprisingly the presence of identifiable pathology following an injury also 
typically predicts worse GOS (Bahloul et al., 2004, Fabbri et al., 2008, Lee et al., 1998, 
Maas et al., 2007).  
"Prognostic calculators" exist which attempt to bring together factors such as 
those outlined above so that an accurate prediction of a patient’s outcome may be 
made at the acute time of injury. Made in collaboration with one another, the CRASH 
(Perel et al., 2008) and IMPACT (Steyerberg et al., 2008) calculators are the most 
commonly used of these. The CRASH calculator can be used on any patient with a GCS 
of 14 or lower, and takes into account the location (by country) of the injury as well as 
the age of the patient, their GCS, if their pupils react to light and if there is a "major 
extra-cranial injury" present (i.e. one which "requires hospital admission within its own 
right"). Using these it predicts the probability of death within 14 days of injury as well 
as the risk of an unfavourable outcome at 6 months post injury (defined as "dead, 
vegetative state or severe disability as measured by the GOS"). By contrast the IMPACT 
calculator allows for the use of a more detailed set of information, taking into account 
factors such as the patients motor score, imaging findings by CT, if hypoxia or 
hypotension are present, as well as glucose and haemoglobin levels. This calculator 
predicts the probability of mortality and unfavourable outcome (again, defined by 
dead, vegetative state or severe disability as measured by the GOS) at 6 months but 
can only be used on moderate or severe TBI patients (GCS of 12 or less). Subsequent 
studies which have investigated these calculators have found them to have a relatively 
high degree of accuracy and lend support to the use of them in a clinical setting 
(Roozenbeek et al., 2012, Honeybul et al., 2014, Panczykowski et al., 2012).  
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1.4 A Note on the Physiological effects of TBI on the Brain 
While TBI is a complex injury, the physiological impact it has on the brain can 
be broadly thought of to fit into two categories. The first of these is characterised by 
the focal damage at the site of injury and the impact that this has on brain functioning. 
The second of these is diffuse damage throughout the brain caused by inertial forces 
and the impact that this has on brain functioning (Werner and Engelhard, 2007). 
1.5 Focal damage 
 Focal damage is defined as damage to the brain which occurs at the site of (and 
as a direct consequence of) a blow to the head. There are a number of different forms 
of injury which can result from this, such as cerebral lacerations / lesions, contusions 
and hematomas in the local area (Andriessen et al., 2010, Maas et al., 2008). A 
contusion describes what is essentially a bruise on the brain where a number of small 
blood vessels rupture that, in the case of a TBI, is often caused by the brain striking the 
skull. Hematomas result from a haemorrhage of local blood vessels and describe the 
accumulation of blood in an enclosed space. These phenomena share a clear close 
relationship and often occur alongside one another. Other literature, particularly that  
which is focused on surgical intervention, may also refer to these under the umbrella 
term of “mass lesion” (Compagnone et al., 2005).  In addition to often occurring at the 
time of injury, contusions / hematomas may also develop in a delayed manner, which 
has been shown to predict worse patient outcome (Statham et al., 1989, Yadav et al., 
2006).  
As these injuries often contribute to raised intracranial pressure, surgical 
intervention is recommended if these are present regardless of if the patient appears 
to be in good health otherwise (Bullock and Povlishock, 2007), but only if the mass 
exceeds a certain size (Mathiesen et al., 1995). Surgical intervention usually takes the 
form of a mass lesion evacuation (if there is tissue / fluid that can be removed) or a 
decompressive craniectomy to relieve pressure (Compagnone et al., 2005). Incidence 
of contusion and hematoma in all TBI patients has been estimated to be 6.3% and 
2.2% respectively (Kalsbeek et al., 1980, Kraus, 1980), while the proportion of severe 
patients who require surgical intervention is approximately 40% (Miller et al., 1981). 
Regarding mild patients, it is estimated that surgical intervention is required in 3% of 
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patients who have sustained a severe enough injury to cause a contusion (Dacey et al., 
1986). Minor hematomas and contusions resolve without intervention. While a 
number of other secondary effects such as oedema, inflammation, excitotoxicity etc. 
are likely to follow focal injuries, they are also shared by diffuse injury and so are 
described in more detail in the shared section 1.7. 
A “coup and contrecoup” injury may also occur, which may best be described 
as a form of secondary focal injury. As the head is struck the brain may move in the 
skull; if it is moved enough by the force of the injury it may impact upon the side of the 
skull opposite to where the head was hit initially, thus creating further focal-type 
damage. The “coup” injury is the main focal damage at the site of the blow while the 
“contrecoup” injury is this second impaction. This often results in additional contusion 
/ hematoma at the contrecoup location (Drew and Drew, 2004) and raises the 
possibility of the brain sustaining what is essentially two focal injuries at opposing 
sides of the brain. As an example, primary frontal lobe damage may therefore also be 
accompanied by secondary trauma to the occipital lobe.  
The severity of a focal injury is dependent on the force and nature of the 
impact. Based on the assumptions of the lesion model (Moses and Stiles, 2002), as a 
focal injury only affects a contained area long term physical and cognitive problems as 
a result of it are underpinned by the damaged location becoming unable to perform its 
function. Damage associated with focal injuries is often visible on anatomical scans 
(Figure. 1.1) and is therefore relatively easy to diagnose and examine. Research has 
shown that severity of injury (as measured by GCS score) is a predictor of abnormal CT 
findings such as these (Gomez et al., 1996), adding further evidence to the statement 
that anatomical scans of mild TBI's may often be "normal appearing". 
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1.6 Diffuse Axonal Injury 
As stated, many patients who have suffered a mild TBI may be deemed fit for 
discharge from hospital care within a relatively short space of time due in-part to 
factors such as normal-appearing anatomical scans. However chronic impairment is 
often still seen in people with unremarkable scans, suggesting that neuronal damage 
that is beyond the diagnostic reach of techniques such as Computed Tomography (CT) 
and standard Magnetic Resonance Imaging (MRI) still exists. Diffuse microscopic 
damage, referred to as Diffuse Axonal Injury (DAI (Adams et al., 1982)), is the 
commonly accepted form of injury which causes this impairment, and also represents 
the other major physiological impact a TBI can have on the brain beyond focal trauma. 
An incident which results in a TBI often involves rapid movements of the head, 
causing inertial effects (accelerational, de-accelerational and rotational forces) to act 
on the brain. As the brain is not a homogenous structure, instead being composed of 
Figure 1.1. A T1 weighted MRI scan of a TBI patient. Focal damage, appearing as a white area of grey 
matter, is visible at the anterior of the left frontal lobe (due to anatomical spacing right and left are 
flipped in this image). 
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numerous different tissues in different orientations, these physical forces stretch and 
strain layers of axons causing damage in a relatively diffuse manner. DAI is what results 
from this pattern of injury. As such, while a contact force such as an object striking the 
head may in itself result in DAI through a secondary shockwave effect, it is incorrect to 
consider such blunt trauma as being a direct cause. DAI is viewed as a largely global 
type of injury, although because of the vulnerable nature of specific neural regions; 
primarily white matter tracts such as the corpus callosum (CC) and the corticospinal 
tract (Adams et al., 1989), it has been suggested that it would be more accurately 
termed a “multi-focal injury”.  
In order to most accurately examine both the presence of, and mechanisms 
involved in DAI, histopathological examination is required. Therefore much of the 
experimental information concerning its mechanisms comes from animal studies or 
experiments on cellular models. DAI is characterised both by the initial, mechanical 
disruption of the neurofilament / cytoskeleton of the axon as well as biochemical 
cascades which follow this (Povlishock and Katz, 2005). Although the initial forces 
involved in very severe DAI can tear an axon in two (“axotomy”), this is rare and it is 
usually secondary effects which are most problematic.   
Assuming that axotomy does not occur at the site of damage, axons initially 
undergo a stretch injury where they can elongate by up to 60% of their original length 
and take on an undulating (Smith et al., 1999) and distended (Smith and Meaney, 
2000) appearance (Figure 1.2, part 2). A “delayed elastic” process may then occur over 
the course of approximately 45 minutes where the axon returns to its original, normal 
appearing form (Figure 1.2, parts 3-5). Axoplasmic transport becomes impeded at the 
site of this primary damage, leading to axonal swelling and the formation of a “bulb” at 
the terminal end of the axon (also sometimes referred to as a “retraction ball”), which 
may be seen forming by 2 hours following injury (Figure 1.2, part 6). The composition 
of this swelling is thought to involve an accumulation of transport materials, organelles 
(Smith and Meaney, 2000) and remnants of the damaged cytoskeleton, such as 
neurofilament sidearms (Chen et al., 1999). This often becomes more severe over the 
course of days / weeks, eventually leading to the axon breaking into two and 
undergoing Wallerian degeneration, the process of which may be ongoing for months 
(Povlishock and Katz, 2005), via this secondary axotomy. While this description can be 
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taken as the textbook explanation of stretch injury, it should be noted that the nature 
of axonal swelling does not necessarily always follow this discrete pattern of a single, 
easily identifiable bulb. Depending on the location and load of the inertial forces, an 
axon may become swollen down almost its entire length (Chen et al., 1999), 
hypothetically as a consequence of a more uniform stretch rather than one with a 
focus at a specific point 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Astrocyte invasion to DAI affected locations is seen at 1 day and myelin is 
observed to visibly disintegrate and “clump” around 7 days post-TBI alongside 
phagocytic cell invasion (Mac Donald et al., 2007). Findings from studies which use 
techniques such as Diffusion Tensor Imaging (discussed further in section 2.3) have 
1 
2 
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6 
Figure 1.2. A series of immunoflourescent microscope images demonstrating an axon undergoing 
stretch injury. Following initial damage, the axon first takes on an undulating appearance, before 
returning to its initial appearance via a delayed elastic process. Finally, an axonal bulb is seen 
developing. Time progression is indicated by numbers. The time between the first and last image is 
approximately 2 hours. Figure adapted with permission from Smith & Meaney, 2000. 
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also suggested that by the chronic time point the myelin sheath may completely 
disintegrate in damaged areas (Song et al., 2003). This further implies that DAI may be 
severe enough to cause damage to the myelin, but mild enough to spare the axon.          
1.7 Secondary Physiological Complications from DAI and Focal Damage 
While the exact cause of damage in focal injury and DAI is different from one 
another, and the immediate physical injury is distinguishable, it should be noted that 
each injury may lead to the same delayed responses. These represent a collection of 
symptoms and changes which are more generally associated with any insult to the 
brain. TBI patients may therefore also present with the phenomena described in this 
section.  
Alterations in cerebral blood flow are common and most often take the form of 
hypoperfusion (decreased blood flow) leading to possible ischemia (Bouma et al., 
1992) which may last for days following the injury; one study reports that 37% of 
severely injured patients suffered low brain tissue oxygenation levels at 2 hours post 
injury, decreasing to 18% after 2 days of treatment (Narotam et al., 2009). Ischemia is 
associated with very poor outcome for the patient and is therefore most frequently 
seen in cases of more severe injury (Inoue et al., 2005).  Hyperperfusion (increased 
blood flow) may also been seen, albeit to a lesser extent (Werner and Engelhard, 
2007). Some research has indicated that hyperperfusion is associated with less severe 
injury and acute injury symptoms (Sakas et al., 1995). Other research has shown that 
while it also predicts a good outcome in many patients, it may also lead to severe 
complications in others due to associated vasoparalysis (Kelly et al., 1997). In these 
cases it is hypothesised that hyperperfusion may therefore variably represent either an 
appropriate functional response to injury in good outcome patients, or a dangerous 
disconnect between blood flow and metabolic need in poor outcome patients (Kelly et 
al., 1997). 
Metabolic functioning is sometimes seen to be impaired leading to a reduction 
in oxygen and glucose consumption, and a reduction in local concentrations of ATP 
(Glenn et al., 2003). This appears to occur as a result of mitochondrial dysfunction 
(Verweij et al., 2000). Hyperglycolysis (increased metabolic uptake of glucose) has also 
been found in locations close to focal injury (Bergsneider et al., 1997). This is thought 
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to occur as a consequence of local ionic inbalances (Bergsneider et al., 1997), and may 
cause further damage to axons if cerebral blood flow does not adequately increase to 
match this increased energetic demand (Chen et al., 2004).  
Excitotoxicity, where an overabundance of excitatory neurotransmitters such 
as glutamate cause neuronal damage through overstimulation (Rothman and Olney, 
1987), is also known to occur following a TBI (Bullock et al., 1998).  Here, the increased 
levels of neurotransmitters leads to increased catabolism of them, which in turn 
causes cellular damage as neurons allow toxic amounts of calcium ions to enter them, 
leading to cell death (Yi and Hazell, 2006). A further influx of calcium and sodium due 
to ion exchange disruption following damage to the sodium channels may also be seen 
(Wolf et al., 2001), while caspase-3 mediated apoptosis has been observed to be 
initiated by 1 day post-TBI (Yakovlev et al., 1997). As apoptosis is an energetic process 
(Liu et al., 1996), if the damaged location does not have access to sufficient ATP then 
necrosis of cells occurs (Andriessen et al., 2010). Interestingly, necrosis has been seen 
to increase in the presence of increased extracellular glutamate (Ankarcrona et al., 
1995) while intracellular calcium may have a mediating role between which of necrosis 
or apoptosis occurs wherein relatively low levels of the ion favour apoptosis and 
relatively high levels favour necrosis (Zipfel et al., 2000).  
Oedema (intracranial swelling due to increased fluid) is also common. This may 
take the form of vasogenic (Dewitt and Prough, 2003) or cytotoxic (Unterberg et al., 
2004) oedema. Vasogenic oedema is characterised by an increase in fluid, ion and 
protein transfer from the endothelial junctions of the blood-brain barrier to the 
extracellular space within brain tissue. Conversely, cytotoxic oedema is characterised 
by increased water concentration in the intracellular space of brain cells such as 
neurons and astrocytes which occurs as a consequence of increased cell membrane 
permeability and a failure in ATP production (as a possible consequence of hypoxia 
(Heo et al., 2005)) meaning the cell lacks the energy requirement to adequately pump 
ions out into the extracellular space (Liang et al., 2007).  
Finally, inflammation may also occur. This is initiated first by an increase in the 
release of various pro-inflammatory cytokines in response to tissue injury, which in 
turn recruit and activate a variety of other molecules and cells (chemokines, 
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macrophages, astrocytes and other “immune cells”), resulting in inflammation 
(Rothwell and Luheshi, 2000, Lucas et al., 2006). These cells and molecules may be 
endogenous to the brain (e.g. astrocytes (Pekny and Nilsson, 2005)) or exogenous such 
that they are part of the body’s broader immune response (e.g. neutrophils (Clark et 
al., 1994)). It is due to these inflammatory processes that damaged tissue is destroyed 
within days. Of particular note here is astrogliosis; the migration of reactive astrocytes 
(a form of glial cell) to the site of damage (Pekny and Nilsson, 2005). In many cases 
these cells remain, effectively causing a lasting scar which is widely acknowledged as 
being a barrier to effective chronic recovery as it impedes reinnervation (Lucas et al., 
2006, Rudge and Silver, 1990, Frisen et al., 1995). However research studying 
transgenic mice has also shown astrogliosis to have important therapeutic effects as 
the absence of it leads to a considerably worsened physiological outcome in terms of 
demyelination, cell death and blood-brain barrier disruption (Faulkner et al., 2004).  
1.8 The Effects of TBI on the Patient 
 Outcome following TBI is very variable both in terms of on-going symptoms and 
their severity. Patients may experience long term cognitive and / or physical disability 
that may in turn impact further on their mental wellbeing (e.g. depression may follow) 
and their social life. There is increased risk of suicide, unemployment, divorce and 
substance abuse following TBI (Ragnarsson et al., 1999). As it is possible for any area of 
the brain to be damaged, it is possible for a wide range of neurologically-based 
symptom to develop. However, as alluded to, focal and diffuse damage contribute to 
deficits in different ways.  
Because of its focus in major white matter tracts, DAI is hypothesised to 
contribute to cognitive dysfunction through disruption of cortical networks, interfering 
with communication between functionally-dedicated neural regions coined 
“nodes”(Mesulam, 1998). It should therefore be thought of differently to cognitive 
dysfunction caused by focal injury, where the driving factor of the impairment is likely 
to be a specific node becoming unable to perform its function following damage to it. 
Determining which of these mechanisms is causing dysfunction in TBI patients can be 
challenging, as both focal and diffuse damage is likely to have occurred. Nevertheless, 
studies on mild and moderate TBI patients (e.g. (van der Naalt et al., 1999)) and others 
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conducted on cases of “pure DAI” (e.g. (Scheid et al., 2006)) have frequently found 
psychological problems, indicating impairment to exist in all injury severities, and 
supporting the hypothesis of lasting DAI-induced impairment following a TBI, with or 
without focal damage. While every injury is undoubtedly individual and different, the 
somewhat predictable nature of DAI in terms of primarily susceptible locations means 
that aspects of network disruption might share a common pattern between different 
patients. 
As also alluded to previously, short term impairment following injury is 
commonly seen in the forms of loss of consciousness (LoC) and post-traumatic amnesia 
(PTA, sometimes referred to as “post-concussive syndrome”, (Annegers et al., 1998)). 
Although research has put forward the notion that these symptoms should not 
necessarily be required for a diagnosis of head injury (Servadei et al., 2001), and that 
clinical attention must still be paid to patients who have no experienced these (Smits 
et al., 2007), they are still both regularly found even in TBI patients with a GCS of 15 
(Batchelor and McGuiness, 2002). As previously discussed in section 1.2, some 
research considers either of both of these as criteria for grading severity of injury in 
patients.  
The definitions of LoC and PTA are arguably best described with reference to 
scales which attempt to grade them. The Galveston Orientation and Amnesia Test 
(Levin et al., 1979) is one of the most widely used of these. By this scale, LoC is 
essentially a state of coma prior to PTA, while PTA then describes the brain moving 
from a total lack of consciousness into an altered state of one on the way to being fully 
aware again. During PTA the patient may be unable to form new memories and 
therefore may not later recall this time (Rao and Lyketsos, 2000, Russell and Smith, 
1961). When the patient regains “normal consciousness” the PTA is deemed to have 
resolved (ignoring any more permanent cognitive deficits the patient may have 
sustained). It is unsurprising that LoC and PTA correlate with severity of injury, and are 
also risk factors for the development of subsequent problems such as seizures 
(Annegers and Coan, 2000). While the differing ways that LoC and PTA are considered 
in defining injury severity means that such comparisons are somewhat tenuous, as an 
approximation LoC rarely lasts longer than 15 minutes while PTA rarely lasts longer 
than an hour in mild TBI (Smits et al., 2007). However in more severe cases these 
16 
 
durations can extend to weeks and months if the patient falls into a significant coma 
(Tate et al., 1991), while a patient in a vegetative state may be considered to never 
recover from them.    
Long term issues following a TBI can be broadly separated into two groups; 
physical problems and cognitive problems. Headaches, pain, dizziness, visual 
impairment and (more rarely) epilepsy are typical physical issues (Arciniegas et al., 
2005). As discussed, cognitive dysfunction is directly attributable to the locations of 
the brain which have become damaged, be they white matter tracts or focal locations. 
Despite the implied variability which can occur from this (and indeed, every case is 
different) certain symptoms are common following TBI. These problems can be most 
broadly considered to involve issues surrounding executive function; attention, 
concentration, speed of information processing etc. (Arciniegas and Silver, 2006), 
although other symptoms such as depression (Silver et al., 2009) personality change, 
unstable emotions and the acquisition of affective / sleep disorders are also typical 
(Reeves and Panguluri, 2011). Severity of symptoms typically increases alongside 
severity of injury (Dikmen et al., 2009).  
1.9 Recovery from TBI 
Similar to many cases of cognitive disruption, patients often recover a degree 
of function following a TBI. While many mildly injured patients do suffer from chronic 
problems, they have a better prognosis than those with a severe injury. Indeed, while 
some research reports that approximately half of mild patients see a “full recovery” by 
1 month post-TBI (Silver et al., 2009), other research which focuses on severe patients 
typically report much higher levels of chronic disability with two thirds of patients still 
experiencing significant cognitive, behavioural and emotional problems two years 
post-injury (Ponsford et al., 1995). Other studies (as previously outlined) estimate that 
approximately half of TBI patients in each severity bracket (i.e. mild, moderate and 
severe) experience some form of chronic disability (Thornhill et al., 2000). 
While a substantial recovery within weeks following a TBI is likely due to the 
resolution of temporary factors such as contusion and oedema, the mechanisms 
underpinning long term recovery are more complex. Pharmacological intervention can 
be useful to help the patient on a symptom-by-symptom basis (e.g. prescribing SSRI’s 
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to help with depression (Fann et al., 2009), while both experience of living with their 
deficits and other rehabilitation techniques can lead to the patients developing 
effective coping strategies (Cicerone et al., 2006). Examples of these include cognitive 
exercises to improve specific skills, being trained to use compensatory objects such as 
a memory book, and psychotherapy to assist with the burden that the patient’s injury 
might be placing on their own mental wellbeing and family members (Ragnarsson et 
al., 1999). There is also substantial evidence that the brain physiologically reorganises 
neural networks to avoid using damaged locations, similar to other neurological 
conditions who’s pathology causes cognitive impairment (be they the functionally 
specific nodes as would be implicated in a focal injury, or parts of white matter tracts 
as would be implicated in DAI, (Castellanos et al., 2011, Buldu et al., 2011, Castellanos 
et al., 2010)).  
1.10 TBI Summary 
 TBI is a common and debilitating condition. It results in a decreased standard of 
life for patients at all injury severities, and as such also places a major, long-term 
burden on healthcare systems worldwide. Even though mild TBI accounts for 
approximately 80% of all cases, it remains understudied within the literature. It is 
therefore of paramount importance to better understand the exact means by which 
injury to the brain is sustained in mild TBI, and how this affects the cognitive outcome 
of a patient. Doing so will lay the foundation for more effective treatment strategies to 
be developed. 
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Chapter 2. Imaging TBI and DAI 
2.1 Imaging TBI: The Principles of MRI 
Magnetic Resonance Imaging (MRI) is an important imaging technique for both 
diagnostic and research purposes. Like any imaging methods, the crux of MRI imaging 
is in generating contrast so that useful images can be produced. MRI exploits how 
different tissues respond when placed in a magnetic field and subjected to pulses of 
radio waves. In more depth, the technique works on the theory that when placed in a 
strong magnet, the magnetic moment of hydrogen atoms (the main component of 
water) in the body will align along the magnetic field. If energy is given to the atoms in 
the form of a radio frequency pulse (RF), the atoms will be knocked off of this 
alignment before gradually returning to the equilibrium state (“relaxing”) when the 
pulse stops. As different tissues have different compositions some achieve this re-
alignment faster than others. At the same time this shift in alignment creates magnetic 
flux which can be detected via changing voltages in receiver coils. Simple images can 
be formed by using the differences in relaxation time to modulate the detected signal 
level, providing contrast between different tissue types. MRI was first used in an 
attempt to detect cancerous tumours by examining differing magnetic relaxation times 
in 1971 (Damadian, 1971) before another pioneering experiment in 1973 used this 
contrast to produce an image (Lauterbur, 1973).  
The MR signal has three main properties which can be manipulated in order to 
gain different types of information about the subject being scanned. The first of these 
is proton density (PD), which refers to the density of water molecules (more water 
means more hydrogen atoms to generate a stronger signal). The relaxation times T1 
and T2 refer to the rate at which the protons return to alignment along the magnetic 
field. T1 refers simply to the time for the atoms to return to full alignment along the 
magnet field, while T2 instead defines the rate at which the signal “dephases” due to 
interactions between different atoms; these interactions between them mean that 
they start to precess at different rates which affects the net magnetisation. 
Each of these factors can be used to produce image contrast. This is achieved 
by manipulating scanner variables to enhance the signal from the factor of interest and 
supress signal from the other two. The main scanner variables we can control to do 
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this are; the length of time between consecutive RF pulses (called TR), the length of 
time we wait from an RF pulse to when we take a signal measurement (called TE) and 
the strength / timing / direction of different magnetic gradients that are applied to the 
subject during scanning (called the b value).  Thus, a PD image would show greater 
intensity in areas of higher water content. A T1 weighted (T1W) scan is adept at viewing 
basic anatomy of the brain and showing areas of fatty tissue. A T2 weighted (T2W) scan 
is adept at showing areas of pathology in the brain such as white matter lesions and 
oedema. While these scan types represent some of the most basic forms of MRI 
images, manipulation of other factors can be used in more advanced means to create 
“advanced MRI images”, as described below.  
2.2 Advanced MRI and DAI 
The identification and diagnosis of DAI following TBI is difficult due to its 
microscopic nature. While CT remains the standard scan for assessment of TBI patients 
(NICE guidelines (2014)) and is effective in detecting focal damage, it is not well 
equipped to detect DAI compared to some other scan techniques. These often attempt 
to use biomarkers as a means of identifying pathology (Bazarian et al., 2007). One of 
the most popular of these alternative methods is the advanced MRI technique of 
Diffusion Tensor Imaging. 
2.3 Diffusion Tensor Imaging 
Diffusion tensor imaging (DTI (Basser et al., 1994)) is an MRI technique that 
uses water molecule movement to provide quantitative information regarding the 
microstructure of the brain in vivo. DTI uses the diffusion coefficient of the MR signal 
to produce image contrast, unlike more conventional MRI scan types which (as 
described) typically use relaxation times instead. In simpler terms this means that the 
diffusion-behaviour of water molecules in the brain is quantified and used to produce 
images which visualise the structural orientation of different brain tissues. This is most 
often used to "image" and analyse the brain's white matter tracts.  
As stated DTI works by using the diffusion coefficient of MR scans for image 
contrast. As the MR signal is primarily produced from water molecules, the amount 
that water diffuses during a scan time through random thermal motion (or "Brownian" 
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motion; approximately 10μm with the timeframe of a typical MR measurement (10-
100ms, (Mori and Zhang, 2006)) is another aspect of the MR signal. While this impedes 
standard anatomical MR scans by fundamentally limiting the resolution which can be 
achieved (effectively introducing blurring beyond a certain, extremely-high resolution 
point), DTI instead exploits this motion by creating an image of this diffusion. This one 
image is achieved by creating two images. The first of these is of the subject (a brain) 
under a strong, linear magnetic gradient, creating a phase difference as atoms 
resonate at different frequencies depending on their position along this gradient. This 
differing rate of precession can be calculated as the “Larmor frequency” using the 
Larmor equation (Equation 1, below), by knowing the scanner bore strength and the 
gyromagnetic ratio of different elements (the frequency of a specific element in a 
magnetic field strength of 1T). A second image is then acquired when an opposite 
gradient of the same strength is applied for the same period of time.  
  
       
 
 
In a hypothetical situation where all atoms in the brain remained static, this 
opposite gradient would cancel out the phase difference from the first, rephasing all 
the atoms perfectly. However, as water diffuses, atoms of different initial phases 
become "out of place". This makes the rephasing of the second gradient imperfect, 
which in turn leads to a signal loss in the second image compared to the first. 
Therefore, by subtracting one of these images from the other, diffusion-based contrast 
is produced. While doing this once only gives information regarding one linear 
direction, it can be repeated using multiple different gradient alignments, gaining 
diffusional information of the brain in a three dimensional space. With a minimum of 
six directions (although ideally many more would be used), this data may then fitted to 
the "diffusion ellipsoid" (Figure 2.1, (Basser et al., 1994)); a mathematical model which 
allows the direction and extent of water diffusion to be visualised in a three 
dimensional space. Each voxel from a DTI image is essentially one of these ellipsoids.  
Equation 1. The Larmor equation; the relationship between the rate of precession of a proton 
( ), the gyromagnetic ratio (γ) and the magnetic field strength ( ). 
[1] 
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As the diffusion of a water molecule will be determined by its surrounding 
structure (it will not be able to diffuse far into the wall of an axon, but will diffuse 
relatively unimpeded down the length of one) this data is capable of producing images 
of the brains microstructure. Further, as comparisons between scans of the brain in 
vivo and in vitro produce similar results, it can also be concluded that DTI 
predominantly detects fixed microstructure and not physiological processes (Sun et al., 
2005). Basic images of the brain produced by this method therefore show tissue 
directionality as indicated by the principle direction which water diffuses in (or the 
water's "anisotropy"). An example of this is given below in Figure 2.2, where a 
computer program has produced a 3 dimensional representation of the brain’s fibres 
based on the underlying water diffusion. 
 
 
 
λ1 
λ3 
λ2 
Figure 2.1. The diffusion ellipsoid. This shape visualises the nature of water diffusion in a voxel and is what DTI 
data is transformed into.  The shape is defined by three directions (the arrows in the figure) which describe the 
direction and extent of water diffusion in a three dimensional space. The directions are referred to as 
eigenvectors while the magnitude's of diffusion in these directions are eigenvalues (or  λ1, λ2 and λ3). λ1 
always described the largest magnitude, while λ2 and λ3 are placed perpendicular to λ1. 
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This method is called tractography and is primarily used to visualise the brain’s 
white matter tracts. Methodologically this is achieved by locating adjacent voxels 
where the anisotropic magnitude is sufficiently large to indicate a surrounding 
structure and the principle directions of anisotropic are aligned, indicating a 
continuous structure, i.e. a nerve fibre tract. Researchers have used this technique for 
projects such as creating atlases of the brains major white matter tracts (Wakana et 
al., 2004). 
Quantitative measurements can be extracted from this method allowing for 
statistical analysis. These are referred to as metrics. One widely used example of these 
is Mean Diffusivity (MD). This is the average of the diagonal terms of the diffusion 
tensor; describing the diffusion characteristics of the while ignoring direction. 
Theoretically, this would be a low figure in locations which contain a large amount of 
structure and would increase as this structure is lost. The Apparent Diffusion 
Figure 2.2. A tractographic image of the brain in sagittal view, created using data collected in this 
Thesis (described in Chapter 5). The structures seen are the calculated nerve fibre tracts. In this 
instance colour is provided purely for aesthetic detail, although is often used as a means of 
indicating tract direction. 
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Coefficient (ADC) is sometimes used as an alternative and is very similar to MD, being 
instead calculated as the average of 3 single orthogonal measured directions. Thus, 
MD and ADC results are the same in purpose and largely identical in methodology. 
They are considered comparative and are both referred to as “MD” following this 
point.  
Further metrics are more directly based on the ellipsoid shape. As λ1 describes 
the direction where water diffuses to the greatest extent, this eigenvalue is often 
interpreted as being indicative of a water molecule diffusing down the cylinder of an 
axon (whereas λ2 and λ3 would then describe water diffusing into the sides of the 
axon). λ1 can be therefore referred to as the Axial Diffusivity (AD), while λ2 and λ3 can 
be averaged to describe diffusion in a radial direction, referred to as Radial Diffusivity 
(RD, see Figure 2.3). When examining diffusion in an axon AD is relatively unrestricted 
compared to RD, as diffusion in the radial direction is impeded by the myelin sheath 
(Song et al., 2003). Measures of anisotropy can then be derived from the Eigen values, 
the most commonly used being Fractional Anisotropy (FA). FA is a number between 0 
and 1 which describes how unidirectional water diffusion is (higher numbers indicated 
higher anisotropy). These principles are outlined in Figure 2.3, overleaf. 
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2.4 DTI in TBI 
Though DAI can be detected with T2-weighted MRI (Scheid et al., 2003), it is not 
easily imaged by standard MRI and CT due to its microscopic nature and is often 
overlooked by such scans (Smith et al., 1995). DTI has been proposed as a useful, in-
vivo method of investigating DAI following TBI (Huisman et al., 2004), using changes in 
DTI metrics to assess the extent of axonal injury. In this view, a “healthy” axon is 
deemed to have a self-containing structure and purposeful direction, giving it high 
anisotropy. However a DAI-damaged axon will have either experienced acute trauma, 
or will be undergoing Wallerian degeneration in the more chronic time-frame. Such 
Figure 2.3. A diagram to demonstrate the calculation of DTI metrics. In this case a hypothetical axon is 
used for the example. Eigenvectors λ1, λ2 and λ3 can be examined to describe Axial Diffusivity (AD; λ1) 
or Radial Diffusivity (RD; λ2 & λ3).  
 
Fractional Anisotropy (FA) can be derived from these by the formula (Equation 2):  
 
 
Mean diffusivity (MD) can be calculated by using the diagonal terms of the diffusion tensor via the 
formula (Equation 3): 
 
 
 
 
 
 
λ2 
λ3 
λ1 
[2] 
[3] 
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events hypothetically increase its MD and lowering its FA as events such as axonal 
disconnection and demyelination occur and affect AD and RD.  
Broadly speaking, there are two main approaches to analysing DTI data. In one 
case software can be used  to place a Region of Interest (ROI) on a DTI scan to then 
extract information about the fibres which run through the specified area (e.g. (Bigler 
and Bazarian, 2010)). Alternatively, the brain can be analysed as a whole by spatially 
normalising the scans of the participants to remove intra-subject variation in brain size 
and shape and then comparing data voxel-to-voxel (e.g. (Kinnunen et al., 2011)). The 
ROI approach represents a focal investigation and has seen the most experimental use. 
It provides high statistical sensitivity within the ROI, although lacks the analytic scope 
of a global technique and needs an a-priori hypothesis regarding a specific location to 
be used effectively. The voxelwise approach represents this global alternative, being 
advantageous in that it can statistically analyse the whole brain, making it effective for 
exploratory analyses. However the additional normalising processing which takes place 
between participant scans means the data in the shared standard space may become 
slightly warped (although this is a common methodological caveat in MR research). 
Ultimately the best method to use will likely depend on the research question.  
The past 13 years have seen an increasing amount of research being conducted 
in this area (Hulkower et al., 2013), leading to recent research claiming that DTI has 
become "the most sensitive and predictive MRI biomarker in mild TBI research" (Bigler, 
2013). Most overlooked however is the inclusion of patients in the acute phase of 
injury (<2 weeks, although this is understandable due to the complications of 
recruiting patients within this timeframe), and examination of mild patients in the 
chronic phase of injury. Longitudinal research is also relatively lacking within the field, 
meaning that assumptions regarding the behaviour of DTI metrics at different time-
points are primarily formed by piecing together work from different experiments / 
patient groups. Further issues include areas of change in the brain following TBI may 
often be missed due to most reports using a ROI approach and also a relative lack of 
data concerning AD / RD alterations in favour of reporting FA alone. With these 
methodological drawbacks, it is best to consider the changes caused by TBI by collating 
results from the literature rather than focusing on individual studies.  
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Acutely, MD does not present a clear picture of change. Reports can be found 
of increasing (e.g. (Inglese et al., 2005, Miles et al., 2008, Lipton et al., 2009)), and 
decreasing (e.g. (Wilde et al., 2008, Naganawa et al., 2004)) MD. Chronically however, 
there are a striking number of papers which demonstrate a MD increase (e.g. (Rugg-
Gunn et al., 2001, Rutgers et al., 2008, Newcombe et al., 2010)) to suggest that 
elevated MD is the expected long term change from TBI. There is a trend that 
decreased MD is a result primarily limited to studies in acute, mild patients (e.g. (Wilde 
et al., 2008, Chu et al., 2010)). MD primarily increasing supports the hypothesis that 
DAI-affected locations generally lose integrity and structure. As cases in which MD 
decreases are mostly acute and mild, the decrease could be driven by phenomena 
such as astrogliosis (Budde et al., 2011), or the formation of oedema which is thought 
to decrease MD acutely (Barzo et al., 1997). Ischemia has also been shown to decrease 
MD acutely which could contribute to this in some cases (Vangelderen et al., 1994).  
FA is the most frequently investigated metric, and is very reliably found to 
decrease following TBI (e.g. (Kumar et al., 2009, Lipton et al., 2009, Matsushita et al., 
2011)). However there are some cases which contradict this by reporting an elevation 
in FA, which are often associated with the same patients who exhibit a decrease in MD 
(e.g. (Bazarian et al., 2007, Wilde et al., 2008)). These cases are again in primarily 
acute, mild patients. It has also been shown that following an acute increase, FA may 
normalise over a period of 3-5 months (Mayer et al., 2010). 
RD is seen to reliably increase following injury (e.g. (Sidaros et al., 2008, 
Arfanakis et al., 2002, Newcombe et al., 2007)) while unexpected decreases have 
occurred only in the same papers which demonstrated an unexpected increase in FA. 
Papers which have examined AD primarily report it as being unchanged (e.g. 
(Newcombe et al., 2007, Ljungqvist et al., 2011, Ewing-Cobbs et al., 2008)) while 
increases (Kraus et al., 2007) and decreases (Arfanakis et al., 2002) are reported in 
fairly similar quantities. As with other metrics however, a more reliable pattern is seen 
in chronic cases where AD convincingly increases (e.g. (Sidaros et al., 2008, 
Caeyenberghs et al., 2010, Newcombe et al., 2010)) in a majority of cases.  
To summarise these anisotropy results, the reliable finding of an FA decrease 
after TBI supports the notion of general disruption of axons, reducing directionality. 
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This appears primarily driven by a fairly reliable increase in RD, likely itself caused by 
the disintegration of the myelin sheath. Cases in which FA increases are the same as 
those where RD decreases and appear to occur in acute, mild TBI subjects. One of 
these papers (Wilde et al., 2008) shows FA to decrease in only 2 of 10 mild (GCS 15) 
subjects, but notes that these were the patients examined at the furthest point post-
TBI (4 and 6 days). This suggests that an FA increase is perhaps a phenomenon of the 
mild, very acute TBI patient. Conclusions regarding what drives this change are difficult 
to form. One hypothesis (Chu et al., 2010) is that the formation of oedema can drive 
FA up in parallel with the MD decrease. This is hypothesised to be due to water moving 
from the extra-cellular space to the intra-cellular space; as extra-cellular water is 
primarily detected in DTI the decreased amount of this leads to decreased MD (Barzo 
et al., 1997). Alternatively it is possible the injury and current after-effects are so slight 
that axons are compressed by the accident rather than strained (Wilde et al., 2008). 
AD also contributes to the FA change with its more variable nature representative of 
the greater number of events which can occur axially; bulb formation, disconnection 
and direct shearing (Polvishock & Katz, 2005) in more severe cases could all imply 
different outcomes for the measure. Indeed, a further hypothesis regarding acute 
increases in FA states this it could be a result of astrogliosis, whereby the long 
processes of invading astrocytes confer increased AD and thus increased FA to the area 
(Budde et al., 2011). Ultimately though, it appears that when the brain stabilises 
chronically AD becomes predictably increased.  
It is cases that both acute and mild which generally introduce the most 
variability to these patterns. This is likely due to both the multitude of initial immune 
responses and their proportionate relationship to injury severity. Chronically, patients 
settle into a predictable pattern of increased MD and decreased FA, which is driven 
primarily by increased RD and AD. It should be noted that mildly injured patients still 
show more variability than severely injured patients in the chronic phase of injury, 
although tend to conform to the pattern described. This is suggestive of neuroanatomy 
with decreased structure due to neuronal death and demyelination. These changes are 
summarised in Table 2.1, below. 
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Attempts to link DTI findings to cognitive outcome have also yielded results, 
suggesting that these metrics can be valid markers of damage. One paper (Salmond et 
al., 2006) found positive correlations in chronically injured patients of mixed injury 
severity between MD and measures of learning and memory in the posterior cingulate, 
hippocampus and temporal, frontal and occipital cortices. Also using chronically 
injured patients of mixed injury severity, another paper (Kraus et al., 2007) employed a 
unique technique termed “white matter load”; the number of their 13 ROI’s with 
reduced FA compared to controls. This was found to correlate to cognitive domain 
scores (summarised scores of multiple individual tests which examine the same, more 
general cognitive function) of executive function and memory, while individual ROI’s 
also showed a large variety of correlations with executive, memory and attention 
domain scores. Further research into mildly injured patients (Miles et al., 2008) 
examined if acute DTI metrics held any power in predicting psychological outcome at 6 
months. One correlation was found between averaged acute FA values from the centra 
semiovale / CC / posterior internal capsule and the “Prioritization form B” test (a test 
of an individual’s ability to prioritise).  
Other work (Little et al., 2010) using another “cognitive domain” approach in 
patients of varying injury severity and time since injury found positive correlations 
between FA in the thalamic tracts and cognitive test scores. While these papers thus 
far used ROI methodology, voxelwise investigations into links between DTI metrics and 
cognitive impairment have more recently surfaced. One of these (Kinnunen et al., 
 MD Mild MD Severe FA Mild FA Severe AD Mild AD Severe RD Mild RD Severe 
Acute Variable     Variable Variable  
Chronic       Variable  
Table 2.1. A Table to demonstrate the changes in DTI metrics following TBI, separated by time since injury and 
injury severity. An arrow indicates that an increase/decrease as a result of TBI in that metric is the most frequently 
reported result, a flat line indicates that no change is the most frequently reported result and “Variable” indicates 
that there is no clear pattern of change reported. 
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2011) used a chronic patient cohort of mixed injury severity and found a correlation 
between FA in the fornix and associative memory in addition to discovering that 
performance on the set-shifting task (a test of executive function) was correlated to 
MD and RD. The directions of all the relationships highlighted here, as well as others 
which have been reported (e.g. (Arenth et al., 2014), are suggestive of greater injury as 
measured by DTI (i.e. decreased FA / increased MD) to underlie greater cognitive 
dysfunction. 
2.5 Magnetic Resonance Spectroscopy 
 Magnetic Resonance Spectroscopy (MRS) is another magnetic resonance 
technique that can be used to investigate TBI by quantifying changes in neural 
metabolite levels. MRS exploits the principle that atoms resonate at slightly different 
frequencies depending on their local (chemical) environment. This phenomenon can 
be manipulated to create plots of signal frequency or “chemical shift” mapped against 
signal intensity - the MR spectrum. Chemical shift essentially represents a range of 
frequencies, the value of which are dependent on both the differing atomic nuclei 
which they originate from and also the B0 strength of the scanner. By referencing the 
shift to the Larmor Frequency of the scanner a new value is created known as "parts 
per million" (ppm), allowing for different atoms to be distinguished from one another. 
The presence of a metabolite can therefore be detected in MRS by the identification of 
a resonance peak at the metabolites known ppm. The size of the peak can also be used 
to assess the concentration of the metabolite (via the area underneath the peak; the 
“peak integral”) or can be expressed as a ratio in comparison to the peak integral of 
other metabolites.  
MRS methodology typically employs voxels of interest (VOI’s) in order to avoid 
saturation from very strong lipid signals which are present in the skull. Alternatively 
post-scan manipulations such as spatial encoding and lipid saturation may be applied 
to address this. Regardless of which of these techniques are applied, analysis of MRS 
data usually then involves investigating metabolite concentrations in pre-defined 
VOI’s. As the concentration of water in brain (>50 molar) is many orders of magnitude 
larger than the concentration of metabolites (millimolar quantities), large areas of 
tissue must be sampled in order to gain a reliable metabolite signal. MRS therefore has 
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a relatively large spatial resolution with sampled volumes usually being at least 1cm3, 
and often more. MRS studies can be divided by use of single voxel or MR spectroscopic 
imaging (MRSI) methodology. The single voxel approach acquires it’s spectrum from 
one relatively large voxel (2-3cm3), while MRSI instead employs imaging gradients to 
localise the signal to a matrix grid, increasing its resolution but requiring more time to 
complete (Marino et al., 2011). Repositioning a large VOI in a longitudinal investigation 
can present difficulties also as the brain is likely to have changed in structure over 
time. However this is primarily problematic for studies obtaining spectra from the site 
of the injury as partial volume of normal tissue is likely to change; many studies use 
the same location (e.g. frontal white matter) as a VOI across all patients. 
2.6 MRS in TBI 
MRS is popular in TBI research due to its uses in quantifying metabolites 
relevant to neural functioning / damage in vivo. The common objective of doing this is 
to investigate TBI using metabolite concentration as a biomarker; analysing the 
concentration of specific metabolites between different experimental groups (e.g. 
controls vs. patients) or against other values of interest (e.g. psychometric test scores) 
to gain insight into way that TBI affects brain functioning. The most commonly studied 
of these are N-acetylaspartate (NAA), Choline (Cho), Creatine plus Phosphocreatine 
(Cr) and Lactate (Lac). Myo-inositol (mI) and glutamate/glutamine (Glx, see Lin et al., 
2005) have also been studied, albeit to a lesser extent. The appearance of a typical 
MRS spectra as well as the locations of these peaks is demonstrated in Figure 2.4, 
below. 
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Reported directions of changes in metabolites are relatively consistent 
following TBI. Of the metabolites described, N-acetylaspartate (NAA) arguably attracts 
the most focus despite its exact purpose in the mature brain being one of intense 
debate. It is known to have a direct relationship with the mitochondrial synthesis of 
ATP and is found almost exclusively in neurons of the CNS (Bates et al., 1996). The 
combination of these facts means it is variably viewed as a marker of cell viability or of 
general neuronal density (Moffett et al., 2007). Acutely, NAA has the most predictable 
alteration with a multitude of studies reporting a decrease following TBI (e.g. 
Figure 2.4. A MRS spectrum demonstrating key metabolite locations. This spectrum was acquired from 
patient data used in this thesis. The MRS sequence used a slice selective short-TE MRSI technique with 
a TR of 3450ms, TE of 35ms, 10x10x18mm voxels (24x20 matrix, 5 slices, 18mm thick, 1 average, 1024 
samples and a spectral bandwidth of 2500 Hz) 
NAA 
Cre 
Cho 
mI 
Glx 20Lipid / 
Macromolecules 
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(Nakabayashi et al., 2007, Tollard et al., 2009, Vagnozzi et al., 2010, Garnett et al., 
2000b)). NAA levels appear related to time since injury, frequently demonstrating a 
“recovery”; after being significantly decreased compared to controls at 3 days, NAA 
was demonstrated to return to control levels by 30 days post injury in a mild patient 
cohort (Vagnozzi et al., 2010). In a severe patient cohort, NAA levels were shown to 
decrease over time to become significantly lowered compared to controls at 10 days 
post injury, before they recovered to control levels in good outcome patients by 40 
days (Signoretti et al., 2008). Such recoveries are more common in milder injury. Cases 
where NAA remains low over time (e.g. (Garnett et al., 2000a)) tend to have a more 
severe patient cohort and it has also been shown that patients who died following 
injury had significantly lower NAA than patients who lived (Belli et al., 2006). Other 
research such as a case study at 21 months post-TBI (Danielsen et al., 2003) is 
suggestive that even with severe injury the recovery may still occur if enough time is 
given. It is not a reasonable assumption however that this recovery represents an 
increase in the number of neurons to control levels. It is instead hypothesised that the 
drop in NAA is due to supressed mitochondrial activity while the recovery is able to 
occur after the brain establishes a normal output of ATP molecules (Vagnozzi et al., 
2010).  
The metabolites found at the Choline peak (Cho, primarily phosphorylchloine 
and glycerophosphocholine (Miller et al., 1996)) are known for their membrane-
related roles, such as being released as a product of inflammation (Brenner et al., 
1993). Cho is reported to increase following injury, although this is not as predictable a 
change as the decrease of NAA. While this increase is often reported (e.g. (Govindaraju 
et al., 2004, Marino et al., 2007, Sarmento et al., 2009)), results in which Cho levels do 
not change appear almost as frequently (e.g. (Vagnozzi et al., 2010, Signoretti et al., 
2008, Kirov et al., 2007)). Chronic and longitudinal investigations have suggested that if 
Cho does increase, it is not subject to the normalisation that NAA demonstrates. One 
study examined patients at an average of 7 days and then a year later, finding Cho 
levels to be increased at both time-points (Holshouser et al., 2006). Longitudinal 
investigations have also supported the idea that a Cho increase can be relatively 
delayed; Cho in TBI patients compared between acute (up to 35 days) and chronic (up 
to 10.6 months) time points was found to increase between the conditions (Garnett et 
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al., 2000a). Considering injury severity, while there appears to be a slight trend for Cho 
to be elevated more frequently in studies with severe patients, there is sufficient 
variability in this explanation from conflicting papers (e.g. severe injury but no Cho 
increase (Wild et al., 1999), or mild injury with a Cho  increase (Govindaraju et al., 
2004)) which complicated interpretation and understanding of the role of Cho as a 
biomarker for cellular injury. It therefore appears that the factors determining an 
elevation in Cho may not be strictly related to severity (i.e. “severity” at least as 
measured by the GCS), or that the specific form of damage caused by DAI may not 
reliably induce a change in Cho.  
The metabolites found at the Creatine peak (Cre, creatine and phosphocreatine 
(Ross and Sachdev, 2004)) function as parts of a transport network to link energy-
intensive sites with areas of ATP production (Wallimann et al., 1992). In TBI research, 
the Cre peak is used primarily as a stable reference point for ratio comparison with 
other metabolites, as it is broadly assumed to be stable due to an insensitivity to injury 
(Ross et al., 1998). Therefore, while it is measured as frequently as NAA and Cho, it is 
often not considered for statistical analysis. Despite this, research has demonstrated 
that its levels can vary with injury. A recent study (Yeo et al., 2011) focused on this 
point, finding Cre levels to be increased acutely before partially normalising chronically 
in a mild patient group. This is supported by other research which has found elevated 
Cre acutely in a mild group while also observing Cre to be correlated with cognitive 
function and emotional distress (Gasparovic et al., 2009). Cre has also been shown to 
be positively correlated with GCS in the chronic phase of injury, further indicating that 
the metabolite’s levels hold a relationship with TBI (Walz et al., 2008). The authors of 
one of these studies suggested that elevated acute Cre could indicate increased energy 
availability and expenditure for immune response and repair processes such as 
membrane pump upregulation (Yeo et al., 2011), basing this hypothesis on previous 
work which has shown that dietary supplements of Cre may have various (physical and 
cognitive) therapeutic effects following a TBI (Sakellaris et al., 2006, Sakellaris et al., 
2008, Sullivan et al., 2000). Results such as these are suggestive that Cre should be 
examined experimentally and that the use of Cre as a stable reference point in ratio 
analysis should be conducted with caution.  
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Lactate (Lac) is a product of anaerobic respiration; the presence of a Lac peak is 
considered a marker of hypoxic (or ischaemic) injury with research indicating it to be a 
product of altered glucose metabolism acutely (Hillary et al., 2007) and to primarily 
proliferate from macrophages chronically (Petroff et al., 1992) (N.B. this study was 
conducted in stroke patients), although compromised long term metabolism could also 
continue to produce Lac. Lac holds the same ppm as lipid and so these can be confused 
unless appropriate spatial saturation is used to eliminate extra-neural lipid signals 
during the acquisition process. The healthy brain does contain low levels of Lac, 
although these are not usually at sufficient concentrations to be detected by MRS (Lin 
et al., 2005). Thus, the analysis of Lac is different to that of other metabolites as 
investigations often look primarily for the presence of a Lac peak, opposed to a change 
in its quantity. Lac has been detected in a number of studies (e.g. (Marino et al., 2007, 
Makoroff et al., 2005, Holshouser et al., 2006)) and most frequently in ones using 
severely injured participants. This relationship to severity is also supported by its 
detection being a strong predictor of a poor outcome in the patient (e.g. (Ashwal et al., 
2000, Holshouser et al., 2000, Brenner et al., 2003)). However there is evidence it is 
not a suitable marker of DAI, as one investigation (Holshouser et al., 2005) found it to 
only be present when the VOI was near a visible injury. Taken together, these previous 
studies suggest that Lac may only be detectable in the most damaged tissue. 
 Myo-Inositol (mI) is known to function as a CNS osmolyte (Fisher et al., 2002). 
It is one of the more difficult metabolites to examine using MRS as it requires a short 
echo time in order to be detected. It is found in high concentrations in astrocytes and 
so an increase in the mI peak has been proposed as a marker of astrogliosis (Hattingen 
et al., 2008). Supportive of this, studies have found mI to increase following injury at 
acute and chronic stages (Garnett et al., 2000a, Danielsen et al., 2003, Ashwal et al., 
2004, Yoon et al., 2005). One study suggested it to be the most elevated in poorer 
outcome patients; a possible indication of gliosis (Ashwal et al., 2004). A negative 
correlation between mI and IQ following TBI in a chronic patient cohort has also been 
reported (Babikian et al., 2006). To date, no studies have reported mI levels in mild TBI 
patients, meaning that a relationship between mI and severity cannot yet be 
commented on. The mixed time course (i.e. time from injury to scan) of these 
investigations suggests a mI increase is a stable change following injury. This further 
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indicates a lasting alteration in the composition of injury sites following TBI to one 
which increasingly favours glial cells compared to neuronal ones, i.e. gliosis.  
Like mI, Glx also requires a short echo time to be detected. The Glx peak is a 
combination of the amino acids glutamine and glutamate, the latter of which is the 
major excitatory neurotransmitter in the brain. Due to the signal being a mix of these, 
and the small number of studies which have reported Glx in a TBI population, there are 
only few hypotheses regarding what any concentration changes mean. After finding 
that raised Glx is associated with poorer outcome in TBI patients, one study suggested 
that a raised Glx peak may reflect heightened extracellular levels of these due to a 
neural membrane breakdown (Shutter et al., 2004); an environment hypothesised to 
be damaging to neurons via excitotoxicity (Arundine and Tymianski, 2004). It’s also 
worth considering if increased Glx may instead reflect increased glutamate-based 
communication between synapses if the local cell population is not too damaged to 
function in this way. Alternatively, a diminished peak could reflect that the local cell 
population is too damaged to function in this matter and instead represent reduced 
glutamate-based communication between synapses. Some recent work (Yeo et al., 
2011) found that Glx becomes increased in white matter but reduced in grey matter in 
acute, mild TBI before finding Glx to normalise chronically. Similar findings were also 
reported in a prior study (Gasparovic et al., 2009), albeit with only a trend for 
increased white matter Glx. However, other work has found Glx to be increased in 
white and grey matter in an acute patient group (Shutter et al., 2004). Due to the 
variability of these results, and the aforementioned issues surrounding a relative lack 
of studies which have reported Glx, there is a lack of a satisfying explanation for either 
direction in change. While Glx is clearly affected by TBI, it is the least well understood 
of the metabolites investigated by MRS and so future work should approach the study 
of it with relatively open hypotheses.  
MRS measures have also produced relationships with cognition. One study 
(Friedman et al., 1998) used a patient cohort of mixed injury severity and time since 
injury and found white and grey matter NAA and Cr to positively correlate with 
psychological domain scores. Another (Ariza et al., 2004) used a chronic patient cohort 
of mixed injury severity and found the ratio of NAA/Cho in the basal ganglia to be 
positively correlated with tests of attention, and for NAA/Cho in the hippocampus to 
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be positively correlated with performance on verbal learning and facial recognition 
tests. Other longitudinal work in mildly injured patients (Yeo et al., 2011) found that 
premorbid intelligence was related to the speed that Glx and Cr (white matter only) 
normalized over time with higher intelligence predicting a faster recovery.  
One consideration to hold in mind when interpreting MRS data is that the poor 
spatial resolution of MRS means that many investigations are unable to create pure 
grey / white matter voxels or test a very specific neural location. This is problematic as 
results have suggested the metabolic reaction to TBI may differ between grey and 
white matter, such as cases where differing NAA and Cho results have been found 
between the types of tissue (Friedman et al., 1998). 
2.7 Limitations to Cognitive Research 
Linking biomarkers to cognitive deficit is a powerful technique. Obtaining such 
a finding indicates that the marker is measuring something neuro-psychologically valid 
while also allowing us to examine how and where neurophysiology influences facets of 
cognition. However there are considerations that should be made both when 
conducting this type of work and examining past literature on the topic. As the number 
of combinations of specific neural regions and cognitive tests are great, direct 
comparisons between reports are difficult to make. It is wise also to refrain from 
making overly-specific conclusions regarding the exact cognitive faculty that a single 
psychometric test measures and the exact anatomical feature it appears to correlate 
with. The popularity of methodology which tests cognition in TBI on a less specific level 
supports this; domain scores which examine “executive functioning” opposed to one 
of the myriad of sub-functions that a particular test is designed to measure, or 
tractography methods such as “white matter load” (Kraus et al., 2007) which uses 
averaged markers of damage from multiple ROI’s instead of one. Although more 
approximate, comparisons between measures such as these often prove highly 
effective in yielding results as they operate more on the level of the neural network 
than a simpler cause / effect relationship, while also eliminating some of the 
heterogeneity between individual TBI’s with regards to both neurophysiological and 
psychological phenomenon. 
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An interesting effect is present within this field with regards to healthy 
participants. Repeating a correlation between a biomarker and a cognitive test score in 
a sample of TBI patients and healthy controls would indicate that that relationship is 
not due to injury, but instead is actually a normal aspect of brain functioning which 
had not been affected by injury. Research often fails to consider controls for their own 
analysis, despite this holding the potential to further validate the DTI / MRS metrics. 
When controls are studied in this way, cognitively-relevant results are sometimes 
found (Little et al., 2010) and sometimes not (Ariza et al., 2004). Examined as a whole 
however, relationships with psychological functioning are not as forthcoming as they 
are with patient groups alone which does support the notion that at least most of 
these findings are caused by injury. One notable case (Kinnunen et al., 2011) found 
controls to contribute to correlations between FA and associative memory when 
analysed with patients, although when analysed as a single group no significant results 
were found. This suggests that control cognitive functioning may vary with measures 
such as FA but that that the healthy FA range is so compact that there is not sufficient 
spread to produce a correlation when analysed on its own. 
2.8 Combining Modalities 
 While DTI and MRS each hold considerable use individually to investigate TBI, 
investigations have been conducted which proves them to more powerful when used 
together. Correlations have been noted between MRS metabolites and DTI metrics 
(e.g. (Babikian et al., 2010)) and combining FA with NAA levels has also proved to hold 
more power in predicting the patients outcome than use of either measure alone 
(Tollard et al., 2009). These findings suggest that MRS and DTI metrics measure 
different aspects of DAI but remain related to one another. Aside from the increased 
information which using more than one technique brings, the use of them in a single 
study would be advantageous in producing metabolic and tractographic data for the 
same patient cohort, making comparisons considerably more valid. Multi-modal 
methods such as these undoubtedly give access to a new level of analysis, however 
research that has been conducted in this way is sparse. These eclectic studies 
represent a vastly underused approach which holds significantly increased power for 
studying the effects of TBI. 
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2.9 Conclusions on Past Research and Thesis Aims 
 MRS and DTI have both proved to be excellent techniques to investigate TBI. 
The ability to quantify axonal damage and neural metabolite levels in vivo held many 
promises when the techniques were both first used in the late 90’s. These promises 
have been fulfilled to an extent by an increase in knowledge; assessment of TBI with 
DTI and MRS metrics has revealed many insights regarding TBI’s effects on the brain at 
a neuronal level, with particular focus on severe and chronic injury. However acute and 
mild patients remain understudied when considering both the potential of data at this 
time point to drive therapy to affect outcome, and majority demographic which mild 
TBI patients represent. In addition the field is hampered by a relative lack of 
longitudinal data making the comparison time points post-TBI problematic, and work 
which combines MRI modalities is largely absent despite the its tremendous potential. 
Further, despite a large increase in knowledge on the topic, work thus far has failed to 
reach any clinically relevant conclusions. Focus should be increasingly placed on 
examining if the literature which has been developed on the topic can be applied to 
give patients better outcomes. 
 This thesis therefore aims to principally examine if the physiological changes 
observed following mild TBI separate to those expected following a severe injury. In 
order to do this, advanced and standard MRI techniques were combined with cognitive 
test data to characterise the neurophysiological and cognitive profile of a 
predominantly mild TBI patient group at both the acute (6 days) and chronic (1 year) 
time-points of injury. Links between the physiology of the brain and cognitive outcome 
will also be sought. It was broadly hypothesised that the mild nature of our patient 
population would lead to novel microstructural and metabolic findings (via DTI and 
MRS investigation), as evidence that the presentation of mild TBI is not simply a less 
severe version of severe injury, but the result of a different underlying set of injury and 
response processes. Specifically;  
 1. (Chapter 4) The relationship between focal lesion load and cognitive 
outcome will be examined. It is hypothesised here that lesion load will predict 
cognitive deficit via correlational analysis, although will not be wholly effective in doing 
this (expecting that DAI will also contribute to cognitive outcome). 
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 2. (Chapter 5) Longitudinal changes in DTI metrics will be examined using TBSS, 
with relationships between DTI metrics and cognitive outcome also being tested. Due 
to the longitudinal / mild nature of our data, it is hypothesised here that acute findings 
will replicate previous research where increases in FA are a marker of cognitively 
relevant damage. As these more novel acute findings are often attributed to transient 
mechanisms which are expected to resolve over time, it is then hypothesised that at 
the chronic time-point the metric alterations will more closely follow the more typical 
pattern of expected changes (i.e. decreased FA) with relationships with cognitive 
outcome also supporting decreased FA as being indicative of damage. 
 3. (Chapter 6) Longitudinal changes in metabolite concentrations will be 
assessed in an MRS investigation, with relationships between metabolic 
concentrations and cognitive outcome also being tested. Metabolites will be ratioed to 
water concentration instead of Cre. It is hypothesised that increases in Cre following 
injury will be observed and relationships with cognitive data will support this change as 
being a marker of damage. Changes in NAA and Cho, and relationships between these 
and cognitive data are also expected, although these findings are hypothesised to 
follow the expected pattern of decreased NAA / increased Cho being markers of 
damage. 
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Chapter 3. Study Overview: Participant Recruitment, Data Collection and 
Preliminary Psychometric Testing 
3.1 Declaration 
 The experiments in this thesis use participant data which was collected as part 
of a large multi-disciplinary research programme. Obtaining participant data; 
participant recruitment, matching of controls to patients, performing scans / obtaining 
psychometric test results etc. was conducted by Mr. Christopher Cowie and 
occasionally additional research assistants. Some of the data was subsequently 
analysed and presented for another thesis authored by Mr. Cowie.  
The current thesis focuses on unused data from that sample. However, for 
completeness some of the more basic aspects of the data covered in this chapter share 
some overlap with the prior work; Mr. Cowie subjected acute data to tests which 
compared psychometric test performance between patients and controls and provided 
further commentary on these findings. Although data in section 3.6 is similar to this, 
the analyses and interpretations presented here were conducted and formed by the 
current author. 
3.2 Recruitment Overview 
 3.2.1 Participant Recruitment: Patients were recruited from the accident and 
emergency and neurosurgery departments at Newcastle General Hospital. Patients 
were initially approached with information about the study while they were still 
inpatients. This approach was made in person by one of; the A&E staff, neurosurgery 
staff, the head injury specialist nurse or by Mr. Cowie following identification he made 
through discussions with hospital staff / examining the hospitals referral log. During 
this initial contact, effort was made to determine if the patient met the study’s 
inclusion criteria. If the criteria were met and the patient was interested they were 
then given the participant information sheet and a minimum of 24 hours, as per the 
ethics requirements for the experiment, to consider participating. Contact was re-
made with them 24 hours later to follow up on their decision and informed consent 
was then taken if they had decided to take part. A scan booking at the Magnetic 
Resonance Centre (MR Centre) was made at the earliest opportunity. If this took place 
while the participant was still an inpatient they were accompanied by a member of the 
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study team to the Centre. If they had been discharged then transport was arranged for 
them.  
 Patients were also made aware at the time of recruitment that they would be 
asked to return for a follow-up set of testing in 1 year. Patients were duly contacted by 
the study team 1 year later and asked if they would return. If they agreed to this, 
transportation was again arranged to the MR Centre and the exact same testing 
procedures were repeated. This marked the end of the patient’s involvement in the 
study. 
Control subjects were recruited by poster and flyer advertising throughout the local 
community. In addition to this certain people / groups of people were approached in 
person, including a local young mothers group, students at a 6th form college (though 
their teacher) etc. Members of the study team also asked people who they knew who 
they believed may be suitable for the study. These more direct methods of control 
recruitment were made in an effort to gain matched subjects. 
3.2.2 Inclusion Criteria: Inclusion criteria were created to ensure both patient 
safety and high data quality. These criteria are outlined below in Table 3.1. Shaded 
cells indicate that the criteria is specific to patient participants only, while non-shaded 
cells apply to patient and control participants. Note that in addition to meeting these 
criteria, control participants were also matched to patients. More information on the 
matching criteria is provided in section 3.2.4.  
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The minimum age limit was applied to avoid consent issues around testing 
children. Restricting the participant sample to adults is also beneficial in keeping all 
participants comparable to one another; research has frequently suggested that the 
response and recovery from TBI differs in children (Tavano et al., 2014, Taylor and 
Alden, 1997), implying that the study of them should be kept separate. An upper age 
limit was also selected for the same reason; older TBI patients have an increased 
likelihood of existing co-morbid conditions which may confound findings, such as 
deteriorating frontal white matter (Salat et al., 2005), and also have limited functional 
recovery following compared to younger adults (Mosenthal et al., 2004). It should be 
noted that one subject over this age (68 years) was recruited on the basis of their 
presentation otherwise being very suitable. 
 GCS of no less than 9 was chosen to avoid the recruitment of any severe 
patients, supportive of the studies broader interests. However this criteria was relaxed 
during recruitment due to recruitment targets not being met. Due to this, one patient 
with a GCS of 7 was used in the study. This patient, H08 (Table 3.2), otherwise 
demonstrated LoC and PTA durations well within the boundaries of moderate patients. 
Aged between 16 and 65 
GCS 9 – 15 
Scan able to be performed within 14 days of injury 
No previous history of serious head injury 
No previous history of neurological problems 
No previous history of psychological problems  
(except depression in the case that it was treated by the GP alone) 
No history of substance abuse 
No injury which would prevent the patient’s transfer to the MR Centre 
Fluent English speaker 
No visual / auditory problems 
No contraindications to MR scanning 
Table  3.1. A list of inclusion criteria for participants in the study. Cells with a shaded background 
indicate that the criteria only apply to a patient participant while those without a shaded 
background apply to patients and controls. 
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It was therefore deemed acceptable to include this patient within the “moderate” sub-
group. It should be noted that testing described throughout Chapters 4-6 considers if 
the inclusion of this moderate sub-group has affected the validity of researching mild 
TBI. 
In order to capture acute patient data, time from injury to scan was initially set 
to be no more than 6 days. However this criteria was also relaxed first to 10 days, and 
finally to 14, after being deemed too ambitious. Problems encountered with the 
original 6 day goal were reported to include logistical difficulties of the scanner being 
placed away from a clinical workplace and the lack of immediate medical support 
which came with this, making the movement and care of more injured patients 
difficult. All patients were scanned within 14 days of their injury. 
Any participants with previous history of any neurological / psychological 
problems or substance abuse were excluded in order to avoid factors which would 
confound the study of the TBI in question alone. A neurological / substance abuse 
history may contribute to an abnormal brain scan, while a psychiatric history could 
impact upon cognitive performance. Further, participants who were not fluent in 
English or who had visual / auditory problems were also excluded so that cognitive 
performance scores would not be impacted by communication issues irrelevant to 
cognitive function. Finally, the study radiographer team assessed each participant to 
ensure it was safe to expose them to the MRI scanner. 
3.2.3 Demographic Information: Demographic information was collected from 
each participant. For all participants (patients and controls), this information included:  
 Age at time of scan  
 Sex  
 Employment status / occupation  
 Educational level. This was categorised into 4 groups; 
o No qualifications 
o GCSE or equivalent 
o A level / Diploma 
o Degree / Higher Degree  
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Additional information was collected from patients specifically, listed below:  
 Any medications they were currently taking (this was asked as another 
means of ensuring that they met the inclusion criteria, e.g. a patient 
taking psychiatric medication would be excluded in case of them having 
an otherwise undisclosed mental illness) 
 Mechanism of injury 
 GCS on admission 
 Presence / duration of Loss of Consciousness (LoC) and Post Traumatic 
Amnesia (PTA) 
 If a headache was present  
 If the patient had vomited  
 If the patient had experienced any seizures 
 Injuries other than to the head which had been sustained in the 
accident 
 If a CT scan had taken place as part of their routine clinical care; if one 
had been performed then the findings from this were also taken 
 
3.2.4 Control Matching: In addition to having to meet criteria outlined in Table 
3.1, controls were matched to patients on age, gender and highest level of education. 
Age and gender were used to keep controls as physically matched to patients as 
possible, while highest level of education was used in an attempt to increase validity in 
neuropsychological comparisons between controls and patients.  
3.3 Final Sample Characteristics 
Approximately 30% of participants initially identified agreed to take part. Of the 
70% who didn’t, half had not met inclusion criteria while the other half declined their 
involvement following some discussion. Participant recruitment ran for 24 months 
from 17/12/2008 until the 16/12/2010, although some follow-up patient testing 
occurred after this period of time. 
3.3.1 Patient Demographics: The final participant sample included 53 patients 
at the acute time point (44 mild, 9 moderate; including the 1 severe patient), 23 of 
whom returned at the chronic time point (18 mild and 5 moderate; not including the 1 
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severe patient). Of the patients who didn’t return for the follow-up testing, 4 actively 
declined to return while the remaining 26 were either not able to be contacted due to 
out of date information or did not respond to attempts made to contact them.  
At the acute time point patients were aged between 16-68 years (mean=33.9, 
SD=14.6) and had a male / female ratio of 44:9. Scanning at this point occurred a mean 
of 6 days post injury (SD=3.2, range=1-14 days). The follow-up group were aged 
between 18-65 years at the time of their acute scan (mean=39.26, SD=15.27) and had 
a male / female ratio of 18:5. Follow-up testing occurred a mean of 379 days following 
the initial scan (SD=22.49 days, range=343-424 days). The main demographic and 
injury characteristics of these of patients are summarised in Table 3.2. 
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All Acute Patients 
(N=53) 
Acute Mild Patients 
(N=44) 
Acute Moderate 
Patients (N=9) 
All Returning 
Patients (N=23) 
Mild returning 
patients (N=18) 
Moderate 
returning patients 
(N=5) 
Gender 
(Male,Female) 
44,9 37,7 7,2 18,5 15,3 3,2 
Age at time of 
acute scan 
(mean±SD) 
33.92±14.6 33.91±14.84 34±14.22 39.26±15.72 39.06±15.77 40±17.33 
Time from injury to 
acute scan in days  
(mean±SD, min-
max) 
6.056±3.2 
1-14 
5.773±2.94 
1-14 
7.44±4.22 
2-13 
6.13±3.252 
1-13 
5.444±2.617 
1-10 
8.6±4.39 
2-13 
GCS (median) 14 14 12 14 14 12 
Average duration 
of Loss of 
Consciousness in 
minutes (mean±SD) 
3.029±4.585 
(19 did not 
experience LoC) 
2.616±4.348 
(17 did not 
experience LoC) 
5±5.43 
(2 did not 
experience LoC) 
2.935±3.995 
(7 did not 
experience LoC) 
2.139±2.785 
(6 did not 
experience LoC) 
5.8±6.46 
(1 did not 
experience LoC) 
Average duration 
of Post-Traumatic 
Amnesia in hours 
(mean±SD) 
13.9±56.41 
(19 did not 
experience PTA) 
2.919±5.704 
(19 did not 
experience PTA) 
66.4±127.9 
(all experienced 
PTA) 
30±87.4 
(10 did not 
experience PTA) 
2.75±7.11 
(10 did not 
experience PTA) 
116.3±160.4 
(all experienced 
PTA) 
Time from acute 
scan to chronic 
scan in days 
(mean±SD, min-
max) 
 
- 
 
- 
 
- 
378.61±22.49 
343-424 
380.89±19.93 
357-423 
370.4±31.4 
343-424 
Table 3.2. A Summary of basic demographic and injury data in the patient group, broken down by injury severity and time-point.  
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32%
26%
9%
8%
19%
6%
Assaults
Falls
Road Traffic Accidents
Sports Injuries
Other
Not Known
3.3.2 Injury Characteristics of the Acute Patients: While each injury is clearly 
individual, after reviewing the causes injuries were split into six categories for ease of 
classification; “assaults”, “falls”, “road traffic accidents”, “sporting accidents”, “other” 
and “not known”. In this case “road traffic accidents” account for instances where a 
collision involving a motorised vehicle occurred (usually a car, although in one case a 
motorcycle). While there were some injuries which involved falling from a moving 
bicycle, these were classed simply as “falls” (except for one case which involved a 
bicycle race, which was categorised as a “sporting accident” instead). “Other” is used 
in cases of accidents which don’t fit immediately into any other category (e.g. one 
patient who accidentally hit their head against a metal door), while “not known” is 
used in cases where the cause was unable to be reported (some patients’ LoC and PTA 
prevented them from being able to remember how they were injured). The 
distribution of these is shown in Figure 3.1, below. 
 
 
 
From Figure 3.1 we see that assaults form the main cause of accident, followed 
relatively closely by falls. This goes against a trend where road traffic accidents are 
often found to be the most common mechanism of injury (one review found it to be 
the leading cause in America, Australia and China (Bruns and Hauser, 2003)) but is 
Figure 3.1. A pie chart to show the distribution of causes of injury in the acute patient sample. 
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supportive of other research based in the UK where falls and assaults were the two 
leading causes, ahead of road traffic accidents (Thornhill et al., 2000).  A total of 12 
patients (22.6% of the total group) were under the influence of alcohol at the time of 
the accident.  
Of the acute patient sample, 50 patients (94.3%) experienced a headache, 31 
(58.5%) experienced vomiting and 4 (7.5%) experienced a seizure. Abnormal imaging 
findings were reported in 44 (83%) of the patients. These initial imaging findings were 
reported from a mix of CT and T1W MRI scans; most of these patients had a CT scan as 
part of their clinical investigations and those who did not had a T1W MRI scan as part 
of this project (later described). 
3.3.3 Injury Characteristics of the Returning Patients: Of the patients who 
returned, “falls” overtook “assaults” as the main cause of the injury when compared to 
the acute patient sample as a whole (assaults became the second most common). 
Sporting injuries also swapped positions with road traffic accidents to become the 
fourth most common type of injury in this patient sub-group. The distribution of these 
is shown in Figure 3.2, overleaf. 
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Of the returning sample, 22 patients (95.6%) had experienced a headache at 
the acute stage, 14 (60.9%) experienced vomiting at the acute stage and 1 (4.3%) 
experienced a seizure at the acute stage. Abnormal imaging findings were reported in 
19 (82.6%) of these patients. Appendix A describes the injury characteristics of all the 
patients in more detail.  
3.3.4 Patient Sub-Group Consistency: Comparing demographic and injury 
information between the main body of patients (all patients at the acute stage) with 
subgroups (e.g. acute mild patients, all follow-up patients etc.) shows good 
consistency. Chi Square test comparison showed that the ratio of male / female 
patients was not significantly different when testing the full acute patient sample 
against any sub-group (this test was not able to be performed against returning 
moderate patients as the sample size was too small). Further, t-test comparison also 
indicated that there was no significant difference between the age of the main body of 
patients and any sub-group. 
Figure 3.2. A pie chart to show the distribution of causes of injury in the returning patient sample. 
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While the most common mechanisms of injury changed slightly between the acute and 
returning patient sample, it should be considered that due to the returning group 
having a reduced number, the actual number of patients that these changes represent 
is small. Indeed, a Chi square test comparison showed no significant difference in the 
ratio of injury mechanisms between the acute and follow-up patient samples. It was 
deemed unnecessary to conduct statistical testing to compare the proportions of 
patients who experienced headache / vomiting / seizure or who had abnormal imaging 
findings, as these are all extremely similar descriptively. 
3.3.5 Control Demographics: The final control sample consisted of 33 
participants. Controls were aged between 19 and 66 years (mean=40.94, SD=15.26) 
and had a male / female ratio of 24:9. Despite attempts to match controls to patients, 
t-test comparison revealed control subjects to be significantly older than both the 
acute mild patient group (p=0.047), and all acute patients considered together 
(p=0.039). Otherwise there was no significant difference between the age of controls 
and acute moderate patients or any of the “returning” patient sub-groups, although 
considering the former findings these non-significant results are possibly due to 
reduced sample size. Chi Square testing showed no significant difference in the male / 
female ratio between controls and all patients / any of the patient sub-groups (except 
moderate returning patients where sample size was too small to test).  
The distribution of educational levels appears similar between conditions 
(Figure 3.3, below), although it should be noted that while GCSE / equivalent is the 
most common level attained in the acute and returning patient sample with 
undergraduate or higher degree being second, these positions are reversed in the 
control group. Similarly, in the returning patients having no qualifications became 
more common than having an A-Level / Diploma. Despite these descriptive differences, 
Chi Square testing showed no significant difference in the ratios of educational levels 
between controls and all patients / any of the patient sub-groups (except moderate 
returning patients due to sample size being too small to test). Table 3.3, below, shows 
this control demographic information in comparison to the patient demographic 
information.
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Control 
(N=33) 
All Acute 
Patients 
(N=53) 
Acute Mild 
Patients 
(N=44) 
Acute 
Moderate 
Patients (N=9) 
All Returning 
Patients (N=23) 
Mild returning 
patients (N=18) 
Moderate 
returning 
patients (N=5) 
Gender (Male,Female) 24,9 44,9 37,7 7,2 18,5 15,3 3,2 
Age at time of acute scan 40.94±15.26 33.92±14.6 33.91±14.84 34±14.22 39.26±15.72 39.06±15.77 40±17.33 
Table 3.3. A summary to compare demographic control data with demographic patient data. Data takes a ratio form when describing gender, and takes the form of 
“mean±SD” when describing the age at the time of the acute scan 
Controls All Acute Patients All Returning Patients 
Undergraduate / Higher Degree No Qualifications GCSE / Equivalent A-Level / Diploma 
Figure 3.3. Pie charts to show the distribution of highest level of education in control and acute / returning patient groups. 
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3.4 MRI Scanning 
 3.4.1 MRI Scanning Protocol: Upon arriving at the MR Centre, participants first 
completed their MRI scan. Scans were performed on a 3T whole body Philips Achieva 
System with an 8 channel head coil as a receiver and a body coil as a transmitter. The 
full scanning protocol took 55 minutes to administer and included anatomical scans 
(T1W) and quantitative data scans (Diffusion Tensor Imaging, quantitative T1 and T2 
mapping, Magnetic Resonance Spectroscopy and Cerebral Blood Flow). The anatomical 
images were positioned parallel with the anterior commissure / posterior commissure 
line (AC / PC line), with the whole brain covered, and the quantitative data scans co-
centred and oriented with these. While resolution of each scan varied, they were 
designed to be multiples of one another to allow for easy comparison between scan 
types. Scanning was performed by the radiographer staff working at the MR Centre, 
while the scan data was downloaded from the scanner to computers for post-
processing and analysis. Not all types of scan data are used in this thesis and as a full 
experimental chapter has essentially been given to each scan type which has been 
used, the full specification of each protocol is described in the accompanying chapter. 
However, generic pre-processing steps which were applied to all scan data are 
described here. These steps were performed by Mr. Benjamin Aribisala, an Image 
Processing Specialist working on the research program. 
 3.4.2 Format Conversion: Scan data taken from the scanner was first converted 
from the scanners native file types (.PAR and .REC extensions) to the “Analyze” format 
(.hdr and .img extensions) so that they were compatible with a range of scan-
processing software. 
 3.4.3 Movement Correction: Correction was required to account for inevitable 
small movements made by the participants during scanning, meaning that the same 
co-ordinate space in any two scans from one participant would not describe the same 
tissue without this correction. Each participants’ set of images were therefore 
registered to their T1W anatomical image. This was done using FLIRT; a linear image 
registration tool which is part of the FSL software package(Smith et al., 2004). During 
this process, each image is translated, rotated, stretched / compressed and skewed in 
each spatial axis to register each image into the same “patient space”.  
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 3.4.4 Fitting: The data from each quantitative scan type was fitted to the 
appropriate model for that data type. This was performed by a mixture of in-house 
software developed by a research associate (for CBF and quantitative T1 and T2 data), 
and by publically available fitting tools available as a part of the FSL software package 
(DTI). MRS data fitting procedures are described in section 6.2.4. 
 3.4.5 Unwarping: This was performed in order to correct for data changes 
influenced by inhomogeneity in the scanner’s magnetic field. For this, a B0 field map 
was acquired using a dual echo 3D GRE sequence (TE1 = 2.5 ms, TE2 = 5.8 ms, TR = 
27ms, transverse orientation, 2mm isotropic resolution, matrix size: 128x128x72, 
accelerated with a SENSE factor of 1.5 in the right-left / phase direction). This field map 
described the non-uniformities in the magnetic field, and was therefore used to 
correct other scan data. For this correction, two more FSL tools were used. PRELUDE 
first performed 3D phase unwrapping of the field map before FUGUE used the field 
map to unwarp the other scans.  
3.5 Neuropsychological Testing 
 3.5.1 Neuropsychological Test Battery: The composition of the test battery 
which was administered to participants was the result of discussions with two local 
consultant clinical psychologists, and designed to measure a variety of cognitive 
domains; attention, concentration, memory and executive function. Table 3.4 lists the 
full test battery / the cognitive functions which each test assesses, while more detail 
on each task is given after. 
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These tests are a mixture of select tasks taken from a number of test batteries 
alongside other common, stand-alone tests. An overview of each task is given below. 
However, as only a subset of the scores gained from each task were used in analyses, 
description of how exact scores were gained from these are given later in section 
3.6.1.1.  
The National Adult Reading Test (NART) (Nelson, 1982). This is a common, 
stand-alone test that is often used in research as a measure of premorbid IQ. The test 
involves the participant reading aloud 50 printed real words. The words chosen are 
included in the test for their irregular, non-phonetic spellings, and while words at the 
start of the list are common they become increasingly unusual as the list progresses. 
Due to this, it is unlikely a participant would be able to correctly pronounce a word 
they do not already recognise.  
Speed of Information Processing (SoIP) (Coughlan, 2007). This test is taken from 
the BIRT Memory and Information Processing Battery (Coughlan, 2007). SoIP involves 
presenting the participant with a single sheet of paper which has multiple rows of five, 
two-digit numbers. The participant is instructed to cross out the second-highest 
Task Cognitive Functions Assessed 
National Adult Reading Task (Test) Premorbid IQ 
Speed of Information Processing (SoIP) Information processing; an aspect of 
executive function 
Design Learning Visuospatial learning, attention, 
concentration, short-term and working 
memory 
List Learning Verbal learning, attention, concentration, 
short-term and working memory 
Paced Auditory and Serial Addition 
(PASAT) 
Information processing, attention, 
concentration and working memory 
Backwards Digitspan Short-term and working memory 
Backwards Spatialspan Short-term and working memory 
Verbal Fluency; Category and Letter 
conditions 
Clustering and switching; aspects of 
executive function 
Colour-word interference (CWIT) Naming, attention and executive function 
Table 3.4. A list of tests and the cognitive domains they purport to measure used in the 
neuropsychological test battery. 
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number on each row as quickly as possible. A total of 4 minutes are allowed for this. 
The participant also completes a second sheet with a similar layout but with a lot of 
“11”’s. They are instructed this time to simply cross out as many “11”’s as possible in 
order to test their motor speed alone. For this portion of the test, 25 seconds is 
allowed. 
Design Learning (Coughlan, 2007). This test is also taken from the BIRT Memory 
and Information Processing Battery. The participants are shown a grid of dots (4x4 – 
“Design A”) which are connected by varying patterns of straight lines, producing an 
overall design. The participant examines the design for 10 seconds and is told to 
remember it before it is hidden, and is then given a blank grid of 4x4 dots and asked to 
repeat the design they have remembered onto this. This is repeated a maximum of 
four more times with the same design, however if the participant produces two 
consecutive, correct responses then the full 5 attempts are not needed. The 
participant is then shown a new design (“Design B”) and the same procedure repeated 
with this. Finally, the participant is asked to once again draw Design A without being 
shown it again. Examples of the Design Learning Stimuli are given in Figure 3.4, below. 
 
 
 
 
 
 
 
 
 
 
 
 
Design Learning Stimulus A Design Learning Stimulus B 
Design Learning Participant 
Response Grid 
Figure 3.4. A demonstration of the stimuli used in the Design Learning Task. “Stimulus A” and “Stimulus B” 
both show examples of what the participant is shown by the examiner. The participant must attempt to 
copy these onto the “Participant Response Grid”. 
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List Learning (Coughlan, 2007). This test is also taken from the BIRT Memory 
and Information Processing Battery. It is identical to Design Learning in procedure, but 
uses a different stimuli. Instead of being shown a design that the participant must 
copy, a list of 15 words (“List A”) is read to them. The participant must attempt to 
recall the whole list, and is given a maximum of five attempts to do so with the list 
being re-read to them once for each attempt. After they recall the list three 
consecutive times, or five attempts have elapsed, a second list of 15 words (“List B”) is 
read to them which they must then attempt to recall. Only one attempt is allowed for 
this second list. Finally, the participant must once again attempt to recall List A, 
without this list being re-read to them.  
Paced Auditory and Serial Addition (PASAT) (Gronwall, 1977). This is another 
common, stand-alone task. This involves the participant listening to a pre-recording of 
someone giving a list of single digit numbers. The participant is instructed to add the 
current number to the one before it, and to repeat that total aloud, i.e. not giving a full 
running total, but the sum of the two most recent numbers. The test is run twice, one 
with intervals of three seconds between numbers being read out and the other with 
two second intervals. A total of 61 numbers are presented to the participant in each 
condition (so that the participant returns a total of 60 answers). The 3 second 
condition therefore lasts 3:03 minutes while the 2 second condition lasts 2:02 minutes. 
Shorter practice runs are performed by the participant for each condition before the 
main one. If a participant fails to give two correct answers during the 3 second practice 
test, they are not administered the test. Likewise, if a participant fails to give a single 
correct answer during the main 3 second test, they are not administered the 2 second 
one. 
Backwards Digitspan (Wechsler, 2008). A task currently featured in the 4th 
edition of the Wechsler Adult Intelligence Scale. This involves the experimenter saying 
aloud sequences of digits of varying lengths (which the test refers to as “spans”), which 
the participant must then repeat to the experimenter but in reverse order, e.g. “4 7 6” 
would become “6 7 4”. Span lengths are performed in blocks of nine (i.e. there are 
nine three digit numbers, nine four digit numbers, nine five digits numbers etc.). Every 
time a participant succeeds in giving two consecutive correct answers at one span 
length, the experimenter switches to the next length up. If a participant gives two 
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incorrect responses in a row then the test is discontinued. Digits are first read out with 
a span of 2, and can increase to 10.  
Backwards Spatialspan (Wechsler, 2006). A task currently featured in the 
Wechsler Non-Verbal scale of ability. This task is similar to Digitspan in that it tests the 
“span” of the participant’s memory, but uses physical patterns instead of numbers. A 
board with ten identical blocks fixed to it in random-appearing locations is presented 
to the participant. From the participant’s point of view, each of the blocks are blank 
and so only differentiated from one another by location. However each block has a 
number printed on the “back” (relative to the participant) of it which the experimenter 
can see. The experimenter uses the numbers to tap certain blocks in certain orders, 
which the participant must watch and then repeat in reverse order. Similar to the 
Digitspan task, the sequences begin with a low number of taps (2) but increase in one 
tap for each two consecutively correct repetitions the participant achieves (up to 10). 
The task is again stopped when the participant gives two incorrect responses in a row. 
A picture of the Spatialspan stimulus is given in Figure 3.5. 
Verbal Fluency; Category and Letter Conditions (Delis et al., 2001). These tasks 
are taken from the Delis-Kaplan Executive Function System tasks. The Letter Condition 
in this task is commonly referred to as “Verbal Letter Fluency” (VLF) while the Category 
Condition is referred to as “Category Fluency”. These tasks each involve instructing the 
participant to state as many words as they can think of that either begin with a specific 
letter (VLF), or to state as many words as they can think of that fit within a specific 
category (Category Fluency). In the VLF condition, three letters are used as cues; “F”, 
“A” and “S”, while in the Category Fluency condition, two categories are used as cues; 
animals and boys names. Participants are given a minute per cue (e.g. a minute for 
each of “F”, “A” and “S” in the VLF condition). In the VLF condition the participant must 
not state names, numbers, places or variations of previously used words. Similarly, in 
the Category Fluency condition, participants must not use variations of previously used 
words (e.g. “horses” would not be accepted after “horse”). 
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Experimenter’s point of view 
Participant’s point of view 
Figure 3.5. Picture of the Backwards Spatialspan stimuli, showing the difference between the 
experimenter’s and participant’s points of view. 
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 Colour-Word Interference Test (CWIT) (Delis et al., 2001). This task is also taken 
from the Delis-Kaplan Executive Function System tasks. It is a derivative of the 
“STROOP” task, where the participants executive function is tested by having to inhibit 
one aspect of a stimulus (e.g. a written word) in favour of another to give a correct 
response (e.g. the colour of ink that the word is printed in). Two baseline conditions 
are first administered to the participant; naming of patches of colour and reading 
colour-words which are printed in black ink. For each of these tasks, a page is shown to 
the participant which contains 60 examples of the stimuli. The participant has 90 
seconds to give as many responses as they can. In the third condition, another sheet of 
60 stimuli is presented to the participant. These stimuli are all colour-words, but 
printed in ink who’s colour doesn’t match the word (e.g “red” or “blue”). The 
participant is instructed to name the colour of the ink, while ignoring what the word 
says and is given 180 seconds to do this. In the final condition, another 60 stimuli are 
given to the participant. These are again colour-words printed in conflicting colour of 
ink, but half of them now have a black box around them. This time, the participant 
must name the colour of the ink when the word doesn’t have a box around it, but 
name the word when it does have a box around it. The participant is again given 180 
seconds to complete this.   
 3.5.2 Neuropsychological Test Battery Administration:  The administration of 
the tests was initially conducted by Mr. Cowie, before being taken over after a period 
of time by two neuropsychology research assistants (Miss. Anna Peel and Mr. Joshua 
Wood). Mr. Cowie trained these assistants in the administration of the battery to 
ensure inter-examiner reliability. The full testing procedure took approximately 1 hour 
and 15 minutes. Participant scores were recorded on paper throughout the testing and 
later transcribed to a computer. The participant completed the test battery during the 
same visit to the MR Centre as their scan, or within 7 days if the patient was unable to 
tolerate both in the same sitting (this was the case for 11 patients who were tested a 
mean of 2.6 days following their scan). Although the administration of the tests was 
split between Mr. Cowie and the research assistants, the initial scoring and totalling of 
the results was conducted only by the research assistants. Further testing of the data 
described next in this chapter (section 3.6) was performed by the author of this thesis. 
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3.6 Preliminary Neuropsychological Comparisons 
 Before experimenting with scan data, basic comparisons between cognitive test 
scores of patients and controls were made in order to assess the cognitive profile of 
the patients and to see if this changed over the course of the year.  
 3.6.1 Methods  
 3.6.1.1 Test Interpretation: While some of the cognitive tests had clear 
outcome scores, others had a number of recorded measures which could be used for 
analysis (e.g. number of errors, number of correct responses, time to complete, 
baseline conditions etc.). Main scores of interest were therefore identified from the 
cognitive tests to be used in these analyses. This identification was made on the basis 
of the instructions given with the specific test to determine the most pertinent 
outcome measures. These are as follows; 
 NART: The error score on the NART test (number of mispronounced words) is 
checked against an accompanying published table to calculate the predicted full IQ of 
the participant. This IQ score is used.  
 SoIP: A total score adjusted for motor speed is calculated using the main total 
(correct) score and the motor speed score. This adjusted score is used.  
 Design Learning: Three total scores are calculated. The first of these is the total 
of all of the correct responses given in the first five attempts made at Design A (“A1-
A5”). The second is the number of correct responses given on the single attempt at 
Design B (“B1”), while the final is the number of correct responses given on the re-
attempt at Design A (“A6”).  
 List Learning: Similar to Design Learning, three total scores are calculated. 
Again, the first of these is the total of all of the correct responses given in the first five 
attempts made at List A (“A1-A5”). The second is the number of correct responses 
given on the single attempt at List B (“B1”), while the final is the number of correct 
responses given on the re-attempt at List A (“A6”). 
 PASAT: Two total scores were used for this, one for each condition (2 / 3 
second intervals). These scores were the percentage of responses the participant gave 
which were correct in each condition. 
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 Backwards Digitspan: As per test instructions, the final score is the participants 
“span”, i.e. the length of the longest string of digits they successfully recalled twice in a 
row. 
 Backwards Spatialspan: As per test instructions, the final score here is also the 
participants “span”, i.e. the length of the longest sequence of blocks they successfully 
recalled twice in a row. 
 Verbal Fluency: Two scores were used for this, one for each VLF and Category 
Fluency conditions. In each case, as per test instructions, these scores were the total 
correct responses that the participant gave across all trials within each condition. 
 Colour-Word Interference Test (CWIT): Two scores were used for this, one for 
each of the experimental conditions (i.e. stating the colour of ink the word is printed 
in, “Colour Naming Condition”, and switching between stating the colour of the ink or 
the word itself, “Switching Condition”). As per test instructions, the time taken to 
complete each task (including the baseline conditions) is first scaled to correct for age 
using an accompanying published table. The final corrected score for Condition 3 is 
then calculated by subtracting the first baseline score (naming colour patches) from 
the initial Condition 3 score. The final corrected score for Condition 4 is calculated by 
subtracting the sum of the first two baseline conditions from the initial Condition 4 
score. 
 A high score on all of these tasks indicate good functioning, apart from CWIT 
data where a low score indicates good functioning. 
 3.6.1.2 Data Analysis: Control scores were first tested for normality by both 
examining histograms / probability plots of their distribution and administering the 
Anderson-Darling test. An analysis was then conducted to compare control NART 
scores against patient NART scores in order to examine for any inherent differences in 
IQ between groups.  
 Test performance on all other tasks was then compared between controls, mild 
and moderate groups using the acute patient data by one-way ANOVA if performance 
had been shown to be normally distributed, or by the Kruskal-Wallis test if it had been 
shown that performance was not normally distributed. Post-hoc tests to this ANOVA 
were conducted; control vs. mild / moderate and mild vs. moderate. As there is a clear 
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hypothesis of greater injury severity predicting worse outcome, these tests were one-
tailed. T-tests were used for these if performance had been shown to be normally 
distributed, or by the Mann-Whitney U test if performance was not normally 
distributed.  
 For testing using the returning patient data it was deemed unsuitable to still 
consider moderate patients as a single group due to the reduced sample size. 
Comparison was therefore made by t-test between controls and all returning patients 
for each cognitive test if performance had been shown to be normally distributed, or 
by the Mann-Whitney U test if it had been shown that performance was not normally 
distributed. These tests were two-tailed as it was not deemed a reasonable to expect 
patients at this time to still underperform compared to controls. 
 Finally, where any significant findings had been found in a particular cognitive 
test, post-hoc regression analyses were conducted on that test in order to examine if 
differences in cognitive test scores were due to being injured or because of the 
potential of a lower pre-morbid IQ. For this, the test score was used as the response 
variable with NART as one predictor variable and if the participant had a TBI or not as 
the other predictor variable. This analysis was conducted once with acute patient data 
and once with follow-up patient data for each previously-significant cognitive test. 
 As not all participants (particularly patients) could complete all cognitive tests, 
the sample size for each comparison described above differed per test. Table 3.5, 
overleaf, summarises the total N for each test and at each time-point. 
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 3.6.2 Results  
 3.6.2.1 NART: Testing was conducted to examine if there were any differences 
in IQ between the two groups. For this, NART scores were used as a measure of IQ to 
compare controls to what should theoretically be the patient’s pre-morbid IQ (if the 
patient NART had a different distribution to controls then there would be evidence 
that pre-morbid intelligence had not been measured). The Anderson-Darling test on 
NART distribution showed that both Control (p=0.119) and Patient (p=0.355) NART 
performance was normally distributed.  
 However, t-test comparison found a significant difference in IQ, as measured by 
NART, wherein control NART (mean=112.03, SD=8.98) was significantly higher than 
Task 
Sub-
Condition 
Control N 
Acute, Mild 
N 
Acute, 
Moderate N 
Returning 
Patients N 
NART - 33 41 7 - 
SoIP - 33 43 8 21 
Design 
Learning 
A1 - A5 33 42 8 21 
B1 33 42 8 21 
A6 33 42 8 21 
List 
Learning 
A1 – A5 33 44 8 21 
B1 33 44 8 21 
A6 33 44 8 21 
PASAT 
2 Second 
Intervals 
31 40 6 19 
3 Second 
Intervals 
31 40 6 19 
Backwards 
Digitspan 
- 
33 43 8 21 
Backwards 
Spatialspan 
- 
33 43 8 21 
Verbal 
Fluency 
VLF 33 41 7 21 
Category 
Fluency 
33 41 7 21 
CWIT 
Colour 
Naming 
33 43 7 21 
Switching 33 43 7 21 
Table 3.5. A summary of the sample sizes for all cognitive analysis. 
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NART of all patients (mean=100, SD=13.1, t(77)=4.88, p=<0.001) and some patient 
subgroups; acute mild patient IQ (mean=99.6, SD=13.4, t(69)=4.74, p=<0.001), IQ of all 
returning patients (mean=104.2, SD=13.5, t(35)=2.41, p=0.021) and IQ of returning 
mild patients (mean=104.4, SD=13.7, t(25)=2.13, p=0.043). While no significant 
difference was found between control NART and moderate patient NART either in the 
acute sample or returning sample, this should be expected due to reduced N in the 
group testing as the mean of these sub-groups was still descriptively lower than that of 
controls (102.3 and 103.6 respectively). 
 
  
 
 
 
 
 
 
 
 Please note the following about how significant findings are portrayed in the 
Figures over the following pages. An asterisk (“*”) above or below a box plot does not 
indicate significance, but instead shows outlier values (counted as any values which are 
1.5 times (or more) outside of the interquartile range). Significance is instead 
represented by the presence of an arrow. A dashed arrow which moves from the 
control boxplot and across the acute patient boxplots (mild and moderate) shows that 
a significant effect was found between those three groups when the data was 
compared by ANOVA / Kruskal-Wallis. Alternatively, a solid horizontal bracket which 
moves between any two group’s box plots indicates a significant difference was found 
between those groups when the data was compared by t-test / Mann Whitney U 
analysis in either the main control vs. returning patient analysis, or any post-hoc 
analyses for the ANOVA. 
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 3.6.2.2 SoIP: The Anderson-Darling test on SoIP distribution showed that 
control (p = 0.119) SoIP performance was normally distributed. One-way ANOVA 
showed a significant effect whereby performance appeared decreased in mild 
(mean=59.39, SD=20.14) and moderate (mean=49.05, SD=13.54) groups compared to 
controls (mean=74.47, SD=21.66, F(2,80)=7.55, p=0.001). One-tailed post-hoc t-test 
analysis revealed all possible differences to be significant; controls performed 
significantly better than both mild (p=0.002) and moderate (p<0.001) patients, while 
mild patients also performed significantly better than moderate patients (p=0.046). 
However, t-test comparison indicated that SoIP performance in controls and returning 
patients (mean=70.4, SD=14.7) was not significantly different (p=0.416). These findings 
are shown in Figure 3.6. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Returning PatientsModerate PatientsMild PatientsControls
120
100
80
60
40
20
S
o
IP
 P
e
rf
o
rm
a
n
c
e
Figure 3.6. Box plot to show SoIP performance in Controls, mild patients and moderate 
patients at the acute time-point, and returning patients. A dashed arrow indicates a 
significant effect in those groups it covers as found by ANOVA / Kruskal Wallis. A solid 
bracket between two specific groups indicates a significant difference as found by t-test / 
Mann Whittney. 
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 3.6.2.3 Design Learning: The Anderson-Darling test on Design Learning 
distribution showed that Control performance was normally distributed in the first 
condition (A1-A5, p=0.119) but was not normally distributed in either of the second 
two (B1; p=0.026, and A6; p=<0.005). The histograms and probability plots for these 
are shown in Figure 3.7. 
 
 
 
 
 
 
  
 
 
 
 
 
 
In the A1-A5 condition: One-way ANOVA showed a significant effect whereby 
acute moderate patient performance (mean=29.75, SD=9.24) appeared decreased 
compared to controls (mean=37, SD=5.86) and mild patients (mean=36.81, SD=7.69, 
F(2,79)=3.57, p=0.033); Post-hoc one-tailed t-test comparison showed no significant 
difference between controls and mild patient performance (p=0.452), but 
demonstrated both controls (p=0.033) and acute mild patients (p=0.039) to perform 
significantly better than acute moderate patients. Further, t-test comparison indicated 
Figure 3.7. Histograms and probability plots to examine for normality in the distribution of Control 
Design Learning scores in B1 (top) and A6 (bottom) conditions. 
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that Control and returning Patient (mean=39.19, SD=6.58) performance was not longer 
significantly different (p=0.223).  
In the B1 condition: Kruskal-Wallis analysis showed no significant difference in 
performance between controls (median=6, average rank=42.3), and acute mild 
(median=6, average rank=39.5) and moderate patients (median=6, average rank=48.6, 
overall p=0.592). Post-hoc, one-tailed Mann-Whitney U analysis showed no significant 
differences between any group comparison; controls vs. mild patients (p=0.312), 
controls vs. moderate patients (p=0.266), mild vs. moderate patients (p=0.161). 
Further, Mann-Whitney U analysis between control and returning patient performance 
(median=6) also showed no significant difference (p=0.478).  
In the A6 condition: Kruskal-Wallis showed no significant difference in 
performance between controls (median=9, average rank=42.8), and acute mild 
(median=9, average rank=41.1) and moderate patients (median=9, average rank=38.3, 
overall p=0.856). Post-hoc, one-tailed Mann-Whitney U analysis showed no significant 
differences between any group comparison; controls vs. mild patients (p=0.370), 
controls vs. moderate patients (p=0.316), mild vs. moderate patients (p=0.371). Mann-
Whitney U analysis between control and returning patient performance (median=9) 
also showed no significant difference (p=0.896). All of the Design Learning findings are 
shown in Figure 3.8. 
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Figure 3.8. Box plots to show Design Learning performance in Controls, mild patients and moderate 
patients at the acute time-point, and returning patients. A1-A5 condition is shown top-right, B1 condition 
is shown top-left and A6 condition is shown bottom. A dashed arrow indicates a significant effect in those 
groups it covers as found by ANOVA / Kruskal Wallis. A solid bracket between two specific groups indicates 
a significant difference as found by t-test / Mann Whittney. 
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3.6.2.4 List Learning: The Anderson-Darling test on List Learning distribution 
showed that Control performance was normally distributed in the first (A1-A5, 
p=0.808) and third (A6, p=0.056) conditions but was not normally distributed in second 
condition (B1, p=0.045). The histogram and probability plot for this is shown in Figure 
3.9. 
 
 
 
  
 
 
 
In the A1-A5 condition: One-way ANOVA showed a significant effect whereby 
acute mild (mean=44.45, SD=12.23) and moderate (mean=34.75, SD=18.34) patient 
performance appeared decreased compared to controls (mean=57.25, SD=8.3, 
F(2,81)=17.36, p=<0.001). Post-hoc, one-tailed t-test comparison showed that controls 
performed significantly better than both mild (p=<0.001) and moderate patients 
(p=0.006), but that there was no significant difference between acute mild and acute 
moderate performance (p=0.094). t-test comparison indicated that Control and 
returning Patient (mean=53.3, SD=10.5) performance was no longer significantly 
different (p=0.159).  
In the B1 condition: Kruskal-Wallis analysis showed no significant difference in 
performance between controls (median=6, average rank=46.2), and acute mild 
(median=5.5, average rank=41.3) and moderate (median=6, average rank=34.2) 
patients (p=0.4). Post-hoc, one-tailed Mann-Whitney U analysis showed no significant 
differences between any group comparison; controls vs. mild patients (p=0.187), 
controls vs. moderate patients (p=0.115), mild vs. moderate patients (p=0.217). Mann-
Whitney U analysis between controls and returning patient performance (median=8) 
also showed no significant difference (p=0.304).  
Figure 3.9. Histograms and probability plots to examine for normality in the distribution of Control List 
Learning scores in the B1 condition. 
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In the A6 condition: One-way ANOVA showed a significant effect whereby 
acute mild (mean=8.73, SD=3.68) and moderate (mean=5.75, SD=5.15) patient 
performance appeared decreased compared to controls (mean=11.94, SD=2.3, 
F(2,81)=14.19, p=<0.001). Post-hoc, one-tailed t-test comparison showed that controls 
performed significantly better than both mild (p=<0.001) and moderate patients 
(p=0.007), but that there was no significant difference between acute mild and acute 
moderate performance (p=0.078). t-test comparison indicated that Control and 
returning Patient (mean=11.24, SD=3.25) performance was no longer significantly 
different (p=0.399). All of the List Learning Findings are shown in Figure 3.10. 
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Figure 3.10. Box plots to show List Learning performance in Controls, mild patients and moderate patients 
at the acute time-point, and returning patients. A1-A5 condition is shown top-right, B1 condition is shown 
top-left and A6 condition is shown bottom. A dashed arrow indicates a significant effect in those groups it 
covers as found by ANOVA / Kruskal Wallis. A solid bracket between two specific groups indicates a 
significant difference as found by t-test / Mann Whittney. 
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3.6.2.5 PASAT: The Anderson-Darling test on PASAT distribution showed that 
Control performance was normally distributed in both conditions (2 second intervals; 
p=0.17, 3 second intervals; p=0.22). In the 2 second interval condition: One-way 
ANOVA showed a significant effect whereby acute mild (mean=39.73, SD=28.17) and 
moderate (mean=18.5, SD=18.69) patient performance appeared decreased compared 
to controls (mean=56.43, SD=12.48, F(2,73)=9.06, p=<0.001). One-tailed post-hoc t-
test analysis revealed all possible differences to be significant; controls performed 
significantly better than both mild (p=<0.001) and moderate (p=0.003) patients, while 
mild patients also performed significantly better than moderate patients (p=0.022). 
However t-test comparison indicated that performance in the Controls and returning 
Patients (mean=56.4, SD=16.8) was no longer significantly different (p=0.499).  
In the 3 second interval condition: One-way ANOVA showed a significant effect 
whereby acute mild (mean=61.45, SD=29.59) and moderate (mean=39.83, SD=28.22) 
patient performance appeared decreased compared to controls (mean=81.2, 
SD=13.52, F(2,73)=9.82, p=<0.001). One-tailed post-hoc t-test analysis showed that 
while controls performed significantly better than both mild (p<0.001) and moderate 
(p=0.009) patients, there was no significant difference between mild and moderate 
patient performance (p=0.067). t-test comparison also indicated that performance in 
the Controls and returning Patients (mean=79.7, SD=13.5) was no longer significantly 
different (p=0.712). All of the PASAT findings are shown in Figure 3.11.  
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Figure 3.11. Box plots to show PASAT performance in Controls, mild patients and 
moderate patients at the acute time-point, and returning patients. The 2 second interval 
condition is shown top and the 3 second interval condition is shown bottom. A dashed 
arrow indicates a significant effect in those groups it covers as found by ANOVA / Kruskal 
Wallis. A solid bracket between two specific groups indicates a significant difference as 
found by t-test / Mann Whittney. 
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3.6.2.6 Backwards Digitspan: The Anderson-Darling test on Backwards 
Digitspan distribution showed that Control (p=<0.005) performance was not normally 
distributed. The histogram and probability plot for this and are shown in Figure 3.12.  
 
 
 
 
 
 
 
 Kruskal-Wallis analysis showed a significant effect in performance whereby 
control performance (median=7, average rank=52.3) was higher than acute mild 
(median=5, average rank=36.9) and moderate (median=5, average rank=28.0) patient 
performance (H=10.67, p=0.005). One-tailed post-hoc Mann-Whitney U analysis 
showed that while controls performed significantly better than both mild (p=0.003) 
and moderate (p=0.004) patients, there was no significant difference between mild 
and moderate patient performance (p=0.189). Mann-Whitney U analysis between 
controls and returning patient performance (median=6) also indicated that controls 
still performed significantly better than returning patients (p=0.037). These findings 
are shown in Figure 3.13. 
 
 
 
 
 
 
 
Figure 3.12. A histogram and probability plot to examine for normality in the distribution of Control 
Backwards Digitspan scores. 
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Figure 3.13. Box plot to show Backwards Digitspan performance in Controls, mild 
patients and moderate patients at the acute time-point, and returning patients. A dashed 
arrow indicates a significant effect in those groups it covers as found by ANOVA / Kruskal 
Wallis. A solid bracket between two specific groups indicates a significant difference as 
found by t-test / Mann Whittney. 
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3.6.2.7 Backwards Spatialspan: The Anderson-Darling test on Backwards 
Spatialspan distribution showed that Control (p=<0.005) performance was not 
normally distributed. The histogram and probability plot for this and are shown in 
Figure 3.14. 
 
 
 
 
 
 
 
 
Kruskal-Wallis analysis showed a significant effect in performance whereby 
control performance (median=8, average rank=50.5) was higher than acute mild 
(median=7, average rank=35.4) and moderate (median=8, average rank=43.1) patient 
performance (H=7.46, p=0.024). Post-hoc, one-tailed Mann-Whitney U analysis 
showed that while controls performed significantly better than mild patients (p=0.003) 
there was no significant difference between control and moderate patient 
performance (p=0.272) or acute mild and acute moderate patient performance 
(p=0.999; a two tailed test was also conducted here which also showed no significant 
difference; 0.486). Mann-Whitney U analysis indicated that performance between 
controls and returning patient performance (median=7) was no longer significant 
(p=0.234). These findings are shown in Figure 3.15. 
 
 
 
 
 
Figure 3.14. A histogram and probability plot to examine for normality in the distribution of Control 
Backwards Spatialspan scores. 
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Figure 3.15. Box plot to show Backwards Spatialspan performance in Controls, mild 
patients and moderate patients at the acute time-point, and returning patients. A dashed 
arrow indicates a significant effect in those groups it covers as found by ANOVA / Kruskal 
Wallis. A solid bracket between two specific groups indicates a significant difference as 
found by t-test / Mann Whittney. 
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3.6.2.8 Verbal Fluency: The Anderson-Darling test on Verbal Fluency 
distribution showed that Control performance was normally distributed in both 
conditions (VLF; p=0.957, Category Fluency; p=0.111). In the VLF condition: One-way 
ANOVA showed a significant effect whereby acute mild (mean=33.83, SD=12.43) and 
moderate (mean=18.57, SD=11.15) patient performance appeared decreased 
compared to controls (mean=41.63, SD=9.38, F(2,77)=13.24, p=<0.001). One-tailed 
post-hoc t-test analysis revealed all possible differences to be significant; controls 
performed significantly better than both mild (p=0.002) and moderate (p<0.001) 
patients, while mild patients also performed significantly better than moderate 
patients (p=0.006). However t-test comparison indicated that performance in the 
Controls and returning Patients (mean=38.8, SD=10) was no longer significantly 
different (p=0.303).  
In the Category Fluency condition: One-way ANOVA showed a significant effect 
whereby acute mild (mean=37.47, SD=9.96) and moderate (mean=25.75, SD=11.71) 
patient performance appeared decreased compared to controls (mean=44, SD=9.02, 
F(2,79)=12.04, p=<0.001). One-tailed post-hoc t-test analysis revealed all possible 
differences to be significant; controls performed significantly better than both mild 
(p=0.004) and moderate (p=0.002) patients, while mild patients also performed 
significantly better than moderate patients (p=0.013). However t-test comparison 
indicated that performance in the Controls and returning Patients (mean=40.05, 
SD=7.56) was no longer significantly different (p=0.091). All of the Verbal Fluency 
findings are shown in Figure 3.16.  
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Figure 3.16. Box plots to show Verbal Fluency performance in Controls, mild patients 
and moderate patients at the acute time-point, and returning patients. The VLF 
condition is shown top and the Category Fluency condition is shown bottom. A dashed 
arrow indicates a significant effect in those groups it covers as found by ANOVA / Kruskal 
Wallis. A solid bracket between two specific groups indicates a significant difference as 
found by t-test / Mann Whittney. 
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3.6.2.9 CWIT: The Anderson-Darling test on CWIT distribution showed that 
Control performance was normally distributed in both conditions (Colour naming; 
p=0.513, Switching; p=0.104). In the Colour Naming condition: One-way ANOVA 
showed no significant effect when comparing control (mean=24.66, SD=9.39), and 
acute mild (mean=26.88, SD=15.43) and moderate (mean=21.86, SD=20) patient 
performance (p=0.599). Post-hoc, one-tailed t-test comparison showed no significant 
in any comparison; control vs. mild patient (p=0.221), control vs. moderate patient 
(p=0.365), mild vs. moderate patient (p=0.273). t-test comparison indicated that 
performance in the Controls and returning Patients (mean=28, SD=23.2) was also not 
significantly different (p=0.53).  
In the Switching condition: One-way ANOVA showed no significant effect when 
comparing control (mean=10.5, SD=10.56), and acute mild (mean=20.93, SD=19.18) 
and moderate (mean=26.43, SD=54.44) patient performance (p=0.065). Post-hoc 
testing here was conducted as two-way t-test comparisons after inspection of the 
means and boxplot (Figure 3.17). It was found that controls performed significant 
worse than mild patients (p=0.004), although there was no difference between 
controls and moderate patients (p=0.47) or mild and moderate patients (p=0.8). t-test 
comparison indicated that performance in the Controls and returning Patients 
(mean=55, SD=199; there was one highly anomalous result which skewed the mean 
up) was also not significantly different (p=0.321). All of the CWIT findings are shown in 
Figure 3.17. 
All findings are then summarised in Table 3.6, following CWIT Figures. 
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Figure 3.17. Box plots to show CWIT performance in Controls, mild patients and 
moderate patients at the acute time-point, and returning patients. The Colour Naming 
condition is shown top and the Switching condition is shown bottom. The highly 
anomalous result in the follow-up condition has been removed to display the graph on a 
sensible scale. 
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Task 
Sub-
Condition 
Acute Mild / 
Acute Moderate 
Post-Hoc Findings Returning 
Patients 
SoIP -  
All comparisons 
significant 
 
Design 
Learning 
A1 - A5  
Controls outperformed 
mild and moderate 
 
B1    
A6    
List 
Learning 
A1 – A5  
Controls outperformed 
mild and moderate 
 
B1    
A6  
Controls outperformed 
mild and moderate 
 
PASAT 
2 Second 
Intervals 
 
All comparisons 
significant 
 
3 Second 
Intervals 
 
Controls outperformed 
mild and moderate 
 
Backwards 
Digitspan 
-  
Controls outperformed 
mild and moderate 
 
Backwards 
Spatialspan 
-  
Controls outperformed 
mild 
 
Verbal 
Fluency 
VLF  
All comparisons 
significant 
 
Category 
Fluency 
 
All comparisons 
significant 
 
CWIT 
Colour 
Naming 
 
 
 
Switching  
Mild patients 
outperformed controls 
 
Table 3.6. A summary of findings from comparing cognitive test scores. 
Key 
         = A significant effect was found when comparing controls / acute mild / acute moderate performance on that 
task by ANOVA or Krukal-Wallis (in every case of this happening patients underperformed compared to controls). 
         = A significant difference was found when comparing control performance against returning patient 
performance on that task by t-test or Mann Whitney U (in every case of this happening returning patients 
underperformed compared to controls). 
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3.6.2.10 Regression Analyses: Regression analyses were conducted to examine 
if these group differences were due to the TBI or a pre-morbid difference in IQ. The 
findings from these are shown in Table 3.7, overleaf. 
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Task Sub-Condition Acute Time-point Follow-up Time-
point 
SoIP - 
NART = 0.084 
Group = 0.029 
R2 = 16% 
p = 0.001 
NART = 0.293 
Group = 0.769 
R2 = 3.3% 
p = 0.433 
Design Learning A1 - A5 
NART = 0.115 
Group = 0.028 
R2 = 6.9% 
p = 0.065 
NART = 0.607 
Group = 0.18 
R2 = 3.6% 
p = 0.403 
List Learning 
A1 – A5 
NART = 0.301 
Group = <0.001 
R2 = 31.2% 
p = <0.001 
NART = 0.141 
Group = 0.405 
R2 = 8.4% 
p = 0.112 
A6 
NART = 0.314 
Group = 0.001 
R2 = 20.4% 
p = <0.001 
NART = 0.044 
Group = 0.932 
R2 = 9.3% 
p = 0.086 
PASAT 
2 Second Intervals 
NART = 0.004 
Group = 0.058 
R2 = 25.3% 
p = <0.001 
NART = 0.019 
Group = 0.857 
R2 = 12.3% 
p = 0.049 
3 Second Intervals 
NART = 0.088 
Group = 0.014 
R2 = 20.5% 
p = <0.001 
NART = 0.018 
Group = 0.588 
R2 = 11.9% 
p = 0.54 
Backwards 
Digitspan 
- 
NART = <0.001 
Group = 0.659 
R2 = 22.4% 
p = <0.001 
NART = 0.008 
Group = 0.249 
R2 = 21.4% 
p = 0.002 
Backwards 
Spatialspan 
- 
NART = 0.235 
Group = 0.064 
R2 = 10.3% 
p = 0.015 
NART = 0.146 
Group = 0.476 
R2 = 7.6% 
p = 0.139 
Verbal Fluency 
VLF 
NART = 0.001 
Group = 0.075 
R2 = 25.1% 
p = <0.001 
NART = 0.01 
Group = 0.989 
R2 = 14.4% 
p = 0.021 
Category Fluency 
NART = 0.01 
Group = 0.069 
R2 = 19.8% 
p = <0.001 
NART = 0.024 
Group = 0.482 
R2 = 14.4% 
p = 0.02 
Table 3.7. As NART had been found to be significant different between patients and controls, multiple 
regression was conducted using NART and “Group” (Patient / Control) as predictors of performance in each 
test which had been shown to be of interest. Individual p values are given for each predictor (highlighted if 
significant), along with the R2 and overall model significance for each analysis. 
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3.6.3 Discussion: At the acute time-point, patients were found to underperform 
on a number of cognitive tests compared to controls (Table 3.6). By comparing these 
tests with the cognitive skills they purport to measure (Table 3.4), patients initially 
appeared to be impaired on various aspects of executive function (information 
processing, clustering and switching) as well as visuospatial and verbal learning, 
attention, concentration, short-term memory and working memory. One interesting 
case comes from mild patients performing significantly better than controls in the 
switching condition of the CWIT task, although this is unlikely to reflect anything injury-
specific and is more possibly an outcome of either / or the CWIT task otherwise 
appearing very insensitive to detecting cognitive deficit in this patient group and 
potential multiple comparison problems. Examining the returning patient data 
indicates that patient cognitive performance improved over the course of a year as 
there was no longer a significant difference in any cognitive test performance when 
compared to controls, except for Backwards Digitspan. This indicates a degree of 
cognitive recovery in most domains (Backwards Digitspan specifically measures short-
term and working memory), although simply examining test performance doesn’t 
allow for conclusions to be made about if this recovery is due to a lack of lasting 
physiological damage or the development of effective coping strategies.  
The cognitive profile of these patients appears in keeping with what is 
commonly reported in the literature. One paper studying mild TBI (Belanger et al., 
2005) found strong deficits in “delayed memory” and verbal fluency in patients when 
studied less than 3 months post-injury. Another paper focusing on mild TBI highlighted 
the attentional deficits that are often found (Cicerone, 1996), while another found 
mild patients to underperform on the PASAT task and a word association test (another 
broad method of investigating executive function, (Brooks et al., 1999)). The apparent 
recovery of our patients at 1 year post injury is also supportive of literature which 
suggests that cognitive function in mild patients improves rapidly during the first few 
weeks following injury, and often normalises by 3 months (Schretlen and Shapiro, 
2003). 
As there was evidence of pre-morbid IQ being lower in patients than in controls 
(section 3.6.2.1) it was necessary to consider if these findings were more influenced by 
the TBI, or by otherwise lower IQ. Regression analysis was conducted for this. At the 
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acute time point, it was found that NART (IQ) and Group (Patient / Control) were 
individually effective in explaining the variance of approximately half of the cognitive 
test scores each (Table 3.7), indicating that the injury was indeed the cause of 
significant deficit in SoIP, Design / List Learning and the 3 second interval condition of 
the PASAT test, but that NART instead contributed to significant deficit in the 2 second 
interval condition of the PASAT test, Backwards Digitspan and Verbal Fluency. At the 
follow-up time point only NART was found to be a significant contributor to the 
variance in some cognitive test scores, although it should be noted again that at this 
time-point patients only still underperformed in the Backwards Digitspan task (where 
NART was a significant predictor).  
There is debate in the literature as to how effective NART is as a measure of 
pre-morbid IQ. One study (Riley and Simmonds, 2003) found that patients with a 
severe TBI performed better on a second NART test taken a year after the first one, 
implying that on-going recovery from their injury improved their performance on the 
test. The authors concluded that NART may therefore underestimate pre-morbid IQ. 
Another recent study also concluded that performance on the NART test within 1 
month of injury also underestimated premorbid IQ, and that mild patients were 
significantly impaired on NART performance within 1 month of their injury compared 
to 6 months post-injury (Skilbeck et al., 2013). In our data, observing that performance 
on a number of tests where NART was the significant predictor improved over time 
(from being significantly different at 2 weeks to not significantly different at 1 year 
against controls) also supports the hypothesis that recovery, and therefore injury, is 
still influencing task performance in cases where the regression analysis did not show 
this; if these acute test differences were only caused by IQ then we would not expect 
to see a change in them over time. 
 Differences in mild and moderate patient performance were also examined at 
the acute time point (this was not repeated for the follow-up data as sample sizes 
were too small). This found that moderate patients were significantly impaired 
compared to mild patients in the 2 second interval condition of the PASAT task as well 
as both conditions of the Verbal Fluency task. Although these were the only significant 
findings, it was observed that this comparison was approaching significance in other 
tasks; SoIP and the A1-A5 condition of the Design Learning Task each produced a p 
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value less than 0.1. With the moderate patient group contributing only 6 - 8 responses 
on cognitive tests it is likely that further significant findings were missed in these 
comparisons due to a small sample size. While these analyses lend support to the 
notion that there are few enough moderate patients in our sample that they don’t 
necessarily skew the data, they also give some evidence that there may be true 
differences between the mild and moderate patients. This will be considered when 
conducting all subsequent analyses.  
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Chapter 4. Examining the Probability Distribution of Lesions 
4.1 Overview 
 This chapter describes procedures to map the distribution of visible, focal 
lesions at the acute phase of injury. Images showing lesion distribution are produced 
for all patients and some relevant patient sub-groups. Further, statistical testing is then 
conducted to examine relationships between total acute lesion volume for each 
patient and variables such as severity of injury, LoC, PTA and psychometric test 
performance. Based on previous research it is hypothesised that lesion distribution 
would be focused in the frontal lobe. It is also hypothesised that the extent of lesioning 
would be related to psychometric test performance, although would not be a wholly 
sensitive predictor of this as some cognitive deficit is expected to be caused by non-
visible DAI.  
4.2 Methodology 
 4.2.1 Data Acquisition: A 3D T1 weighted sequence was used to obtain basic 
regional anatomy, with scanning taking place in a saggital orientation with 1mm 
isotropic resolution (MPRAGE, TR=8.1ms, TE=4.6ms, matrix size 240×216×180) and 
accelerated with a SENSE factor of 2 in the right-left direction. Image intensity 
correction was applied with the CLEAR reconstruction algorithm.  
The T1 mapping used a rapid inversion recovery sequence with segmented 
inversion slab method and multi-slice single shot EPI readout. Images were scanned in 
a transverse orientation with 2mm isotropic resolution (TR=15s, TE=24ms, matrix size 
128x128x72) and accelerated with a SENSE factor of 2 in the right-left phase direction. 
The 72 slices were split into 6 segments of 60mm width, with each segment being 
imaged at 12 inversion times from 0.25s to 2.5s in even steps, with the order of slices 
being varied throughout these to form the complete relaxation curve.   
The T2 mapping images (GRASE, TR=4.7s, TE=20ms – 160ms in 8 even steps 
[each slice being imaged at 8 different echo times], matrix size 128x128x24) were 
scanned in a transverse orientation with 2mm isotropic resolution and collected in 
segments of 5 k-space lines. 
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1 2 3 
Figure 4.1. A demonstration of the lesion removal technique. 1. Shows a T1W scan of a patient with a visible focal 
lesion in their anterior frontal lobe (the focal damage extends fully to the boundaries of the ROI when also 
examining the qT1 and qT2 scans). 2. Shows the ROI drawn around the affected area. 3. Shows the binary lesion 
image created by this ROI. 
 
All scan data was subjected to movement correction, fitting and unwarping as 
described in section 3.4. 
 4.2.2 Lesion Segmentation: Mr. Cowie had previously conducted work which 
involved removing visible focal lesions from the 3D T1W and quantitative T1 and T2 
scans taken at the acute stage, so that normal-appearing brain tissue could be 
investigated. To do this, the T1W scan was first inspected, and a binary ROI drawn 
around any abnormalities using MRIcro software. This ROI was then overlayed in turn 
onto the quantitative T1 and T2 scans and extended to include any further visible 
lesions which became visible between scan types, resulting in each patient having a 
single ROI which defined visible damage in all 3 modalities. Lesions were identified in a 
total of 45 patients; 36 mild patients and all moderate patients. This new image 
therefore only contained voxels with values of either “0” (areas where lesion had been 
identified) or “1” (areas of normal appearing tissue). This process is demonstrated in 
Figure 4.1. While Mr. Cowie then used these as masks to eliminate areas of lesion from 
scan datasets, these data were recovered here as the first step in producing images to 
show the most commonly damaged locations in TBI patients. 
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4.2.3 Lesion Data Manipulation and Visualisation: The FSLMaths tool (included 
in the FSL package) was first used to invert the lesion ROI images, so that areas which 
contained damaged tissue now had a value of “1” while healthy tissue had a value of 
“0”. This was achieved by subtracting “1” from each image before multiplying each of 
these new images by themselves. Each patient’s basic T1W scan was then individually 
registered to MNI152 (2mm) standard space using the FLIRT tool of the FSL package. 
The accompanying lesion ROI images were included as secondary images during these 
registrations, so that the same registering manipulations which FLIRT applied to the 
T1W scan were also applied to the lesion ROI, creating a set of lesion ROI images in 
MNI152 (2mm) standard space. As this registering process sometimes creates new, 
non-binary values around the edges of lesions due to blurring from the warping 
process, FSLMaths was again used to threshold these new images so that all voxels 
with a value less than “1” once again became “0”. 
These steps produced a dataset consisting of comparable lesion ROI’s for each 
patient. FSLMaths was then used to create averaged images of these so that the most 
commonly damaged locations could be visualised in standard space (adding the images 
together and then dividing that image by the total number in the group). This averaged 
image was then used as an overlay on top of the MNI152 (2mm) standard template. 
This method was first used on all acute patient data, although an error was found at 
this stage. One of the lesion ROI images had areas defined outside of the bounds of the 
brain. In order to correct this, a further binary mask was created based on the MNI152 
(2mm) template, where any brain tissue had a value of “1” and anywhere outside of 
the brain had a value of “0”. This mask was then multiplied with any final, averaged 
overlays to remove the additional voxels.  
Following this correction, MRICron was used to produce final averaged images 
demonstrating locations of common acute damage within different patient groups; all 
patients together, mild patients, moderate patients, patients who returned at follow-
up (AFu) and patients who did not return at follow-up (AL). Images which combined 
mild / moderate groups and AFu / AL groups were also made. While the images of only 
one groups data used a single colour of varying intensity to show lesion distribution, 
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these combined images used different colours for each base overlay so that the 
distribution of lesions between the sub-groups could be directly compared. In these 
instances, manipulations were made to the overlays so that the colour shading was 
solid (i.e. was not affected by how frequently lesions were found in a given area) for 
visual clarity. 
 4.2.4 Lesion Volume Analyses: The fslstats tool (a part of FSL) was used to 
extract the number of non-0 voxels present in each patient’s lesion ROI image (the 
images used for this were the final versions of the lesion ROI’s after all manipulations 
had been applied, i.e. they had been registered into standard space and then re-
thresholded to remove any voxels which didn’t hold a value of exactly “1”). As these 
images only contain “1”’s, for lesion space, and “0”’s, for non-lesion space, this 
number therefore describes the total number of lesion voxels per patient, in standard 
space and can be considered a measure of total lesion volume per patient.  
 Patients who did not have any lesions were assigned a value of “0”, before 
having this data combined with the total number of lesion-voxels for all the other 
patients. These values were then subject to a number of statistical comparisons. The 
first set of analyses focused on testing for lesion volume differences between sub-
groups of patients, and seeking to find relationships between lesion volume and non-
psychometric variables (i.e. GCS, PTA and LoC). The distribution of the total lesion voxel 
count was first examined for normality using the Anderson-Darling test in the following 
groups: all patients, mild patients, moderate patients, AFu patients and AL patients. 
The total number of lesion-voxels was then compared between mild / moderate 
groups, and AFu and AL groups using t-tests if the data was normally distributed and 
the Mann-Whitney U test if the data was not normally distributed. The comparison 
between mild and moderate patients was one tailed due to the clear hypothesis that 
greater injury severity would be expected to lead to a greater amount of lesions. 
Correlational analyses were also conducted. For these, the distribution of GCS, PTA and 
LoC scores were first examined by the Anderson-Darling test to assess normality. 
Correlations were then sought between the total lesion-voxel count and GCS / PTA / 
LoC using Pearsons correlation if data was normally distributed, and Spearmans rank if 
data was not normally distributed. Finally, “FSLutils” tools were used to extract the 
total number of non-zero voxels present in the MNI152 (2mm) template brain, so that 
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relevant results which reported “total lesion voxel count” could also be reported as the 
% of the brain which the lesion occupies. 
The second set of analyses focused on testing psychometric data with lesion 
volume data. For these, the acute scores on all psychometric test where patients had 
been found to underperform compared to controls (as previously summarised in Table 
3.6) were correlated against total lesion-voxel count. Pearsons correlation was 
conducted in the case of normally distributed data while Spearmans rank correlation 
was used in the case of non-normally distributed data (while the distributions of GCS, 
PTA and LoC are reported here, the distributions of psychometric test scores can be 
found in section 3.6.2). These correlations were conducted considering all patients as a 
single group. Finally, groupwise analyses were also conducted comparing test scores 
between patients with visible lesions and patients without visible lesions. The data 
used here were the acute scores on all psychometric tests where patients had been 
found to underperform. t-tests were used for normally distributed data and Mann-
Whitney U was used for data which was not normally distributed. All testing was 
conducted using an alpha value of 0.05. 
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4.3 Results 
4.3.1 Lesion Distribution in all Patients: Visual inspection (Figure 4.2) indicates the anterior, inferior and lateral parts of the 
frontal and temporal lobes to be most frequently damaged, although lesions are also found in many other cortical locations around the 
brain. The marginally posterior, medial parts of the brain appear the most unaffected. 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2. Outputs showing areas of visible damage in all patients at the acute time-point. The variation in shading represents frequency of lesioning in that location; 
the shade of colour becomes brighter and more intense if more lesions were found in that area.  
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 4.3.2 Lesion Distribution in Mild Patients: Visual inspection (Figure 4.3) again indicates the anterior, inferior and lateral parts of 
the frontal and temporal lobes to be the most frequently damaged while other damage is more sporadically found around the cortex. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3. Outputs showing areas of visible damage in mild patients. The variation in shading represents frequency of lesioning in that location; the shade of colour 
becomes brighter and more intense if more lesions were found in that area.  
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 4.3.3 Lesion Distribution in Moderate Patients: Despite the greatly reduced sample size for this patient sub-group, visual 
inspection (Figure 4.4) again shows a similar pattern of damage to mild patients with lesions most strongly concentrated in the anterior, 
inferior and lateral parts of the frontal and temporal lobes with other damage more sporadically distributed around the cortex. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4. Outputs showing areas of visible damage in moderate patients. The variation in shading represents frequency of lesioning in that location; the shade of 
colour becomes brighter and more intense if more lesions were found in that area.  
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4.3.4 Direct Mild / Moderate Comparison of Lesion Distribution: Contrasting the distribution of damage in the mild and moderate 
patient groups (Figure 4.5) does show a number of locations where damage is only present in one group, particularly in the mild group, 
although with a similar overall distribution (as indicated by the purple areas).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5. Outputs showing areas of visible acute damage split by mild and moderate patients. Areas of mild patient damage are represented by blue while areas of 
moderate damage are represented by red. Locations where damage was only present in a single group is therefore shown in only that colour, while areas of common 
damage between these sub-groups are mixed, creating a purple shading. Note that shading of base colours is solid (i.e. the same shade regardless of how often lesions 
were found in that location) for clarity. 
= Mild Patients = Moderate Patients = Both 
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 4.3.5 Lesion Distribution in the AFu Sub-Group: Visual inspection of the lesion distribution in the AFu patient sub-group (Figure 
4.6) again shows a similar pattern as previously reported. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.6. Outputs showing areas of visible damage in the AFu patient sub-group. The variation in shading represents frequency of lesioning in that location; the shade 
of colour becomes brighter and more intense if more lesions were found in that area.  
97 
 
 4.3.6 Lesion Distribution in the AL Sub-Group: Visual inspection of the lesion distribution in the AL patient sub-group (Figure 4.7) 
again shows a similar pattern as previously reported.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.7. Outputs showing areas of visible damage in the AL patient sub-group. The variation in shading represents frequency of lesioning in that location; the shade 
of colour becomes brighter and more intense if more lesions were found in that area.  
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4.3.7 Direct AFu / AL Comparison of Lesion Distribution: Contrasting the distribution of damage in the AFu and AL patient groups 
(Figure 4.8) does show a number of locations where damage is only present in one group, particularly in the mild group, although again 
with a similar overall distribution (represented by the turquoise areas).  
 
 
 
 
 
 
 
 
 
Figure 4.8. Outputs showing areas of visible acute damage split by patients who did return at follow-up (AFu) and patients who did not return at follow-up (AL). Areas 
of AFu damage are represented by green while areas of AL damage are represented by blue. Locations where damage was only present in a single group is therefore 
shown in only that colour, while areas of common damage between these sub-groups are mixed, creating a turquoise shading. Note that shading of base colours is solid 
(i.e. the same shade regardless of how often lesions were found in that location) for clarity. 
= AFu Group = AL Group = Both 
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 4.3.8 Lesion Volume Analyses: Testing for normality of the lesion-voxel counts 
using the Anderson-Darling test showed data to not be normally distributed in all 
patient, mild patient, AFu patient and AL patient groups (all p values <0.005), likely due 
to the high number of patients with no visible lesions. Only the data in the moderate 
patient group was shown to be normally distributed (p=0.371). This necessitated using 
non-parametric statistics for all further groupwise and correlation analyses which 
involved the lesion-voxel counts (i.e. all analyses except psychometric performance 
between patients with lesion vs patients without lesions, where the analysis 
techniques used were governed by the normality of the psychometric data itself). 
Regarding the first set of analyses (concerning non-psychometric data), Mann-
Whitney U analysis showed a significant difference between the total lesion-voxel 
count of mild (median=2773.5 (1.21% of total brain volume)) and moderate patients 
(median=8177 (3.58% of total brain volume), p=0.037, one-tailed test) but showed no 
significant difference between AFu (median=2569 (1.12% of total brain volume)) and 
AL patients (median=3995.5 (1.75% of total brain volume), p=0.478, two-tailed test). 
No significant correlations were found between total lesion-voxel count and GCS 
(p=0.059), LoC (p=0.981) or PTA (p=0.391).  
Regarding the second set of analyses (concerning psychometric data), 
correlational analysis showed two significant, negative correlations between total 
lesion-voxel count and each of the Verbal Fluency conditions at the acute time-point; 
VLF (R=-0.319, p=0.027, Figure 4.9), Category Fluency (R=-0.308, p=0.03, Figure 4.10). 
As the general pattern of these correlations were quite weak it was decided that 
multiple comparison correction was appropriate. Following bonferoni correction 
(which revised the alpha value to 0.005) these did not remain significant. The full set of 
correlational findings are shown overleaf in Table 4.1. No other correlations were 
significant. 
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Groupwise analyses on psychometric data showed significant differences on all 
tests except SOIP and Backwards Digitspan / Spatialspan wherein patients without 
lesions performed better than patients with lesions. These findings are shown overleaf 
in Table 4.2.
Task Test Sub-Category R value p value 
SOIP - -0.071 0.619 
Design Learning A1-A5 -0.269 0.059 
List Learning 
A1-A5 -0.195 0.167 
A6 -0.169 0.232 
PASAT 
2 Second Intervals -0.157 0.298 
3 Second Intervals -0.228 0.128 
Backwards 
Digitspan 
- -0.123 0.39 
Backwards 
Spatialspan 
- 0.027 0.85 
Verbal Fluency 
VLF -0.319 0.027 
Category Fluency -0.308 0.03 
Table 4.1. Results from Spearmans Rank correlation analyses between the total lesion-voxel count 
and all performance on psychometric tests where patient had previously found to be impaired. 
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4.4. Discussion 
 4.4.1 Lesion Distribution: The overall probability distribution of lesions (Figure 
4.2) shows evidence that the anterior, inferior frontal cortex is the area of the brain 
most frequently injured to the extent that lesions can be seen on more basic 
anatomical scans. Other lesioning was detected more sporadically around the rest of 
the cortex, albeit to a lesser extent. These findings support previous work which found 
cortical contusions, particularly present within the anterior, inferior and lateral aspects 
of the frontal and temporal lobes to account for 84% of detectable, non-DAI damage 
Task 
Test Sub-
Category 
Descriptive Data of 
Non-Lesion Group (N) 
Descriptive Data of 
Lesion Group 
p value 
SOIP - 
Mean = 69.7, SD = 21.6 
(7) 
Mean = 55.9, SD = 
18.7 (44) 
0.154 
Design 
Learning 
A1-A5 
Mean = 41.33, SD = 
2.58 (6) 
Mean = 34.91, SD = 
8.5 (44) 
<0.001 
List Learning 
A1-A5 
Mean = 52.13, SD = 
9.05 (8) 
Mean = 41.3, SD = 
13.7 (44) 
0.014 
A6 
Mean = 11.63, SD = 
2.77 (8) 
Mean = 7.66, SD = 
3.94 (44) 
0.005 
PASAT 
2 Second 
Intervals 
Mean = 57.1, SD = 27 
(8) 
Mean = 32.7, SD = 
26.5 (38) 
0.042 
3 Second 
Intervals 
Mean = 77.9, SD = 18.2 
(8) 
Mean = 54.6, SD = 
30.6 (38) 
0.011 
Backwards 
Digitspan 
- Median = 6 (7) Median = 5 (44) 0.122 
Backwards 
Spatialspan 
- Median = 7 (7) Median = 7 (44) 0.743 
Verbal 
Fluency 
VLF 
Mean = 42.43, SD = 8.9 
(7) 
Mean = 29.8, SD = 
13.1 (41) 
0.008 
Category 
Fluency 
Mean = 44.43, SD = 6.6 
(7) 
Mean = 34.2, SD = 11 
(43) 
0.005 
Table 4.2. Results from groupwise testing comparing psychometric performance (on tests where patients 
were previously found to be impaired) between patients with lesions and patients without lesions. t-tests 
were used where data was normally distributed and Mann-Whittney U tests were used where data was not 
normally distributed. 
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following closed head injury (Gentry et al., 1988). Medial parts of the brain and areas 
marginally posterior to these (the thalamus, splenium of the corpus callosum etc.) 
appeared to have been spared of lesions detectable by these types of scans. Examining 
patient sub-groups showed some areas which were damaged in one sub-group but not 
in the counterpart sub-group. However the overall distribution remained comparable, 
supporting that neither the mild / moderate or AFu / AL groups are fundamentally 
different to one another (Figures 4.3-4.8). 
 The distribution of these lesions is perhaps unsurprising as most methods of 
injury (road traffic accidents, assaults etc.) would tend to involve impacts to the front / 
front sides of the head. Injuries which primarily involve the back of the head are less 
conceivable. As such the number of lesions which were detected in areas such as the 
occipital lobe are likely relatively reduced because of this, or may have been caused by 
contra-coup injury which affected only a proportion of otherwise frontal injuries.  
 4.4.2 Lesion Volume Analyses: Further experimentation extracted the total 
number of lesion-voxels for each patient as a measure of that individual’s total volume 
of lesions. This data was first used to again test for differences between mild / 
moderate and AFu / AL groups. As may be expected, moderate patients had a 
significantly higher lesion-voxel count compared to mild patients. Supporting this, a 
correlational analysis comparing lesion-voxel count with GCS was nearly-significant; 
this would have suffered from a lack of power coming from more severe scores and 
would likely have been significant with more moderate patients. AFu and AL 
comparison showed no significant difference supporting that the patients who did and 
who did not return for follow-up examination had no fundamentally different pattern 
of focal lesions. Neither LoC and PTA correlated with lesion-voxel count, implying that 
the duration of unconsciousness or amnesia associated with the injury are not related 
to the amount of visible lesions. 
Lesion volume information was also examined in relation to psychometric 
performance. Correlations were sought between lesion-voxel count and acute test 
scores in tasks where patients had previously been shown to underperform. Two of 
these were initially significant with performance on both conditions of the Verbal 
Fluency task (VLF and Category fluency) negatively correlating with lesion-voxel count, 
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implying that higher lesion volume is related to worse performance. However these 
did not retain significance following bonferroni correction. However, groupwise testing 
of performance on this set of tasks between patients with lesions and patients without 
lesions returned many significant results, all indicating worse performance in patients 
with lesions.  
 These psychometric findings support previous literature which indicates the 
areas that have been shown to be most frequently damaged to be relevant to aspects 
of cognition which our psychometric battery tests. Research has found various areas of 
the frontal lobe to be involved in a broad range of cognitive functions including 
executive control, inhibition, attentional selection, working memory (specifically 
including storage of spatial and object information) and problem solving (Duncan and 
Owen, 2000, Smith and Jonides, 1999, Aron et al., 2004, Dias et al., 1996). The frontal 
lobe is in fact so often associated with executive function-style tasks (as most of our 
cognitive test battery involves) that some research interchangeably uses the term 
“frontal lobe tasks” with “executive tasks” (Miyake et al., 2000). Areas of the temporal 
lobe are also known to be involved in functions utilising aspects of memory such as 
declarative memory and encoding of verbal and non-verbal information (Squire et al., 
2004, Kelley et al., 1998). 
The reason why correlational analysis returned fewer findings than groupwise 
analysis is likely because examining total lesion volume is a blunt a method of 
predicting test scores which measure specific deficits. Mesulams neural node theory 
(Mesulam, 1998) implies that all that specific cognitive function is dependent on a 
network of focal nodes involved with that process. Total lesion volume across the brain 
is therefore irrelevant to a single test score provided that some of the relatively small 
areas of the brain which govern the cognitive domain measured by the test are 
damaged. As groupwise analysis between patients with / without lesions ignores total 
lesion volume (opposed to correlational analysis which depends upon it) this is 
therefore more accurate predictor of task performance. 
However, not all tasks were shown to be related to visible lesions, supporting 
theories of non-visible damage also affecting cognitive outcome following TBI. As DAI 
has been shown to occur in mild TBI and to predominantly affect major white matter 
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tracts it should be considered that some of the cognitive symptoms displayed by these 
patients could be primarily due to microscopic damage.  
4.5 Chapter Summary 
 Lesion probability mapping has shown our patient cohort to primarily suffer 
from visible damage to anterior, inferior and lateral aspects of the frontal and 
temporal lobes. While the acute distribution of lesions does not appear different 
between mild / moderate patients and patients who did / did not return at follow-up, 
further statistical testing concerning lesion volume implied that visible lesion volume 
may increase with injury severity. Groupwise and correlational analysis also suggested 
that visible lesions predict worse psychometric test performance, although measuring 
the actual volume of lesioning is not as sensitive a measure of doing this as simply 
noting if the patient does or does not have visible lesions. Finally, as some test 
performance remained un-related to the presence of / volume of lesioning there is 
evidence to suggest that non-visible damage may also be contributing to some 
cognitive deficit. As such, he specific hypothesis that lesion load would be a reasonable 
predictor of cognitive deficit is not supported, although the findings do more broadly 
indicate that focal lesions partially contribute to cognitive outcome.  
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Chapter 5. Diffusion Tensor Imaging Investigation 
5.1 Overview 
 This chapter describes a DTI-based investigation conducted on the group of 
participants previously described in Chapter 3. This investigation aimed to expand on 
previous work in the field by focusing on patient groups and research techniques 
which have been arguably underused thus far in DTI research pertaining to DAI 
following TBI and acquired cognitive deficit. We present a comprehensive, longitudinal 
DTI study in mild and moderate TBI, using TBSS to examine DTI metric changes 
between acute and chronic time points and explore how this relates to acquired 
cognitive deficits following TBI. We hypothesised that the cognitive dysfunction widely 
observed during the acute period post TBI would have a neurobiological correlate in 
acute DAI detected by diffusion imaging changes. We further hypothesised that this 
would still be recognisable in the chronic phase. The main aspects of this investigation 
have been published (Croall et al., 2014) (Appendix C), although additional analyses / 
details are provided here.  
5.2 Methodology  
5.2.1 DTI Data Acquisition: Participants were scanned using a single shot EPI 
diffusion sequence on a 3T Philips Achieva MRI scanner with an 8 channel SENSE head 
coil. A 3D T1 weighted sequence was used to obtain basic regional anatomy (MPRAGE, 
TR=8.1ms, TE=4.6ms, matrix size 150×240×240, isotropic 1mm resolution). DTI scans 
were collected with the following parameters: TR/TE=2524/71ms, 24 slices, 
b=0,1000smm-2, 16 direction, 2x2x6mm3 resolution. A magnetic field map sequence 
was also acquired for correction of geometric distortion of the DTI scans (dual echo 3D 
GRE, TR=27ms, TE=2.6/6.1ms, matrix 128x128x72, 2mm resolution). 
5.2.2 Main DTI Data Analysis: DTI scans were processed using the FSL toolbox 
(Smith et al., 2004). Raw scan data were corrected for geometric distortion (FUGUE) 
and residual eddy current effects were removed by affine registration of each scan to 
the b=0 s.mm-2 image. Scans were then fit to the diffusion tensor model to produce 
maps of mean diffusivity (MD), fractional anisotropy (FA) and principle eigenvalues and 
eigenvectors. Voxelwise statistical analysis of the data was carried out using the TBSS 
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(Smith et al., 2006) package. Figure 5.1 describes the steps involved in using TBSS and 
gives examples of typical outputs. For each subject all diffusion scans were 
transformed into the MNI152 standard space using non-linear registration (FNIRT) to a 
target FA template image provided in TBSS. The accuracy of the nonlinear 
transformation was verified by visual inspection of the data. A mean FA skeleton 
representing the centres of all tracts common to the group was created by averaging 
the registered FA images and then thresholding the mean FA image at FA>0.2. Each 
subject's registered FA data was then projected onto the mean FA skeleton, which 
accounted for residual misalignments between subjects after the initial nonlinear 
registration. Data for MD and the 3 principle eigenvalues were also projected onto the 
mean skeleton by using non-linear registration and projection vectors from the FA 
images.  
The resulting registered sets were fed into voxelwise cross-subject statistics. All 
TBSS statistical analyses were run with 5000 permutations other than those ran with 
500 permutations, as described in section 5.2.3. Additionally, “threshold free cluster 
enhancement” (TFCE (Smith and Nichols, 2009)) output images were used for analysis 
with p < 0.05 being treated as significant. TFCE is a non-binary technique where 
clusters of significant voxels are identified and enhanced in the output image. It 
achieves this by producing a new value for each voxel which is the weighted sum of the 
local clustered signal. TBSS was used to examine differences in acute DTI metrics (FA, 
MD, AD and the constituent parts of RD; λ2 and λ3) in a between subjects control vs. 
patient analysis. Follow-up DTI metrics were analysed by between subjects control vs. 
patient analysis. All patients were considered as a single group when testing for 
control versus patient metric differences. However some post-hoc analyses focused on 
examining any differences between mild and moderately injured patients (described in 
section 5.4.2).  
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5.2.3 Neuropsychological Data Analysis: Due to strong cognitive deficits being 
shown between all experimental groups in cognitive test scores (described in Chapter 
3), VLF, Category Fluency, PASAT (3 second condition) and SoIP test scores were 
chosen to be (separately) regressed against FA in TBSS as a pilot investigation (run with 
500 permutations). T-stat images were examined from these as a means of looking at 
the raw findings; only regressing voxels with a T-stat above 3 were counted as 
“significant”. The number of these significant pixels were counted from each of these 
images using the histogram function in the software ImageJ. PASAT returned no 
significantly regressing pixels, while a summary of the other three cognitive test results 
Figure 5.1. A visualisation of how TBSS works and examples of typical outputs. TBSS warps all 
participant scans into standard (MNI) space (part A) in order to conduct voxelwise analysis. A 
“mean FA skeleton” (part B) is produced to highlight the location of white matter tracts in this 
standard space. The skeleton is combined with the MNI 1mm brain (part C) and used as a mask to 
determine the voxels which are to be subject to analysis. Any locations which produce significant 
results following analysis are highlighted (part D). In this case, blue locations show areas of 
negative regression between FA and VLF scores. 
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is shown in Table 5.1, below; VLF convincingly returned the most significant results and 
was chosen to be investigated further. To determine whether there was a relationship 
between DTI changes and cognitive performance TBSS was used to perform regression 
analysis of VLF scores against FA, MD, AD and the constituent parts of RD; λ2 and λ3, 
while controlling for NART in both acute and follow-up conditions. This analysis was 
completed for controls and patients separately. λ2 and λ3 images were averaged to 
create a single image for RD. As not every patient was able to complete the 
psychometric tests due to reasons relating to their injury, sample size for statistical 
testing which involved this data was reduced compared to testing which involved only 
DTI metric data (acutely; 7 patients were excluded, chronically; 2 patients were 
excluded). Additionally, as psychometric data for 1 control participant was absent this 
also reduced the Control group to 32 for relevant testing.  
 
 
 
Test (type of 
regression) 
No significant pixels 
above T-stat 3 
Comments on location 
Letter 
Fluency 
(positive) 
55 
Brainstem and short fibres between superior 
parietal / frontal lobes. 
Letter 
Fluency 
(negative) 
4789 Very diffuse spread.  
Category 
Fluency 
(positive) 
79 
Diffuse areas within brainstem, cerebellum, 
occipital and frontal lobes. 
Category 
Fluency 
(negative) 
1618 Very diffuse spread 
SOIP 
(positive) 
53 Very diffuse spread 
SOIP 
(negative) 
165 
One focal spot in short fibres between 
occipital and parietal lobes. 
Table 5.1. An overview of how many pixels with a T-stat above 3 were found to regress when 
comparing FA with VLF, Category Fluency, PASAT (3 second conditions) and SoIP. PASAT is not 
included here as no regressing pixels were found.  
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5.3 Results 
Please note that the slices used in figures have been chosen for both clarity of 
results and ease of comparison between analyses and time-points. However due to the 
widespread nature of reported changes, some tract locations which demonstrated a 
significant result may be reported in the text but not shown in a figure. The co-
ordinates used in the following figures are in MNI space. 
5.3.1 Acute Groupwise Differences in Diffusion Metrics: At the acute time 
point groupwise control versus patient comparison revealed multiple, widespread 
locations of increased FA (Figure 5.2), AD (Figure 5.3) and MD (Figure 5.4) in the 
patient group with a complex spatial relationship to one another. The FA increases 
were observed bilaterally in a tract later identified as the ascending fibres of the 
corpus callosum (see section 5.4.1) and also association fibres. Major locations of 
increased MD were posterior aspects of the ascending fibres of the corpus callosum 
and also association fibres. These changes in FA and MD were seen to overlap with 
increased AD. While AD showed extensive increases throughout the white matter 
tracts, RD did not demonstrate any locations of significant difference.  
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Figure 5.2. TBSS outputs demonstrating locations of FA change following TBI at the acute time point. All 
changes are increases (coloured red/yellow) in the Patient group compared to controls. Z co-ordinates are 
based around the AC/PC line being Z=0. Colour bar values are 1 – p value. 
 
Y = -57 -27 3 33 
X = -30 -10 10 30 
Z = -30 -10 0 10 
20 30 40 50 
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Figure 5.3. TBSS outputs demonstrating locations of AD change following TBI at the acute time point. All 
changes are increases (coloured red/yellow) in the Patient group compared to controls. Z co-ordinates are 
based around the AC/PC line being Z=0. Colour bar values are 1 – p value. 
 
Y = -57 -27 3 33 
X = -30 -10 10 30 
Z = -30 -10 0 10 
20 30 40 50 
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Figure 5.4. TBSS outputs demonstrating locations of MD change following TBI at the acute time point. All 
changes are increases (coloured red/yellow) in the Patient group compared to controls. Z co-ordinates are 
based around the AC/PC line being Z=0. Colour bar values are 1 – p value. 
 
Y = -57 -27 3 33 
X = -30 -10 10 30 
Z = -30 -10 0 10 
20 30 40 50 
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5.3.2 Chronic Groupwise Differences in Diffusion Metrics: Comparison of 
follow-up patient (12 months post injury) vs. control data showed groupwise 
differences in the patients but with altered patterns of changes compared to the acute 
time point (Figures 5.5-5.7). FA was now decreased in the Anterior Forceps but was no 
longer different to control in the locations where the most widespread differences had 
been seen acutely (Figure 5.5). In further contrast with the acute data, RD was now 
increased in areas such as the anterior forceps, thalamic projections and association 
fibres (Figure 5.6), while AD had returned to normal and did not demonstrate any 
locations of significant difference in the follow-up patient vs. control analysis; a 
complete reversal of the pattern observed acutely. MD remained significantly 
increased in the same locations where it was observed acutely, but had also expanded 
to include the same part of the Anterior Forceps where FA was decreased (Figure 5.7).  
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Figure 5.5. TBSS outputs demonstrating locations of FA change following TBI at the chronic time point. All 
changes are decreases (coloured blue/light blue) in the Patient group compared to controls. Z co-ordinates are 
based around the AC/PC line being Z=0. Colour bar values are 1 – p value. 
 
Y = -57 -27 3 33 
X = -30 -10 10 30 
Z = -30 -10 0 10 
20 30 40 50 
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Figure 5.6. TBSS outputs demonstrating locations of RD change following TBI at the chronic time point. All 
changes are increases (coloured red/yellow) in the Patient group compared to controls. Z co-ordinates are 
based around the AC/PC line being Z=0. Colour bar values are 1 – p value. 
 
Y = -57 -27 3 33 
X = -30 -10 10 30 
Z = -30 -10 0 10 
20 30 40 50 
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Figure 5.7. TBSS outputs demonstrating locations of MD change following TBI at the chronic time point. All 
changes are increases (coloured red/yellow) in the Patient group compared to controls. Z co-ordinates are 
based around the AC/PC line being Z=0. Colour bar values are 1 – p value. 
 
Y = -57 -27 3 33 
X = -30 -10 10 30 
Z = -30 -10 0 10 
20 30 40 50 
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5.3.3 Acute Cognitive Testing and TBSS Analysis: While full psychometric test 
performance differences between patients and controls was covered in detail in 
Chapter 3, VLF findings are repeated here for clarity. Patients VLF performance (Mean 
= 31.6, SD = 13.3) was significantly worse at the acute time point compared to controls 
(Mean = 41.63, SD = 9.38, t(77) = 3.95, p < 0.001). Widespread locations of negative 
regression between acute FA and acute VLF scores (controlling for NART) were found 
in the patient group in the ascending fibres of the corpus callosum, the superior 
corona radiata and other association fibres (Figure 5.8). Analysis of the other DTI 
metrics revealed locations of positive regression between acute VLF and RD (Figure 
5.9) in the same locations as the FA results, and small locations of positive regression 
between acute VLF and MD in posterior association fibres (Figure 5.10). Acute VLF and 
acute AD did not demonstrate any locations of regression. The control group showed 
no locations of any regression between any metric and VLF. 
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Figure 5.8. TBSS outputs demonstrating locations of regression between FA and VLF scores (controlling for 
NART) in the Patient group at the acute time-point. All regressions are negative (coloured blue/light blue). Z 
co-ordinates are based around the AC/PC line being Z=0. Colour bar values are 1 – p value. 
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Figure 5.9. TBSS outputs demonstrating locations of regression between RD and VLF scores (controlling for 
NART) in the Patient group at the acute time-point. All regressions are positive (coloured red/yellow). Z co-
ordinates are based around the AC/PC line being Z=0. Colour bar values are 1 – p value. 
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Figure 5.10. TBSS outputs demonstrating locations of regression between MD and VLF scores (controlling for 
NART) in the Patient group at the acute time-point. All regressions are positive (coloured red/yellow). Z co-
ordinates are based around the AC/PC line being Z=0. Colour bar values are 1 – p value. 
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5.3.4 Chronic Cognitive Testing and TBSS Analysis: Follow-up cognitive test 
scores showed no significant difference in patient vs. control comparisons. Follow-up 
patient VLF was regressed against follow-up DTI metrics. This was conducted despite 
the lack of a groupwise difference in patient VLF performance in order to see if any 
evidence of the acute regression remaining chronically. Negative regressions between 
FA/VLF remained in the fibres of the corpus callosum although were far less 
widespread than in the acute condition, remaining primarily in the Body of the corpus 
callosum (Figure 5.11). A very small cluster of negative regression between AD/VLF 
was also located in the right CC fibres, although this was deemed too small to be a 
confidently reportable finding. RD/MD did not regress with VLF. Note that the 
illustrated slices used in Figure 5.11 have been changed from those used previously in 
order to better show these findings. All of these main findings are further summarised 
in Table 5.2. 
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Figure 5.11. TBSS outputs demonstrating locations of regression between FA and VLF scores (controlling for 
NART) in the Patient group at the chronic time-point. All regressions are negative (coloured blue/light blue). Z 
co-ordinates are based around the AC/PC line being Z=0. Colour bar values are 1 – p value. 
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 Fractional 
Anisotropy 
Mean Diffusivity Radial Diffusivity Axial Diffusivity 
Groupwise Diffusion Tensor Imaging findings versus Control Group 
Acute 
 
 Ascending CC 
and assoc. fibres 
 Posterior CC 
(splenium) and 
assoc. fibres 
No difference  Widespread WM 
tracts 
Chronic 
 
 Anterior 
forceps 
 Posterior CC 
(splenium), 
assoc. fibres and 
anterior forceps 
 CC, thalamic 
projections 
assoc. fibres and 
anterior forceps 
No difference 
Diffusion Tensor Imaging vs. Verbal Letter Fluency 
Acute  CC, ascending 
CC fibres and 
assoc. fibres 
correlates with 
poorer VLF score 
 CC and assoc. 
fibres correlates 
with better VLF 
score 
 CC, ascending 
CC fibres and 
assoc. fibres 
correlates with 
poorer VLF score 
No regression 
Chronic  CC, correlates 
with poorer VLF 
score (although 
less widespread 
than acutely) 
No regression No regression  CC fibres 
correlates with 
poorer VLF score 
(very small 
location) 
Table 5.2. A summary of results from main DTI group-wise and regression analyses. 
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5.4 Post-Hoc Analyses 
 A total of three post-hoc analyses were conducted. 
 An analysis to replicate the main TBSS findings in a tractography investigation 
(5.4.1). 
 An analysis to identify any potential differences between mild and moderate 
patients (5.4.2). 
 An analysis to identify any potential differences between those patients who 
did and did not return for follow-up testing (5.4.3, and Appendix B). 
 5.4.1 Post-Hoc Tract Analysis  
  5.4.1.1 Aim: One tract had featured particularly prominently in acute 
groupwise and regression analysis findings (Figure 5.12). As the damage TBI and DAI 
causes can affect white matter tracts in a way which impacts upon DTI metrics in ways 
which may lead to problems such as different tracts being measured between groups 
(e.g. in cases where there may be selective destruction of crossing fibres following 
TBI), it was decided that a more detailed, tractographic investigation of this region 
would be appropriate so that tract structure could be more directly observed. 
Additionally, as it was unclear which specific tract was exhibiting this increased FA, this 
analysis also sought to identify it.  
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 Based on the location the tract was deemed most likely to be the ascending 
fibres from the corpus callosum. Therefore a tractographic, ROI-based analysis was 
conducted on the acute data using the program DTI Studio (Jiang et al., 2006) which 
focused on capturing these fibres and extracting FA, AD, RD and MD values from them. 
Groupwise analysis was then also conducted in an attempt to replicate the acute FA 
increase in the patient group. 
 5.4.1.2 Methodology: Philips REC files were subject to automatic image 
registration before being converted to maps of the diffusion metrics by calculation of 
the diffusion tensor. A colour FA map was used for visualisation and the sagittal plane 
was displaced by a small number of slices (usually 4) towards the left hemisphere until 
Figure 5.12. A TBSS output with arrows to highlight the unknown tract. This particular output shows acute 
increases in patient FA at a z-coordinate level of 40. 
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it sat on the edge of the corpus callosum (Figure 5.13, A). The axial plane was then 
displaced to a location marginally superior to the top of the corpus callosum, allowing 
visualisation of the ascending fibres in the axial view (Figure 5.13, B). Using the “cut” 
function, an oval ROI was then drawn on the sagittal view encompassing the entirety 
of the CC (Figure 5.13, C). Continuing with the “cut” function, a second rectangular ROI 
was then drawn on the axial slice encompassing the length of projected fibres (Figure 
5.13, D). The 3D view was then inspected and any unwanted fibres which had been 
included (e.g. from other tracts than the CC, Figure 5.13, E) were excluded by use of 
the “not” function. Throughout this, the general appearance of tract structure was 
visually examined with regards to any notable differences between control and patient 
tract appearance. Metric data was extracted from the fibres and used for comparison 
with VLF scores. Control metric values were tested for normality with the Anderson-
Darling Test, and found to all be normal. Comparisons between patient and control 
metrics (AD, RD, FA and MD) were therefore made using t-tests while a regression 
analysis also examined any relationship between patient metrics and VLF performance, 
controlling for NART.
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A: Sagittal plane was 
moved marginally into the 
left hemisphere. 
B: Axial plane was placed in 
a location slightly superior 
to the top of the CC so that 
the ascending fibres 
(highlighted) could be 
seen. 
C: Using the “cut” function, 
an oval ROI was drawn 
around the CC in the 
sagittal plane. 
D: Using the “cut” function, 
a rectangular ROI was 
drawn around the 
ascending fibres in the axial 
plane. 
E: Any unwanted fibres 
were visually identified and 
removed by a “not” 
function ROI to finish (F). 
A B C 
D E F 
Figure 5.13. Instructions for localising the ascending corpus callosal fibres in DTI Studio. A: Sagittal plane is moved marginally into the left hemisphere. B: Axial plane is risen 
to a location slightly superior to the top of the CC so that the ascending fibres (highlighted) can be seen. C: Using the “cut” function, an oval ROI is drawn around the CC in the 
sagittal plane. D: Using the “cut” function, a rectangular ROI is drawn around the ascending fibres in the axial plane. E: Any unwanted fibres are visually identified and removed 
by a “not” function ROI to finish (F). 
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 5.4.1.3 Results: Control and patient tract shape and structure appeared broadly 
comparable with one another with no clear repeated differences. Findings from 
statistical analyses are shown in Table 5.3. From the Table, we see that FA is once 
again shown to be significantly higher in the patient group than in controls, although in 
this instance this increase appears to be due to decreased RD rather than increased 
AD. The negative regression between FA and VLF was also replicated, with a positive 
underlying regression between RD and VLF being shown to drive this. 
 
 
 
  5.4.1.4 Summary: DTI estimates tract structure based on the underlying 
diffusion tensors. While DTI has been shown to accurately replicate actual white 
matter tracts in the brain (Wakana et al., 2004), this type of estimation is imperfect as 
the calculation of the tract can be undermined by various other factors which also 
affect the diffusion tensor. For example the existence of two fibre bundles of 
perpendicular orientations in one location would result in a low anisotropy value 
despite there being strong fibre organisation. Previous research has also found that 
Metric Control Values Patient Values 
Control 
vs. 
Patient 
p value 
Metric 
Regression 
Statistics 
NART 
Regression 
Statistics 
FA 
Mean=0.3986 
SD=0.0405 
Mean=0.4309 
SD=0.0498 
0.002 
T Value=-2.36 
p=0.023 
T Value=1.5 
p=0.141 
AD 
Mean=0.001321 
SD=0.000105 
Mean=0.001295 
SD=0.000085 
0.234 
T Value=0.91 
p=0.37 
T Value=2.83 
p=0.007 
RD 
Mean=0.000687 
SD=0.00009 
Mean=0.000631 
SD=0.00007 
0.005 
T Value=2.57 
p=0.014 
T Value=2.26 
p=0.029 
MD 
Mean=0.000898 
SD=0.00009 
Mean=0.000853 
SD=0.00007 
0.018 
T Value=2.15 
p=0.037 
T Value=0.133 
p=0.01 
Table 5.3: Results from groupwise and regression analysis (with VLF) using data derived from tractographic 
analysis of the ascending fibres of the corpus callosum 
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the physical stress of the inertial forces involved in DAI is greater on axons which are 
oriented away from the direction of the main local fibre bundle (Cloots et al., 2011). If 
axons of one orientation are selectively damaged this would not only increase the local 
FA value but also mean create the potential of a patient / control difference in the 
same area being due to measurements from what are essentially two different tracts. 
Other research has also demonstrated how injuries such as TBI can lead to problems in 
tractography; Squarcina et al., (2011) showed how the often-expected reduction in FA 
which might follow TBI leads to tract estimation often failing in areas of high damage. 
Thus the analysis presented here aimed to resolve such possible confounds by visually 
localising the same tract in both experimental groups and replicating the metric 
changes as reported by TBSS.  
 Tracts appeared visually comparable between patient and control groups. 
Groupwise testing also replicated the main TBSS analysis for this region by comparing 
metric values from the same localised tract. Although the groupwise results are slightly 
inconsistent considering the finding of decreased RD, these findings for the most part 
repeated those of the main TBSS analysis for this region. Some deviations in the 
pattern of findings are reasonable considering the likelihood for error in 
tractographically defining the exact same region that the TBSS analysis had 
highlighted.  
 It should also be noted that the positive regression found in both analyses 
between RD and VLF possibly indicates a degree of decreased RD which may not have 
been substantial enough to show as a significant result in the TBSS analysis (discussed 
further in section 5.5.3) but becomes more detectable when more directly examining 
the tract in question. It should also be considered if a reduction in RD as reported here 
could be due to perpendicular fibres being destroyed; however on this point such an 
event would also be expected to lead to increase in AD in the same location which is 
counter to the findings here where AD is statistically unchanged but also descriptively 
decreased in patients. This disparity of AD findings between tractography and TBSS 
analyses suggests that the AD changes for this region in the TBSS analysis may have 
been confounded by additional changes other than tract structure. On balance it 
seems most reasonable to conclude that the tract structure of this location was 
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broadly comparable between patients and controls. Additionally, it can be concluded 
that the identity of the tract was indeed the ascending fibres of the corpus callosum.  
5.4.2 Post-Hoc Examination of Mild and Moderate Patients  
 5.4.2.1 Aim: As a primary objective of this thesis is the examination of mild TBI, 
additional testing was conducted to examine if including 9 moderate patients with the 
44 mild ones had skewed the data in any way which would undermine this.  
 5.4.2.2 Methodology: A TBSS analysis was conducted comparing all acute 
metric data between mild and moderate patients. This analysis was also repeated, but 
using the Mayo classification system for mild / moderate patients (Malec et al., 2007). 
In this way, many “mild” patients (as measured by their GCS score alone) were re-
classified to “moderate” if they had any clinical imaging findings. This meant that 13 
patients remained “mild” while the “moderate” contained the remaining 40. Finally, a 
further TBSS analysis was conducted to investigate if the main findings of the 
investigation would have been any different if only the mild patients (as measured by 
GCS) had been used. To do this, all main analyses were repeated using mild-only 
patient data. 
 5.4.2.3 Results: No areas of any significant difference were found in any metric 
when comparing mild and moderate patients classified by either the GCS or Mayo 
classification. It should be noted that this was the only analysis where the Mayo 
classification system was used to define patient severity; from this point on “mild” and 
“moderate” are once again defined by GCS score alone. Acute mild patient vs. control 
TBSS analysis revealed a comparable set of results where FA was increased (driven by 
increased AD) alongside some locations of increased MD (Figure 5.14 compared to the 
original analysis of the whole group shown in Figures 5.2 – 5.4). 
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Figure 5.14. Acute, groupwise TBSS outputs using only the mild patient data. 
FA 
AD 
RD 
MD 
-20 0 20 40 Z = 
132 
 
 Chronic mild patient vs. control TBSS analysis did not reveal any findings at the 
p=0.05 level, however did show a comparable set of results where FA was decreased 
(driven by increased RD) and MD was increased when the significance threshold was 
reduced to p=0.15, as shown in Figure 5.15. As the group size for mild alone was now 
only 18 patients (compared to the whole chronic group), the lower significance is most 
likely due to reduced statistical power associated with the smaller sample size.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FA 
AD 
RD 
MD 
-20 0 20 40 Z = 
Figure 5.15. Chronic, groupwise TBSS outputs using only the mild patient data. 
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 Acute TBSS analysis regressing VLF scores with mild patient metrics revealed a 
comparable set of results where FA negatively regressed with VLF (driven by a positive 
VLF / RD regression) and MD positive regressed with VLF (Figure 5.16). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.16. Acute, TBSS regression outputs using only the mild patient data 
-20 0 20 40 Z = 
FA 
RD 
MD 
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 Finally, chronic TBSS analysis regressing VLF scores with mild patient metrics 
also revealed a comparable set of results where a negative regression between FA and 
VLF remained in the anterior forceps (Figure 5.17).  
 
 
 
 
 
 
 
 
 
 
 5.4.2.4 Summary: Comparisons between mild and moderate patients by either 
GCS or Mayo severity classifications showed no differences, strongly suggesting that 
there is no underlying physiological difference which would have interfered with the 
main TBSS results. Additionally, repeating the main analyses using only the mild 
patients produced the same set of results aside from one (groupwise examination of 
mild patients at the chronic time-point) which required a reduction in alpha value 
which may be expected considering the reduced sample size. Including a minority of 
moderately injured patients has therefore not undermined the validity of investigating 
mild TBI. 
 5.4.3 Post-Hoc examination of Patients who did not return at Follow-up: 
Further analysis was conducted to investigate if there were any difference between 
the AFu and AL patient subgroups (i.e. the acute data of those  patients who did and 
who did not return for follow-up testing). There were many analyses conducted in 
FA 
 
 5 10 15 20 
25 30 35 
Figure 5.17. Chronic, TBSS regression outputs using only the mild patient data 
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order to do this, and so for the sake of clarity they are reported fully in Appendix B, but 
summarised here.  
 Preliminary testing involved conducting further TBSS analyses involving AFu vs. 
control comparisons (to see if the main findings of the study would remain the same if 
only those patients who returned at follow-up had been used) and AFu vs. AL 
comparisons. Initial differences were found wherein AFu vs. control TBSS comparisons 
did not fully replicate the findings earlier reported (section 5.3.1) when using all 
patients as a whole group. Further, a difference in FA was found when comparing the 
AFu group against the AL group, where higher FA was found in a small number of 
locations in the AL group. It was considered that a reduction in statistical power could 
have influenced these, and that being able to examine the actual spread of metric 
values in tract locations of interest (i.e. where FA was found to be increased in the AL 
group) would be beneficial . 
 Further analyses were therefore conducted. Average metric values from tract 
sections were extracted and tested, and a full examination of any differences in 
psychometric data between AFu and AL groups was conducted. Testing of the metric 
values indicated that the previously reported differences were likely due to sample 
size, and examination of the spread of data in the location where increased FA was 
reported in the AL group showed a very similar spread of data. It was concluded that 
the AFu and AL groups are likely not inherently different from one another, and that 
any differences which may exist will not have affected the findings of the study. 
5.5 Discussion 
This study found patterns of diffusion change following mild and moderate TBI 
compared to control subjects which varied in location and direction between the acute 
and chronic time point. FA was found to be raised acutely, but decreased chronically 
following TBI and with a different spatial distribution at each time, suggesting that 
diffusion changes evolve over time. The acute increase was largely driven by increased 
AD, while the chronic fall was driven by increased RD. Negative regressions between 
FA and VLF were also identified at both acute and follow-up times revealing a 
biological basis for the cognitive dysfunction. While the acutely increased FA could be 
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due to immune response factors, the chronic negative FA/VLF regression is suggestive 
of a lasting type of damage where cognitive deficit is driven by increased FA.   
5.5.1 Acute Metric Changes: The observation of areas of acutely increased MD 
is consistent with the previous literature (e.g. (Inglese et al., 2005, Miles et al., 2008)). 
Widespread increases in FA were also found. Although this is an unusual finding in the 
wider neuroimaging literature, similar observations have been reported in a minority 
of other small scale imaging studies, particularly in acute, mild TBI patients (e.g. 
(Bazarian et al., 2007, Wilde et al., 2008, Chu et al., 2010, Mayer et al., 2010, Ling et al., 
2012, Yallampalli et al., 2013)) and has been hypothesised to be due to the formation 
of oedema(Ling et al., 2012). However, both in experimental models and clinical 
studies in TBI, the presence of cytotoxic oedema is also associated with reduced MD 
(or its alternative metric: apparent diffusion coefficient (Marmarou et al., 2006, Ito et 
al., 1996)). In the current study MD was either unchanged, or increased. Additionally, 
our groupwise increases in FA were associated principally with elevated diffusion along 
the axon (increased AD), while RD was unchanged. In previous studies reporting 
increased FA, RD was typically reduced where reported (Mayer et al., 2010, Chu et al., 
2010, Ling et al., 2012). Cytotoxic oedema therefore does not explain our observations 
and the lack of such findings is suggestive that it might not be present within this 
predominantly mild patient cohort. 
One further possibility which was considered by post-hoc testing (Section 5.4.1) 
is selective destruction of specific fibres. For example, greater destruction of fibres of 
one orientation compared to another may induce an increase in FA. However the 
analysis presented concluded that tract structure appeared largely comparable 
between patients and controls, and for the most part also succeeded in repeating the 
TBSS results. Previous research has also demonstrated larger axons to be subject to 
greater strain during TBI (Jafari et al., 1997). Large axons would exhibit higher RD and 
lower FA. Destruction of these through this selective vulnerability could lead to areas 
populous with large axons seeing an FA rise following TBI as the relative proportion of 
intact, but smaller, FA-high axons increases. However, while either or both of these 
phenomenon could contribute towards an increase in FA, as they both focus on 
neuronal loss neither would be expected to resolve over time. The manner in which 
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areas which demonstrated an acute increase normalised at the chronic time-point 
would be troublesome to explain if these explanations were to be principally used. 
Another acute factor which might influence an FA change is excitotoxicity. With 
this, increased excitatory amino acids following injury (predominantly glutamate 
(Bullock et al., 1998)) causes over-activation of neurons which leads to either necrosis 
or apoptosis (Zipfel et al., 2000). However such degradation or destruction of neurons 
would be considered to lower FA as they would cause a marked decrease in its 
structure, meaning excitotoxicity is also unlikely to be driving this finding. Research 
showing excitotoxicity to increase with the severity of injury (Palmer et al., 1993) is 
also suggestive that it might not be a prevalent injury within this mild/moderate 
patient cohort. Another possible explanation is increased temperature in the brain. 
The possibility of a temperature increase should also be considered. Higher 
temperature has been shown to increase reported diffusion levels in DTI metrics 
(Reischauer et al., 2009) and hyperthermia is a known effect to follow TBI (Jiang et al., 
2002). This could cause AD to increase although leave RD relatively unaltered if the 
myelin sheath were to be intact at this phase. However hyperthermia is mainly found 
in severely injured patients and also associated with an outcome of moderate or 
severe disability as measured by the GOS (Geffroy et al., 2004). It is therefore unlikely 
to have occurred in this predominantly mild patient cohort. Additionally, this previous 
work shows that hyperthermia typically involves temperature increases in the range of 
1-30C (with higher figures indicating increasingly severe injuries) which is very unlikely 
to be statistically influential considering that a difference of 50C is required to produce 
a discernible effect on metric values (Reischauer et al., 2009). 
 Another alternative explanation may lie in the findings of other recent work 
which has suggested astrogliosis as a possible cause of acute FA increases. Following 
injury, fibrous astrocytes often undergo reactive astrogliosis migrating to the site of 
injury, locally increasing the density of these cells (Pekny and Nilsson, 2005). It was 
reported that the organisation of these cells increased the AD within the affected 
tissue, while RD remained unchanged thus increasing the measured FA (Budde et al., 
2011). Although MD was not reported, this increase in AD (without any change in RD) 
would also increase the reported MD. Considering this hypothesis, it is also possible 
that the lack of any AD change in the tractography analysis may be due to this process 
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being more detectable in TBSS as this includes more of the area that surrounds the 
tract. Our observations are therefore most consistent with astrogliosis and with the 
known chronology of the immune response following CNS injury (Mac Donald et al., 
2007), and therefore we consider astrogliosis to be the most likely underlying cause of 
our finding of increased acute FA. Future research could expand to using the recent 
method of Diffusional Kurtosis in conjunction with DTI. Studies have shown this 
combination brings increased sensitivity in detecting cognitively-relevant physiological 
change (Grossman et al., 2012) and astrogliosis (Zhuo et al., 2012) compared to DTI 
alone. 
5.5.2 Chronic Metric Changes: Follow-up data supported the wider literature in 
chronic brain injury with findings of reduced FA, although the affected tract locations 
were not the same as the locations where FA was seen to be increased acutely. 
Locations of acutely increased FA (e.g. the ascending fibres of the corpus callosum) had 
normalised by the follow-up time point and did not show a statistical difference 
compared to controls. Conversely, other locations (e.g. the anterior forceps) which did 
not show any significant change acutely progressed to reduced FA chronically. This 
indicates that though many different white matter tracts may be affected by DAI they 
are not subject to exactly the same injury / response pattern; locations which appear 
damaged acutely may appear normal chronically and while areas subject to long term 
damage may appear normal acutely. This finding emphasises the importance of 
controlling for time since injury in similar studies on TBI patients. 
The FA decrease was driven by an underlying RD increase, while MD was 
increased extensively and AD was unchanged. Raised RD is evidence that the axonal 
membrane and myelin sheath have disintegrated (Song et al., 2002). The reductions in 
FA were observed principally in the anterior forceps, suggesting that this region has 
experienced the most severe long term damage following TBI. This finding is supported 
by the fact that anterior callosal fibres are known to be sensitive to DAI and damage to 
them relates to long term prognosis (Matsukawa et al., 2011). The normalisation of AD 
values further implies that its acute increase was due to a temporary factor such as 
mild astrogliosis (chronic scars are sometimes known to form following this, although 
only in severe cases (Sofroniew, 2009)). It should be noted that at both time-points 
locations of increased MD always overlapped with underlying increases of AD/RD. 
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Therefore, while MD is one of the simplest diffusion metrics to measure and may 
therefore have a role in the general detection of tissue injury, our data demonstrates 
that interpretation of altered MD requires full assessment of the diffusion 
eigenvectors. 
5.5.3 Acute Cognitive Testing: Patients were found to underperform on the VLF 
task in the acute phase after injury with their performance strongly and negatively 
regressing with white matter FA and positively regressing with RD and MD. These 
regressions were located across widespread areas of the white matter tracts and 
particularly within the ascending fibres of the corpus callosum in the left hemisphere. 
This finding supports previous work which has shown the VLF network of healthy 
individuals to involve frontal, parietal and temporal locations with an emphasis in the 
left hemisphere (Gaillard et al., 2000, Pihlajamaki et al., 2000).  
While the groupwise increase in FA was mainly due to increased AD, the 
relationship with cognitive performance was driven by a positive regression between 
RD and VLF which implies the presence of a subtle reduction in RD. The contrasting 
observation that RD was not significantly different in the acute injury phase between 
the patient and control groups in groupwise analysis, but reduced RD was associated 
with differences in functional performance between patients, is likely due to differing 
statistical power between tests. The variance of RD values explained by regression 
within the acute patient group is large whereas the difference in mean RD values 
between the two groups is small, making regression within groups more powerful than 
between group comparisons. 
Within the axon, undamaged neurofilament has been shown to be related to 
both larger axon diameter and more efficient conduction velocity (Kriz et al., 2000), 
while DAI is associated with disruption of the neurofilament, involving loss of 
neurofilament sidearms via trauma-induced proteolysis (Maxwell et al., 1997). We 
therefore postulate that reduced axonal diameter may contribute to altering both 
diffusion properties (reducing RD and increasing FA) and to the deficit in VLF 
performance which becomes more severe as RD decreases.  
5.5.4 Chronic Cognitive Testing: Chronically, patient performance on VLF was 
not significantly different to that of the controls, suggesting a degree of recovery in 
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terms of cognitive performance. However negative regressions between FA and VLF 
were still found. These chronic regressions presented primarily in the body of the 
corpus callosum and the anterior forceps as opposed to the more diffuse pattern seen 
acutely. This shift of location to connecting fibres between the two hemispheres could 
be indicative of network reorganisation to increase right hemisphere involvement as a 
compensatory mechanism, as has been demonstrated previously (Voets et al., 2006). 
Further future work is needed to investigate whether this is the case. 
Examining AD and RD did not provide evidence that either was specifically 
responsible for the chronic relationship between performance and FA, implying that 
relatively slight changes in each are contributing to this finding. The finding that 
decreased FA was associated with better VLF performance in the chronic phase is one 
which is challenging to explain due to its apparent contradiction to counterpart 
groupwise findings in the same tract location which indicate FA to decrease as a result 
of damage, and also its relative novelty with respect to the wider literature. Many 
events are known to occur in the chronic phase of injury such as a relative increase in 
the proportion of axons with smaller diameters (Jafari et al., 1997), glial scarring 
(Stichel and Muller, 1998) and network reorganisation (Voets et al., 2006), all of which 
may contribute to an effect whereby the patients with the greatest VLF deficit have 
the highest FA, despite FA being generally reduced compared to controls. Further 
investigations are required to determine the exact mechanisms behind this finding, but 
it is highlighted as an avenue for future research.  
5.5.5 Limitations and Considerations of Post-Hoc Analyses: The loss of patients 
to follow-up reduced our statistical power to detect longitudinal change. Patients 
either declined to return for further testing (4/53) or were lost to further contact 
(26/53). We attribute these losses to the mild nature of our participant’s injuries 
(possibly making them less inclined to devote further time to the study), and the 
relatively long (1 year) gap between assessments. It was considered whether those 
patients returning at 12 months were either likely to suffer greater on-going symptoms 
than those who did not return, or be influenced by socio-economic or medical-legal 
factors (whereby a potential diagnosis of long-term damage or on-going cognitive 
dysfunction may be seen as advantageous). This type of patient self-selection is 
difficult to quantify and cannot be ruled out in this cohort. Initial TBSS analyses 
141 
 
comparing the acute data between patients who did and did not return produced 
findings of FA changes which were suggestive that there may indeed be a physiological 
difference between these sub-groups (section 5.4.3 and Appendix B). However further 
analysis utilising ROI’s concluded that this was likely an artefact of diminished 
statistical power. Evaluation of differences in cognitive performance at baseline 
between these sub-groups showed a difference in VLF, but not in any other task. This 
indicating that each of these sub-groups were suffering from broadly comparable 
levels of cognitive impairment at baseline, and that as the AFu group was found to 
outperform the AL group in VLF that the main findings would if anything be an 
underestimation of the changes experienced in mild TBI. 
A proportion of our patient group were also unable to complete psychometric 
testing due to reasons pertaining to their injury (12% acutely and 9% at follow-up), 
reducing the sample size for the regression analyses. Since our hypothesis was that 
cognitive dysfunction is secondary to microstructural damage, those patients who 
were unable to complete the tests would be expected to have the greatest 
microstructural damage. Excluding such individuals would then bias against detecting 
an effect, again suggesting that our observations are a lower estimate of the 
importance of white matter injury on cognitive performance following mild TBI. 
Age was also not controlled for in these analyses; FA is known to decrease in a 
number of areas as people get older (Pfefferbaum et al., 2000). Previous demographic 
testing revealed controls to be significantly older than the acute mild patient sample, 
and all acute patients considered together as a group (Section 3.3.5). It should 
therefore be considered that this could have influenced the finding of increased FA in 
the acute patient sample compared to controls. However it should also be noted that 
the returning patient sample was not significantly different in age compared to 
controls. If age had contributed to FA changes, this would therefore be expected to be 
seen in comparing the patients who did and who did not return for follow-up testing. 
As discussed, testing of these groups concluded that they were comparable to one 
another. It is therefore unlikely that age differences drove the increased FA finding.  
Finally, our mixed mild and moderate cohort is a potential confound for 
understanding the effect of mild TBI alone. Comparison of the patient groups (mild 
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versus moderate) did not show any significant differences in any diffusion metric 
either by GCS or Mayo severity classification. Further, in comparison to healthy 
subjects and during regression against VLF performance, exclusion of the moderate 
patients did not change the direction or distribution of any findings, (other than a 
reduction in statistical power expected with the smaller group size). Finally, only 2/9 
moderate patients had GCS less than 10, so this moderate group is towards the milder 
end of injury. The findings are therefore consistent with revealing the microstructural 
changes associated with mild injury severity. 
5.6 Chapter Summary 
This longitudinal study has produced a comprehensive picture of the diffusion 
imaging changes following mild/moderate TBI and how these can relate to cognition in 
a large cohort of patients. Detailed analysis of the complete set of diffusion metrics 
suggest that gliosis rather than cytotoxic oedema is most consistent with changes in 
these metrics following acute mild TBI. We have also further quantified acute findings 
by identifying a proportional relationship with VLF which we have shown persists into 
the chronic injury phase, at a more subtle but still detectable level. The importance of 
investigating the component parts of FA is also shown by groupwise / regression 
findings in the acute phase that would have proved conflicting had they not been 
shown to be separately driven by AD and RD, respectively. The full potential of DTI to 
detect different physiological changes resulting from TBI, and to show which among 
these is affecting cognition, is highlighted while avenues for future research are also 
indicated. As such, the hypotheses of increased FA indicating cognitive relevant 
damage at the acute time-point are supported. However, while the hypothesis that 
metric changes at the chronic time-point would appear more “typical” with respect to 
the wider literature is also validated, the ongoing negative relationship between FA 
and VLF at this point is contrary to the expectation that relationships with cognitive 
outcome would also support the groupwise finding of decreased FA being an indicator 
of damage. 
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Chapter 6. Magnetic Resonance Spectroscopy Investigation 
6.1 Overview 
 This chapter describes a, longitudinal, ROI-based MRS investigation on the 
same participant group introduced in Chapter 3 and studied in Chapters 4 and 5. Here, 
metabolic changes post-TBI are characterised at both the acute and chronic time-
points. Relationships between metabolite concentration and cognitive function are 
also examined. The ROI’s chosen are a mix of locations selected based either on 
previous published research, or shown to be of particular relevance in this patient 
group from findings using DTI in Chapter 5. We hypothesised that metabolite 
concentration may act as a marker of DAI, and also hold relationships with the 
observed cognitive deficit described in Chapter 3.  
6.2 Methodology 
 6.2.1 MRS Data Acquisition: This experiment utilised 3D T1W scan data 
(previously described in 4.2.1) and MRS scan data. The MRS sequence used a slice 
selective short-TE MRSI technique with a TR of 3450ms, TE of 35ms, 10x10x18mm 
voxels (24x20 matrix, 5 slices, 18mm thick, 1 average, 1024 samples and a spectral 
bandwidth of 2500 Hz) with outer volume saturation. The total scan duration for MRS 
acquisition was 21 minutes. 
6.2.2 Regions Investigated: Several thousand voxels were collected in each 
subject. Due to a lack of standard global investigative techniques for MRS data, this 
created the need to focus the analysis. For this reason, five regions were chosen to be 
investigated. These were the ascending fibres of the corpus callosum, the caudate, the 
putamen, the thalamus and the posterior cingulate cortex. These specific locations 
were chosen for a variety of reasons. They are all relatively large structures / areas, 
meaning they are practical in terms of voxel placement. Together, they also form a 
variety of white matter, and cortical / deep grey matter regions that are mostly 
normal-appearing by standard imaging techniques in this patient group (section 4.3). 
This was deemed appropriate as findings from the DTI experiment in Chapter 5 
indicate the presence of diffuse damage, which we seek to investigate further. 
Previous literature has also indicated each of these locations as being of interest 
following TBI, as explained below. 
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A region of superior white matter (SWM) was first chosen in an attempt to best 
capture the ascending fibres of the corpus callosum, based on DTI findings from 
Chapter 5. These results indicated that this tract holds importance in this patient 
cohort with respect to both relatively novel metric changes in the acute phase of injury 
(where patient FA was found to be raised) and cognitive functioning in both the acute 
and chronic phases of injury (where negative regressions with VLF performance were 
found). Experimentation here on this region is therefore intended as a natural follow-
up to this previous work. The voxel is best placed to capture these fibres, although 
likely contains a higher proportion of other white matter which is not a part of this 
tract. 
The caudate has been shown to be subject to atrophy following TBI (Kim et al., 
2008) and to be related to some cognitive facets regarding risk taking (Newcombe et 
al., 2011) (although this is not something directly measured by the psychometric test 
battery used in this project, a proved relationship with cognitive function was deemed 
worthy of further examination). BOLD signal changes have also been detected in the 
area in fMRI experiments following mild TBI (Gosselin et al., 2011), further showing the 
vulnerability of the region to the effects of injury.  
The putamen has also been shown to be subject to atrophy following TBI 
(Warner et al., 2010, Sidaros et al., 2009). Although current literature does not report 
links with cognitive deficit post-TBI, altered BOLD signals are also found in the 
putamen after mild TBI (Gosselin et al., 2011), implying a possible link with cognitive 
outcome.  
Cognitively-relevant alterations in the thalamus following TBI have been found 
(Grossman et al., 2012), with one paper suggesting that the resulting integrity of the 
thalamic tract plays a key role in any executive dysfunction which may be present 
(Little et al., 2010). Other work has found the thalamus to be subject to decreased 
metabolic rates of glucose after injury (Hattori et al., 2003). While one MRS paper has 
found no significant thalamic metabolic alterations in a mild patient cohort (Kirov et 
al., 2007), it was still deemed appropriate to include this area as an ROI on the balance 
of the other previous findings. The current investigation also has a substantially larger 
group of patients than this previous study (53 compared to 20), giving us a greater 
sensitivity to detect change.  
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Finally, the posterior cingulate cortex (PCC) was chosen so that a cortical grey 
matter structure could also be examined. The PCC has been shown to be vulnerable to 
structural change following DAI (Kim et al., 2008). The PCC is known to be a central 
aspect of the brain’s default mode network, and has been previously found to be 
affected by TBI such that it is not as effectively inhibited during active tasks after injury 
(Bonnelle et al., 2012). Other work which has produced similar findings has suggested 
that it may play a central role in cognitive recovery due to reported increased 
connectivity following TBI which also correlated with faster cognitive response times 
(Sharp et al., 2011).   
6.2.3 Voxel Placement: Voxels were placed bilaterally for each of these regions 
aside from the PCC which used a single voxel on the brains midline. A total of nine 
voxels were therefore examined per participant. The locations of the five regions are 
demonstrated in Figures 6.1 – 6.5. The placement of these was achieved by visual 
inspection of the participants T1 weighted anatomical scan in MRIcro which was 
matched to a corresponding grid of MRS voxels. Determining the desired location on 
the T1W scan therefore also identified the MRS voxel which occupied the same space. 
However, there was often wasn’t a single corresponding voxel which clearly 
represented the desired region. In these cases, a choice between possible voxels had 
to be made based on which gave the best representation by a combination of either / 
both including a substantial portion of the desired region and containing minimal 
contamination from neighbouring neural areas.  
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Figure 6.1: Instructions with visual example pertaining to the placement of the voxels for superior white 
matter. Image overlay shows ideal voxel locations. 
Defining the region around the ascending 
fibres of the corpus callosum involved first 
identifying the centre of the corpus callosum 
by examining a saggital slice down the 
midline of the brain. Maintaining this Y co-
ordinate, the points of white matter that 
were immediately superior and lateral to 
either side of the body of the corpus callosum 
were then located as shown. Voxels were 
taken bilaterally. 
Superior White Matter (SWM) 
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Figure 6.2: Instructions with visual example pertaining to the placement of the voxels for the caudate. 
Image overlay shows ideal voxel locations. 
The caudate was located mainly by 
examination of the axial view of the T1W 
scan where the margins of the nucleus 
are most clear. Voxels were taken 
bilaterally. 
The Caudate 
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Figure 6.3: Instructions with visual example pertaining to the placement of the voxels for the putamen. 
Image overlay shows ideal voxel locations. 
The putamen was also located mainly by 
examination of the axial view of the T1W 
scan, although the boundaries can also 
be seen in the coronal and saggital 
views. Voxels were taken bilaterally. 
The Putamen 
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Figure 6.4: Instructions with visual example pertaining to the placement of the voxels for the thalamus. 
Image overlay shows ideal voxel locations. 
Being a large structure, voxel placement 
within the thalamus was relatively 
uncomplicated. Regions to the posterior 
of it were often chosen in an effort to 
avoid contamination from the putamen 
and caudate. Voxels were taken 
bilaterally. 
The Thalamus 
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Figure 6.5: Instructions with visual example pertaining to the placement of the voxels for the posterior 
cingulate cortex. Image overlay shows ideal voxel location. 
A unilateral grey matter region to the 
anterior of the occipital lobe was chosen for 
the final voxel. This was on the same superior 
/ inferior plane as the corpus callosum and as 
close to the splenium / forceps major as 
possible without any contamination. As this 
was on the brains midline, many voxels fell 
either to one side or the other. In cases 
where one was not clearly more central then 
the other, the voxel to the right of the image 
(left of the brain) was chosen. 
The Posterior Cingulate Cortex 
(PCC) 
151 
 
6.2.4 MRS Data Treatment: Spectroscopic analysis was performed off-line 
using the automated, standard evaluation software jMRUI. For visual display, data 
were pre-processed with 5 Hz exponential line broadening, Fourier transformed and 
manually phase corrected. The residual water peak was filtered using a Hankel Lanczos 
Singular Values Decomposition Filter (HLSVD). MRS data were then evaluated in the 
time domain using the QUEST algorithm which was used to fit a weighted combination 
of metabolite signals directly to the in vivo spectroscopic data. The algorithm uses 
prior knowledge based on a metabolite basis set of known concentrations measured in 
vitro. Results were inspected for quality by consideration of factors such as line width 
and residual signal, and discarded if they were not of a suitable standard. Peak areas of 
NAA, Cho and Cr were obtained. 
It is standard practice in spectroscopic analysis to make inferences about 
changes in metabolite concentration not by directly examining that metabolite, but by 
creating a ratio of that metabolite with something else which is assumed to be 
experimentally stable. This is done to correct for signal decay caused by different parts 
of the brain being different distances from the head coil. As the Cre peak is assumed to 
be stable, it is therefore common in TBI research to see NAA and Cho concentrations 
investigated through NAA/Cre and Cho/Cre ratios (e.g. (Garnett et al., 2000a, Garnett 
et al., 2000b, Holshouser et al., 2006, Signoretti et al., 2008, Vagnozzi et al., 2010)). 
However recent evidence has suggested that Cre may be subject to change following 
TBI, or related to severity or outcome (Walz et al., 2008, Gasparovic et al., 2009, Yeo et 
al., 2011). Due to this, the current work aimed to avoid using the metabolite as a stable 
reference point. Similar to one of these previously cited experiments (Gasparovic et al., 
2009), water concentration was used instead as a stable reference point. NAA, Cho and 
Cre peak amplitudes were therefore divided by the water content of the same space 
(as measured by the proton density of that location) to create comparable ratios.  
MRS metabolite levels were normalised to the water signal determined from a 
proton density image available in each subject. To achieve this, the proton density was 
first registered into the same space as the corresponding T1W image using FSL. A 
matlab script was then created which extracted the average of the proton density 
image voxels which occupied the same area as each MRS voxel. As these values were 
in the magnitude of hundreds-of-thousands, they were divided by 100,000 in order to 
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make the data more reasonable to experiment with. The metabolic peak amplitudes 
were then divided by these transformed proton density values for the same location. 
These final figures were used for all subsequent statistical analyses. Although these 
final values are technically still arbitrary units and not actual metabolite concentration 
(in order to achieve this, other considerations such as the number of protons in each 
molecule would need to be dealt with), they are still proportional to concentration and 
therefore appropriate to conduct analyses with.  
 6.2.5 Statistical Analyses: Final values of NAA, Cho and Cre were subjected to 
multiple statistical comparisons. Groupwise testing primarily involved comparing 
patient and control metric values at each time point, but also involved testing with 
acute patient sub-groups to examine for differences between mild and moderate 
patients and those patients who did (AFu) and did not return (AL) for follow-up testing.  
Testing with psychometric data involved examining correlations with key 
psychometric test measures in patient (all acute / all follow-up) groups, with each 
group being correlated with the corresponding performance data (i.e. acute patient 
metabolic data with acute patient performance / returning patient metabolic data with 
returning patient performance). The rationale behind these are described in detail in 
section 6.3.8, prior to the cognitive findings. Post-hoc analyses were also conducted, 
the methods and rationale of which are described in section 6.4. 
At each stage of testing data was subjected to the Anderson-Darling test for 
normality to determine the types of analyses to be used. For metabolic concentrations, 
control values were examined for each metabolite in each ROI as an indicator of which 
test to use for groupwise testing against corresponding acute / returning patient 
values. Non-parametric correlational analyses for cognitive testing were used if either 
the corresponding control metabolic data for a given metabolite / region or the control 
distribution of test scores for the psychometric task being tested against (section 3.6.2) 
were found to be non-parametric. As before, if data was found to be normally 
distributed then t-tests were used for groupwise testing while Pearsons R was used for 
correlations. If data was found to not be normal then the Mann-Whitney U test was 
used for groupwise testing while Spearmans Rho was used for correlations. 
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6.3 Results 
 6.3.1 Typical Spectra and Sample Size Differences due to discarded Spectra: 
Typical MRS spectra for patients and controls are shown below in Figure 6.6. 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Spectra such as these were considered to be good quality (judging by factors 
such as fitting, symmetry etc.), and are shown here as an example of the standard 
which all spectra were measured against. Linewidth was also examined and the data 
for any metabolite was discarded if the accompanying peak had a linewidth above 
40Hz (qualitatively speaking, very few of the spectra which were kept were close to 
this boundary, and most appeared to be within the range of 20Hz +/- 5Hz). A number 
of spectra in each ROI did not meet these standards and were discarded. The author 
noted a pattern wherein a given participant would typically produce acceptable or  
Figure 6.6: Typical control (left) and acute patient (right) spectra. Both voxels are from the right 
hemisphere voxel of the superior white matter. 
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Table 6.1: Sample sizes for metabolic data for each participant group. Some data was lost due to 
spectra being of insufficient quality. Control sample sizes are reduced from a possible total of 33, 
mild sub-groups are reduced from 44 and 18 (acute and chronic time-points, respectively) while 
moderate sub-groups are reduced from 9 and 5 (acute and chronic time-points, respectively) 
non-acceptable spectra from all voxels, likely due to a confounding variable from the 
time of scanning such as participant movement. This meant that final sample size for 
each group in each ROI was reduced by varying degrees. Table 6.1 summarises the 
total N for each group which was tested in this Chapter. 
 
 
 
 
Similar to findings shown in Chapter 3, the following pages include a number of 
box plots. Once again, an asterisk above or below a box-plot does not indicate 
significant but instead shows outliers in the data (counted as any values which are 1.5 
times (or more) outside of the interquartile range). Significance is indicated by arrows 
which run between the box-plots of the two groups who the significant difference refers 
to (solid in the case of a sig. difference involving acute patient data, and dashed in the 
case of a sig. difference involving follow-up patient data). In this case, testing was only 
conducted using t-test or Mann Whitney U analysis. 
Region Control N 
Acute Patient N 
(mild / 
moderate) 
Returning 
Patient N (mild 
/ moderate) 
Superior 
White Matter 
Left 28 35 / 7 16 / 2 
Right 28 35 / 7 15 / 1 
Caudate 
Left 27 35 / 8 11 / 2 
Right 27 36 / 9 12 / 2 
Putamen 
Left 26 37 / 9 12 / 1 
Right 26 37 / 9 13 / 1 
Thalamus 
Left 24 37 / 9 16 / 1 
Right 25 38 / 9 16 / 2 
PCC - 26 38 / 9 16 / 1 
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6.3.2 Metabolic Findings in the Superior White Matter: Testing for normality 
on control data showed that all metabolic concentrations were normally distributed 
except for left hemispheric Cre (p=<0.005).  
At the acute stage of injury, groupwise testing revealed patients to have a 
number of significantly different metabolic concentrations to controls. NAA and Cre 
were each increased in patients in each hemisphere of the brain. However this was no 
longer the case at follow-up, where no differences were found between patients and 
controls. These groupwise results are shown in Table 6.2, and visualised in Figures 6.7-
6.9.  
 
 
 
 
 
 
 
Time-
point 
Metabolite 
Left Hemisphere (Control, 
Patient, p value) 
Right Hemisphere (Control, 
Patient, p value) 
Acute  
NAA 
0.1118±0.0217 
0.1446±0.0465 
<0.001 
0.117±0.0236 
0.1515±0.0394 
<0.001 
Cho 
0.01317±0.00482 
0.01468±0.00532 
0.223 
0.01428±0.00428 
0.01563±0.00535 
0.247 
Cre 
Median=0.07989 
Median=0.11702 
<0.001 
0.0938±0.0247 
0.1175±0.0372 
0.002 
Chronic 
NAA 
0.1189±0.0272 
0.357 
0.1228±0.0304 
0.513 
Cho 
0.01298±0.00426 
0.893 
0.01408±0.00436 
0.885 
Cre 
Median=0.08174 
0.698 
0.1002±0.0288 
0.462 
Table 6.2: Results from groupwise testing comparing metabolic concentrations between controls and 
acute patients / returning patients in the superior white matter. Metabolite/water ratio values are given 
as “mean±SD” unless otherwise stated in the cell (this is dependent on the statistical test for that 
particular comparison being parametric or non-parametric). 
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Figure 6.8: Boxplot showing Cho distributions in the superior white matter in each hemisphere to 
highlight the differences between patient and control values. Bold arrows indicate when a difference 
is significant. 
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Figure 6.7: Boxplot showing NAA distributions in the superior white matter in each hemisphere to 
highlight the differences between patient and control values. Bold arrows indicate when a difference 
is significant. 
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Figure 6.9: Boxplot showing Cre distributions in the superior white matter in each hemisphere to 
highlight the differences between patient and control values. Bold arrows indicate when a difference 
is significant. 
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6.3.3 Metabolic Findings in the Caudate: Testing for normality on control data 
showed that all metabolic concentrations were normally distributed except for right  
hemispheric Cre (p=0.049) and left hemispheric NAA (p=0.033).  
At the acute stage of injury, groupwise testing revealed patients to have a 
number of significantly different metabolic concentrations to controls. NAA was 
increased in patients in the right hemisphere, while Cho and Cre were each increased 
in patients in the left hemisphere. However this was no longer the case at follow-up, 
where no differences were found between patients and controls. These groupwise 
results are shown in Table 6.3, and visualised in Figures 6.10-6.12. 
 
 
 
 
 
 
 
Time-
point 
Metabolite 
Left Hemisphere (Control, 
Patient, p value) 
Right Hemisphere (Control, 
Patient, p value) 
Acute  
NAA 
Median=0.08123 
Median=0.08625 
0.317 
0.0782±0.0226 
0.915±0.0292 
0.034 
Cho 
0.01677±0.0035 
0.01927±0.0066 
0.043 
0.0166±0.00549 
0.01886±0.00568 
0.101 
Cre 
0.0715±0.174 
0.0842±0.0278 
0.021 
Median=0.06673 
Median=0.07633 
0.091 
Chronic 
NAA 
Median=0.09307 
0.583 
0.0838±0.0228 
0.416 
Cho 
0.0156±0.00609 
0.53 
0.01313±0.0061 
0.085 
Cre 
0.083±0.0336 
0.266 
Median=0.07847 
0.303 
Table 6.3: Results from groupwise testing comparing metabolic concentrations between controls and 
acute patients / returning patients in the caudate. Metabolite/water ratio values are given as 
“mean±SD” unless otherwise stated in the cell (this is dependent on the statistical test for that 
particular comparison being parametric or non-parametric). 
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Figure 6.11: Boxplot showing Cho distributions in the caudate in each hemisphere to highlight the 
differences between patient and control values. Bold arrows indicate when a difference is significant. 
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Figure 6.10: Boxplot showing NAA distributions in the caudate in each hemisphere to highlight the 
differences between patient and control values. Bold arrows indicate when a difference is significant.= 
160 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hemisphere
Participant Group
Le
ft
Ri
gh
t
Re
tu
rn
in
g 
Pa
tie
nt
s
Ac
ut
e 
Pa
tie
nt
s
Co
nt
ro
ls
Re
tu
rn
in
g 
Pa
tie
nt
s
Ac
ut
e 
Pa
tie
nt
s
Co
nt
ro
ls
0.20
0.15
0.10
0.05
C
re
 (
w
a
te
r-
c
o
rr
e
c
te
d
 a
m
p
li
tu
d
e
)
Figure 6.12: Boxplot showing Cre distributions in the caudate in each hemisphere to highlight the 
differences between patient and control values. Bold arrows indicate when a difference is significant. 
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6.3.4 Metabolic Findings in the Putamen: Testing for normality on control data 
showed that only left hemispheric Cho was normally distributed. All other metabolites 
were non-parametric (left / right NAA p values; 0.006 / <0.005, right Cho p value; 
<0.005, left / right Cre p values; 0.012, <0.005).  
At the acute stage of injury, groupwise testing revealed patients to have a 
number of significantly different metabolic concentrations to controls. NAA and Cre 
were each bilaterally increased in patients, while Cho was also increased in the left 
hemisphere of the brain. At the follow-up time-point, NAA was still increased in the 
left hemisphere (although it had normalised in the right) while Cre was still increased 
bilaterally. Additionally, while Cho had normalised in the left hemisphere, it was now 
decreased in the right hemisphere. These groupwise results are shown in Table 6.4, 
and visualised in Figures 6.13-6.15. 
 
 
 
 
Time-
point 
Metabolite 
Left Hemisphere (Control, 
Patient, p value) 
Right Hemisphere (Control, 
Patient, p value) 
Acute  
NAA 
Median=0.08987 
Median=0.10831 
0.014 
Median=0.09068 
Median=0.1186 
0.003 
Cho 
0.01673±0.0041 
0.02168±0.00574 
<0.001 
Median=0.01707 
Median=0.02041 
0.052 
Cre 
Median=0.07163 
Median=0.09311 
0.005 
Median=0.07305 
Median=0.0973 
0.026 
Chronic 
NAA 
Median=0.10519 
0.019 
Median=0.09967 
0.169 
Cho 
0.01376±0.0043 
0.05 
Median=0.01351 
<0.001 
Cre 
Median=0.1014 
0.005 
Median=0.1001 
0.021 
Table 6.4: Results from groupwise testing comparing metabolic concentrations between controls and 
acute patients / returning patients in the putamen. Metabolite/water ratio values are given as 
“mean±SD” unless otherwise stated in the cell (this is dependent on the statistical test for that 
particular comparison being parametric or non-parametric). 
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Figure 6.13: Boxplot showing NAA distributions in the putamen in each hemisphere to highlight the 
differences between patient and control values. Bold arrows indicate when a difference is significant. 
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Figure 6.14: Boxplot showing Cho distributions in the putamen in each hemisphere to highlight the 
differences between patient and control values. Bold arrows indicate when a difference is significant. 
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Figure 6.15: Boxplot showing Cre distributions in the putamen in each hemisphere to highlight the 
differences between patient and control values. Bold arrows indicate when a difference is significant. 
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6.3.5 Metabolic Findings in the Thalamus: Testing for normality on Control 
data showed that all metabolic concentrations were normally distributed.  
Groupwise testing revealed patients to have a number of significantly different 
metabolic concentrations to controls. At the acute stage of injury, NAA was increased 
in patients in the right hemisphere. This was still the case at the follow-up time-point, 
where left hemispheric NAA was also now found to be increased. These groupwise 
results are shown in Table 6.5, and visualised in Figures 6.16-6.18. 
 
 
 
 
 
 
 
  
Time-
point 
Metabolite 
Left Hemisphere (Control, 
Patient, p value) 
Right Hemisphere (Control, 
Patient, p value) 
Acute  
NAA 
0.0934±0.0291 
0.1001±0.0234 
0.336 
0.0937±0.0255 
0.1092±0.0313 
0.027 
Cho 
0.01607±0.00538 
0.01876±0.00549 
0.056 
0.01728±0.0056 
0.01913±0.00632 
0.208 
Cre 
0.0645±0.0201 
0.0725±0.0195 
0.119 
0.0714±0.0279 
0.0808±0.0243 
0.16 
Chronic 
NAA 
0.133±0.0461 
0.005 
0.1291±0.051 
0.012 
Cho 
0.01672±0.00935 
0.797 
0.01727±0.00787 
0.997 
Cre 
0.0869±0.0474 
0.081 
0.0942±0.0441 
0.064 
Table 6.5: Results from groupwise testing comparing metabolic concentrations between controls and 
acute patients / returning patients in the thalamus. Metabolite/water ratio values are given as 
“mean±SD” unless otherwise stated in the cell (this is dependent on the statistical test for that particular 
comparison being parametric or non-parametric). 
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Figure 6.17: Boxplot showing Cho distributions in the thalamus in each hemisphere to highlight the 
differences between patient and control values. Bold arrows indicate when a difference is significant. 
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Figure 6.16: Boxplot showing NAA distributions in the thalamus in each hemisphere to highlight the 
differences between patient and control values. Bold arrows indicate when a difference is significant. 
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Figure 6.18: Boxplot showing Cre distributions in the thalamus in each hemisphere to highlight the 
differences between patient and control values. Bold arrows indicate when a difference is significant. 
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6.3.6 Metabolic Testing in the PCC: Testing for normality on Control data 
showed that all metabolic concentrations were normally distributed. 
 Groupwise testing revealed patients to have a number of significantly different 
metabolic concentrations to controls. At the acute stage of injury, Cho and Cre were 
increased in patients. While Cre remained increased at the follow-up time-point, Cho 
became decreased. These groupwise results are shown in Table 6.6, and visualised in 
Figures 6.19-6.21. 
 
 
 
 
 
 
 
 
 
Time-
point 
Metabolite  Control, Patient, p value 
Acute 
NAA 
0.0639±0.0135 
0.0723±0.0246 
0.065 
Cho 
0.00788±0.00188 
0.00999±0.00374 
0.002 
Cre 
0.0456±0.0132 
0.0589±0.0186 
0.001 
Chronic 
NAA 
0.0696±0.0135 
0.176 
Cho 
0.00603±0.00195 
0.004 
Cre 
0.059±0.0145 
0.005 
Table 6.6: Results from groupwise testing comparing metabolic concentrations between controls and 
acute patients / returning patients in the PCC. Descriptive values are given as “mean±SD” unless 
otherwise stated in the cell (this is dependent on the statistical test for that particular comparison 
being parametric or non-parametric). 
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Figure 6.19: Boxplot showing NAA distributions in the PCC to highlight the differences between 
patient and control values. Bold arrows indicate when a difference is significant. 
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Figure 6.20: Boxplot showing Cho distributions in the PCC to highlight the differences between patient 
and control values. Bold arrows indicate when a difference is significant. 
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Figure 6.21: Boxplot showing Cre distributions in the PCC to highlight the differences between patient 
and control values. Bold arrows indicate when a difference is significant. 
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6.3.7 Metabolic Findings Summaries: Table 6.7, below, shows the directions of 
metabolic changes (if any) in each voxel in the patients compared to controls. 
 
 
Voxel 
Acute Time-point Follow-up Time-point 
NAA Cho Cre NAA Cho Cre 
Superior 
White 
Matter 
Right ↑ - ↑ - - - 
Left ↑ - ↑ - - - 
Caudate 
Right ↑ - - - - - 
Left - ↑ ↑ - - - 
Putamen 
Right ↑ - ↑ - ↓ ↑ 
Left ↑ ↑ ↑ ↑ - ↑ 
Thalamus 
Right ↑ - - ↑ - - 
Left - - - ↑ - - 
PCC - - ↑ ↑ - ↓ ↑ 
 
6.3.8 Note on Multiple Comparisons Problem with Cognitive Data: While the 
nature of Chapter 5’s DTI investigation made it difficult to investigate more than one 
cognitive test (due to the complexity of conducting and reporting multiple TBSS 
regression investigations), examining correlations between cognitive and metabolic 
data here is far less restrictive and presented an opportunity to create many 
comparisons. We argue that the nature of DAI means making such broader 
comparisons is appropriate; as DAI affects many cognitive networks, it also affects the 
patient’s cognition in a very broad manner. This is evidenced by the many locations of 
damaged white matter tract in our patient group which were found in the previous 
chapter (section 5.3), and the number of tests which our patient group were shown to 
hold an acute deficit in (section 6.3.2).  
There was therefore a motivation to examine correlations between numerous 
cognitive tests and numerous metabolites / ROIs, as focusing on only a specific 
comparison would likely mean ignoring a great number of other relationships which 
are equally important and valid. However this would of course create a number of 
Type 1 errors and there was concern that traditional multiple-comparison correction 
Table 6.7: A summary of all metabolic changes in patients compared to controls for each ROI, at each 
time point. Upwards-pointing arrows indicate an increase while downwards-point arrows indicate a 
decrease. 
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methods would simply eliminate all findings due to a very high total number of 
comparisons. For example, a set of correlations which compared all key data in each 
main participant group (controls and acute / chronic patients) would lead to 1215 
individual p-values, bonferroni correction of which would create an unrealistically-
achievable new alpha value of 0.00004. In considering how to conduct the cognitive 
investigation of the MRS data it was therefore necessary to reach a compromise where 
the comparisons made were focused, but at the same time did not undermine the 
project’s broader objective of investigating DAI and its cognitive consequences. 
It was first decided that only a subset of cognitive tests from the full battery 
should be used. This subset was chosen so that it focused tests where patients have 
been shown to hold a deficit, but as a whole still measured a wide variety of cognitive 
domains. VLF was retained due to the findings of Chapters 3 and 5, which indicated 
(some) our patients to hold a deficit in it and for it to be of relevance to their 
neurophysiological changes, respectively. The A1-A5 and A6 conditions of the List 
Learning task were also retained. This was again partially because patients had been 
shown to hold a deficit in these (Table 3.6), but also as the task purports to measure a 
large number of cognitive facets (Table 3.4). List Learning was chosen instead of the 
comparable Design Learning as testing had shown our patients to hold deficits in more 
of its conditions (Table 3.6). Finally, PASAT (3 second intervals) was chosen. Patients 
had been shown to hold a deficit in this task (Table 3.6) and it also measures 
“information processing” which is a major cognitive facet not specifically examined by 
either VLF or List Learning (Table 3.4). PASAT (3 second intervals) was chosen instead 
of other tasks in the battery which measure information processing (PASAT with 2 
second intervals and SoIP) as patients were shown to comparably hold the greatest 
deficit in it. Together, this small subset of tasks measure clustering, switching, verbal 
learning, attention, concentration, short-term memory, working memory and 
information processing.  
Secondly, consideration was given to metabolites, where it was decided that all 
3 should be retained for testing. This decision was made firstly as each metabolite was 
seen to change in a number of locations in earlier groupwise analysis (Table 6.7), 
indicating each of them to be experimentally important in these patients. Secondly, 
there is a unique value to investigating each of NAA, Cho and Cre. The uses and 
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implications of investigating NAA and Cho concentration data in a TBI setting (neuronal 
viability/mitochondrial activity and membrane inflammation respectively) are distinct 
from one another and each infer upon important physiological processes which could 
indicate / act as a marker for cognitive function. Equally, while the implications of Cre 
concentration could be considered comparable to NAA (each are hypothetically 
related to local energetic output), the experimental study of it is relatively novel. As 
groupwise changes in Cre were also widely observed in it in earlier testing this 
indicates that it is affected by injury in our patient group and therefore is of interest to 
study further with regards to cognitive outcome. Thus, with none of the metabolites 
appearing relatively redundant with regards to cognitive testing it was deemed 
inappropriate to eliminate any at this stage. 
Regarding selecting ROI’s it was also decided that all should be retained. This 
decision was made based upon our argument that DAI represents a single 
phenomenon which affects regions in a diffuse pattern. Therefore, the inclusion of 
multiple ROIs is a valid method of investigating this single variable (particularly in the 
case here where each ROI was chosen based upon an a-priori hypothesis) and not 
comparable to a case where the inclusion of multiple regions represents testing of 
multiple variables. Thus, methods of multiple comparison correction are not 
appropriate in this context. 
As the above methods of selection would still lead to a relatively large number 
of independent comparisons, an informed approach was used to discard findings as a 
method of correction. The following method was chosen instead of a standard method 
of multiple-comparison correction as there was still strong concern that using a 
technique such as bonferroni would still be too stringent such that Type 1 errors would 
simply be replaced by Type 2 errors. It was decided that a relationship (where p=<0.05) 
may only remain if it was repeated at least once in a different voxel. E.g. if NAA was 
found to positively correlate with VLF in acute patients in the left caudate, that finding 
may only be kept if another positive correlation (p=<0.05) between NAA / VLF in the 
acute patient group was recorded in another voxel. This was based upon the logic that 
a repeated finding in this manner is strong support that that specific correlation 
represents a “real” effect; a relationship between a metabolic change and cognitive 
function as a result of DAI may be expected to be present in various regions (examining 
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TBSS outputs from Chapter 5, e.g. Figures 5.2-5.4 show this). Conversely there is no 
reason that a significant-by-chance finding would be repeated in this manner. It should 
be noted that as the chronic TBSS findings (Figure 5.5) suggested that a significant 
relationship between cognition and physiology may exist in a confined location there is 
still a reasonable risk of the creation of Type 2 errors from this method. However we 
argue that on balance this is a reasonable compromise which will allow only for the 
detection of “real” relationships.  
Finally, only the main patient groups (all acute patients and all chronic patients) 
were subject to the above testing. However, any specific correlations which were 
found to be significant in these groups were repeated in the control group. i.e. the 
same metabolite / test relationships, in the same ROIs. This was in order to examine if 
the significant findings were as a result of injury or not. The following bullet points 
summarise the above paragraphs. 
 Only VLF, Letter Fluency (A1-A5 and A6 conditions) and PASAT (3 second 
conditions) were used for testing. 
 All metabolites were investigated as each represents a measurement 
with unique potential implications for cognitive outcome. 
 All ROI’s were investigated as we argue they together are more 
comparable to measuring a single variable (DAI) to measuring multiple 
variables which are independent of one another. 
 Correlations were only be retained if that specific cognitive test / 
metabolite relationship is found to be significant (p<0.05) in at least two 
of the ROIs. 
 These correlations were examined only in the acute and chronic patient 
groups, although any significant findings (i.e. which are reported at 
p<0.05 in more than one ROI) were repeated in the control group in 
order to examine if they are a result of injury or not.  
 
Thus, only repeated significant (p=<0.05) cognitive findings are included in the 
following pages. All other correlations (either only having found to be significant once, 
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or non-significant) are not reported or discussed for the sake of clarity and spatial 
limitations.  
6.3.9 Correlations between Metabolite Concentrations and Psychometric 
Performance: Corroborating psychometric test performance together in the manner 
described by the previous section revealed that both of the retained conditions of the 
List Learning Task (A1-A5 and A6) held repeated positive correlations with Cho in the 
returning patient group. VLF also held repeated negative correlations with NAA in the 
returning patient group. No correlations were found in the control or acute patient 
groups by the criteria used here. 
The A1-A5 condition of the List Learning task positively correlated with Cho 
twice. Once in the left hemisphere of the SWM (r=0.473, p=0.048), and once in the 
right hemisphere of the thalamus (r=0.504, p=0.033). These findings are shown in 
Figure 6.22 
 The A6 condition of the List Learning task also positively correlated with Cho 
twice. Once in the right hemisphere of the SWM (r=0.525, p=0.037), and once in the 
left hemisphere of the thalamus (r=0.645, p=0.004). These findings are shown in Figure 
6.23. It should be noted that both the A1-A5 and A6 condition findings were reported 
from the same brain location, albeit in opposite hemispheres. 
Finally, VLF negatively correlated with NAA twice. Once in the right hemisphere 
of the SWM (r=-0.504, p=0.047), and once in the PCC (r=-0.54, p=0.025). These findings 
are shown in Figure 6.24. 
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Figure 6.22: Scatterplot (with regression) showing all the significant correlations between Cho and 
performance on the List Learning (A1-A5) task in the returning Patient group. 
Figure 6.23: Scatterplot (with regression) showing all the significant correlations between Cho and 
performance on the List Learning (A6) task in the returning Patient group. 
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Figure 6.24: Scatterplot (with regression) showing all the significant correlations between NAA and 
performance on the VLF task in the returning Patient group. 
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6.4.1 Post-Hoc Testing with Acute Patient Sub-Groups 
 6.4.1.1 Aim: Similar to previous chapters, testing was undertaken to ascertain if 
there were any differences between the acute data of the patients who did return for 
follow-up testing (AFu) and the acute data of those who did not (AL), and mild / 
moderate patient subgroups in metabolic concentrations. While AFu / AL testing was 
undertaken to examine for any methodological problems with comparing data from 
the acute patient group with data the reduced returning patient group, mild / 
moderate testing was undertaken to further examine the validity of considering mild 
and moderate TBI as a single “non-severe” injury. 
 6.4.1.2 Methodology: Groupwise testing of all metabolic concentrations in all 
voxels was repeated (as described in 6.2.5) to compare metabolic concentrations 
between AFu / AL and mild / moderate groups. Control data distribution (as described 
in sections 6.3.2 – 6.3.6) was used as an indication of if parametric or non-parametric 
analyses should be used for a given metabolite in a given voxel. As before, due to the 
reduced sample size of the returning patient group, mild / moderate comparisons 
were only able to be made with the acute patient data. 
 6.4.1.3 Results; AFu / AL Comparison: Of testing from all metabolites in all 
regions, one significant difference was found between AFu and AL patient sub-groups. 
Cho in the left voxel of the SWM was found to be significantly higher in the AFu group 
(Table 6.8). In the main groupwise analyses where all patients were compared against 
controls, Cho showed no significant difference in this region. Following this finding, 
further testing was considered necessary. Groupwise comparison between AFu / AL 
and Control Cho in the left voxel of the SWM was conducted. Cho in this region was 
found to be significantly higher in the AFu sub-group (mean=0.01718, SD=0.00562) 
than in the control group (mean=0.01317, SD=0.00482, t(32)=-2.5, p=0.018). However 
no difference was found when testing Cho in this region of the AL sub-group 
(mean=0.0128, SD=0.00431) against controls (t(49)=0.29, p=0.772). This indicates that 
Cho may be expected to increase in this region (contrary to the earlier main groupwise 
findings), but that a characteristic of patients who did not return for follow-up testing 
in our participant group initially prevented this from being found. 
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Voxel 
NAA (AFu patient descriptive 
values, AL patient descriptive 
values, p value) 
Cho (AFu patient descriptive 
values, AL patient descriptive 
values, p value) 
Cre (AFu patient descriptive 
values, AL patient descriptive 
values, p value) 
SWM 
Right 
Mean/SD=0.1482/0.0412 
Mean/SD=0.1543/0.0385 
0.625 
Mean/SD=0.01675/0.00593 
Mean/SD=0.01471/0.00475 
0.234 
Mean/SD=0.113/0.0355 
Mean/SD=0.1213/0.0389 
0.478 
Left 
Mean/SD=0.1494/0.0447 
Mean/SD=0.141/0.0484 
0.564 
Mean/SD=0.01718/0.00562 
Mean/SD=0.0128/0.00431 
0.01 
Median=0.12657 
Median=0.1065 
0.055 
Caudate 
Right 
Mean/SD=0.0907/0.0323 
Mean/SD=0.0923/0.0266 
0.859 
Mean/SD=0.01731/0.00552 
Mean/SD=0.02034/0.00555 
0.073 
Median=0.07155 
Median=0.08273 
0.233 
Left 
Median=0.09345 
Median=0.08497 
0.268 
Mean/SD=0.01876/0.00639 
Mean/SD=0.01971/0.00689 
0.642 
Mean/SD=0.0807/0.0192 
Mean/SD=0.0873/0.0337 
0.43 
Putamen 
Right 
Median=0.12829 
Median=0.11421 
0.767 
Median=0.02067 
Median=0.01931 
0.15 
Median=0.1006 
Median=0.08859 
0.362 
Left 
Median=0.11126 
Median=0.09945 
0.489 
Mean/SD=0.02138/0.00381 
Mean/SD=0.02196/0.00714 
0.727 
Median=0.09713 
Median=0.08494 
0.397 
Thalamus 
Right 
Mean/SD=0.1072/0.0361 
Mean/SD=0.1111/0.027 
0.682 
Mean/SD=0.01856/0.00562 
Mean/SD=0.01963/0.00695 
0.564 
Mean/SD=0.075/0.0199 
Mean/SD=0.0859/0.0269 
0.118 
Left 
Mean/SD=0.0986/0.0239 
Mean/SD=0.1013/0.0235 
0.696 
Mean/SD=0.01842/0.00615 
Mean/SD=0.01902/0.00499 
0.724 
Mean/SD=0.0694/0.0182 
Mean/SD=0.075/0.0205 
0.332 
PCC - 
Mean/SD=0.073/0.0285 
Mean/SD=0.0717/0.0212 
0.859 
Mean/SD=0.00896/0.29 
Mean/SD=0.01089/0.0042 
0.071 
Mean/SD=0.056/0.0158 
Mean/SD=0.0615/0.0208 
0.305 
Table 6.8: Groupwise findings from comparing metabolic concentrations of all metabolites in all voxels between AFu and AL patient sub-groups. 
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6.4.1.4 Results; Mild / Moderate Comparison: A number of significant 
differences were found between metabolic concentrations of acute mild and moderate 
patient groups. Mild NAA was significantly higher than moderate NAA in each 
hemisphere of the SWM, and in the PCC. Additionally, mild Cho was significantly higher 
than moderate Cho in the right putamen and the PCC. All findings are shown in Table 
6.9. 
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Voxel 
NAA (mild patient descriptive 
values, moderate patient 
descriptive values, p value) 
Cho (mild patient descriptive 
values, moderate patient 
descriptive values, p value) 
Cre (mild patient descriptive 
values, moderate patient 
descriptive values, p value) 
SWM 
Right 
Mean/SD=0.1605/0.0348 
Mean/SD=0.1063/0.03 
0.002 
Mean/SD=0.01623/0.00543 
Mean/SD=0.01264/0.00402 
0.071 
Mean/SD=0.1223/0.0369 
Mean/SD=0.0937/0.0308 
0.059 
Left 
Mean/SD=0.1529/0.0439 
Mean/SD=0.1032/0.0384 
0.014 
Mean/SD=0.01525/0.00527 
Mean/SD=0.01182/0.00497 
0.138 
Median=0.1189 
Median=0.08866 
0.28 
Caudate 
Right 
Mean/SD=0.0951/0.0291 
Mean/SD=0.0772/0.0266 
0.1 
Mean/SD=0.01932/0.00604 
Mean/SD=0.01703/0.00364 
0.162 
Median=0.08205 
Median=0.06858 
0.356 
Left 
Median=0.08987 
Median=0.07456 
0.206 
Mean/SD=0.01949/0.00703 
Mean/SD=0.0183/0.00444 
0.553 
Mean/SD=0.0857/0.0287 
Mean/SD=0.0779/0.0243 
0.443 
Putamen 
Right 
Median=0.12707 
Median=0.09919 
0.524 
Median=0.02078 
Median=0.01523 
0.022 
Median=0.09551 
Median=0.09776 
0.698 
Left 
Median=0.11082 
Median=0.10285 
0.825 
Mean/SD=0.02245/0.00559 
Mean/SD=0.01855/0.00557 
0.084 
Median=0.09576 
Median=0.08511 
0.58 
Thalamus 
Right 
Mean/SD=0.1073/0.0258 
Mean/SD=0.1165/0.0477 
0.569 
Mean/SD=0.01947/0.00595 
Mean/SD=0.01786/0.00776 
0.553 
Mean/SD=0.0781/0.0236 
Mean/SD=0.0908/0.0254 
0.178 
Left 
Mean/SD=0.0998/0.0246 
Mean/SD=0.1011/0.0196 
0.867 
Mean/SD=0.01859/0.00558 
Mean/SD=0.01931/0.00542 
0.716 
Mean/SD=0.0704/0.0195 
Mean/SD=0.0797/0.0187 
0.188 
PCC - 
Mean/SD=0.0779/0.0229 
Mean/SD=0.0487/0.0171 
0.001 
Mean/SD=0.01048/0.00375 
Mean/SD=0.0079/0.0031 
0.05 
Mean/SD=0.0613/0.0186 
Mean/SD=0.0488/0.0158 
0.06 
Table 6.9: Groupwise findings from comparing metabolic concentrations of all metabolites in all voxels between acute mild and moderate patient sub-groups. 
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6.4.1.5 Summary: The significant difference between Cho of the AFu and AL 
patient sub-groups in the left SWM is suggestive that Cho is higher in this region in 
those patients who did return at follow-up. Further testing which showed Cho to be 
significantly higher in this region in the AFu sub-group compared to controls, but not in 
the AL sub-group, indicated that Cho might be expected to increase in this region 
following injury, but possibly only in a subset of patients.  It should be considered if 
this could have affected the main results in any way.  
 In the main groupwise findings where all patient metabolic data was compared 
against controls (sections 6.3.2-6.3.6), Cho in this region was not found to be 
significantly different between patients and controls at the acute time-point. However 
the further finding of Cho being significantly higher in the AFu sub-group but not in the 
AL sub-group (compared to controls) indicates that this region might be susceptible to 
an acute increase in Cho following a TBI, but only in specific patients. As increased Cho 
following injury has been previously hypothesised to indicate cell membrane 
inflammation (Brenner et al., 1993), it could be that a trend exists in those patients 
who did return whereby there were experiencing more difficulty with their injury and 
thus were more motivated to attend to it further. In this way, increased Cho in this 
region at the acute time-point could be predictive of long-term difficulty. Indeed, 
although Cho was not found to be increased in this voxel at the follow-up time-point 
(where, by definition, only the AFu patient group was tested), it did show positive 
correlations with two of the psychometric tests (Figures 6.22 and 6.23). This finding is 
therefore suggestive that a physiological difference may exist between those patients 
who did and those patients who did not return, with ongoing severity of injury 
potentially being the dividing factor. However as only one difference was found in all 
the voxels, it is not considered problematic to more broadly compare the full acute 
patient group with the returning patient group. Indeed, the uniqueness of this finding 
could also indicate that it is a Type 1 error. 
 As the mild / moderate comparisons clearly showed a strong effect between 
these sub-groups, discussion of this is included with the rest of the main summary for 
this chapter in the next section (6.5.3).  
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6.4.2 Post-Hoc Testing with NAA/Cre Ratios 
 6.4.2.1 Aim: The primary groupwise findings in this Chapter show a 
considerably different pattern of metabolic changes, with particular regard to NAA 
increasing following TBI. However as a relatively novel method of using water 
concentration as a stable reference point was used in place of Cre, additional analyses 
presented here aimed to conduct groupwise testing using the more traditional 
approach of using NAA/Cre values in order to see how comparable our data is to the 
wider literature findings. 
 6.4.2.2 Methods: Raw peak values of NAA (i.e. not corrected to water 
concentration) were divided by raw values of Cre to create NAA/Cre ratios for all 
subjects in all voxels. As per previous analyses, these were then compared between 
controls vs. acute / returning patient data for each voxel by t-test / Mann-Whittney U 
depending on if the control NAA/Cre distribution for that location was shown to be 
normal by the Anderson-Darling test. 
 6.4.2.3 Results: Anderson-Darling normality testing revealed control values of 
NAA/Cre in the following voxels to be not normally distributed: left SWM (p=0.045), 
left Caudate (p<0.005), right Putamen (p<0.005), PCC (p<0.005). Groupwise analysis 
showed that NAA/Cre was significantly lower in patients compared to controls at both 
time-points in the PCC voxel. No other comparisons were significant. Full results are 
shown overleaf in Table 6.10, with the findings from the PCC voxel then shown in 
Figure 6.25. 
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Voxel 
Acute NAA/Cre 
Comparison (Control, 
Patient, p value) 
Chronic NAA/Cre 
Comparison (Patient, p 
value) 
SWM 
Right 
Mean/SD=1.311±0.341 
Mean/SD=1.361±0.385 
0.574 
Mean/SD=1.266±0.301 
0.652 
Left 
Median=1.251 
Median=1.258 
0.569 
Median=1.362 
0.285 
Caudate 
Right 
Mean/SD=1.13±0.221 
Mean/SD=1.17±0.254 
0.48 
Mean/SD=1.059±0.199 
0.305 
Left 
Median=1.195 
Median=1.18 
0.571 
Median=1.046 
0.525 
Putamen 
Right 
Median=1.23 
Median=1.258 
0.865 
Median=1.02 
0.067 
Left 
Mean/SD=1.223±0.326 
Mean/SD=1.194±0.308 
0.713 
Mean/SD=1.103±0.288 
0.252 
Thalamus 
Right 
Mean/SD=1.43±0.453 
Mean/SD=1.419±0.411 
0.923 
Mean/SD=1.87±1.67 
0.293 
Left 
Mean/SD=1.483±0.478 
Mean/SD=1.432±0.337 
0.585 
Mean/SD=1.93±1.16 
0.141 
PCC - 
Median=1.330 
Median=1.197 
0.015 
Median=1.23 
0.019 
Table 6.10: Groupwise findings from comparing the NAA/Cre ratio values between controls and 
patients. 
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6.4.2.4 Summary: As previously discussed, decreased NAA/Cre values are often 
found following TBI (e.g. (Nakabayashi et al., 2007, Tollard et al., 2009, Vagnozzi et al., 
2010, Garnett et al., 2000b)), meaning the current replication of this in the PCC voxel is 
not surprising. What is more interesting is that lower NAA/Cre values were still 
reported in this patient group where NAA and Cre (referenced to water) had otherwise 
been found to increase. Comparing Table 6.10 to Table 6.7 indicates that, when 
examining water-corrected data, the PCC voxel exhibited increased Cre but unchanged 
NAA at each time-point. Combining these observations suggests that some previous 
reports of decreased NAA/Cre may be due to increased Cre but unchanged NAA. The 
lack of other significant “ratio” findings in the current dataset is likely due to the 
general pattern of increases in NAA and Cre often occurring at the same time, which 
also suggests that using Cre as a stable reference point in ratio analysis may lead to a 
loss of power in detecting change in both NAA and Cre should increases in each 
happen at the same time. 
 
 
Figure 6.25: Boxplots to visualise NAA/Cre ratios between controls and acute / returning patients in 
the PCC voxel. Both patient groups are significantly lower than controls. 
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6.5 Discussion 
This investigation presents results of increased NAA, Cho and Cre at the acute 
phase of injury, and increased NAA and Cre but decreased Cho at the chronic phase of 
injury. Additionally, while no relationships were found between metabolic 
concentrations and psychometric performance acutely, a number of correlations were 
found using the follow-up data indicating that the changes in the metabolite levels of 
NAA and Cho relate to cognitive outcome. However, none of these correlations 
occurred in a location with an accompanying groupwise change. I.e. all instances 
where patient Cho and NAA was found to significantly correlate with psychometric test 
performance occurred in regions where Cho and NAA concentration were normal 
compared to controls. This implies that a more complex view may be needed to 
explain what exactly a “healthy” metabolic concentration is following a TBI. Finally, 
further examinations of patient sub-groups suggested that while these findings are for 
the most part common to both mild and moderate patients, in some instances the 
reported acute groupwise changes are more prominent in the mild sub-group. 
6.5.1 Groupwise Findings and the use of Ratios in MRS Investigations: 
Increased acute NAA following injury is arguably among the most prominent of our 
findings, both by how frequently it was recorded as a response in our patients but also 
in its novelty with respect to the wider literature. These acute increases often 
normalised by the chronic time-point, but in some instances remained raised while in 
another became raised after being acutely normal. If it is subject to any change, NAA is 
very predictably found to decrease regardless of injury severity; this change has been 
reported in acute / sub-acute, mild / non-severe injury (Sivak et al., 2014, Kirov et al., 
2013, Johnson et al., 2012). While it is sometimes found to normalise over a short 
period time (Vagnozzi et al., 2010), or normalise in patients with a good outcome 
(Signoretti et al., 2008) (lending support to the theory that a change in its 
concentration may be short-lived / indicative of more severe damage), it is often also 
seen to remained decreased (Tollard et al., 2009, Garnett et al., 2000a). To the 
author’s knowledge, no study has ever reported an increase in NAA at any time-point 
or in any patient severity following TBI. The reason for decreased NAA which is most 
often cited is it being due to the neuronal loss / impaired neuronal function incurred in 
DAI. Detecting an increase following injury in a number of locations and at both acute 
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and chronic time-points is therefore contradictory to this established view and 
suggestive that the broad use of lower NAA as a marker of axonal damage is 
oversimplified, at least when applied to patients with acute, mild TBI. The fact that 
these patients may show different hallmarks of injury to other injury groups is also 
supported by the clear and significant changes in white matter diffusion properties 
presented in Chapter 5, which are also contradictory to findings in more injured 
patients.  
 It should also be noted that most previous literature reports metabolites data 
as ratios to the Cre or Cho peaks rather than to a water reference signal, making direct 
comparison to our data more complex. Statements made in the previous paragraph of 
“decreased NAA” more accurately refer to “decreased NAA / Cre”, although are almost 
always interpreted in the former, more straightforward manner. This is done under the 
assumption that Cre is stable following TBI, and therefore using it as a statistical 
reference point in this manner benefits the analyses by eliminating compromising 
effects such as variations in coil signal intensity. However more recent research has 
started to consider the idea that Cre may also be affected by TBI, with some studies 
finding it to either increase in patients (Yeo et al., 2011) or correlate with other 
measures such as cognitive test scores (Gasparovic et al., 2009) and GCS (Walz et al., 
2008) in a direction which supports increased Cre as being a marker of damage. It was 
because of these previous findings that the statistics in this chapter were conducted 
using absolute metabolic values which were instead ratioed against water 
concentration as a means of correction.  
 Our work also lends support to Cre being subject to change following injury. 
Like NAA, Cre was also found to be acutely increased in six of the nine possible voxels, 
and remained raised in three of these at the chronic time-point, strongly indicating 
that it can be subject to a change in concentration following injury. If Cre is expected 
to change in this manner, previous literature findings must be reconsidered in light of 
this. A finding of decreased NAA / Cre may not be due to an actual decrease in NAA, 
but rather an increase in Cre. This was further evidenced by the post-hoc investigation 
here which found NAA/Cre ratio values to be decreased in patients in voxels where 
increased water-corrected Cre but unchanged NAA had been found. Alternatively, an 
increase of both in concentration may not be detected if one is divided by the other, as 
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also appeared to be the case in the same post-hoc investigation. We present 
compelling evidence that the use of Cre as a stable reference point is subject to error 
and that doing so can lead to misinterpretations when considering which metabolite 
concentrations have changed and in what direction. While some previous papers have 
shown spectra which demonstrate that (un-ratioed) patient NAA is lower than control 
NAA (Garnett et al., 2000b), It seems feasible that increases in Cre could contribute to 
the repeated finding of decreased NAA / Cre ratios, and also to a lack of reported 
increased NAA / Cre ratios. As such our primary finding of increased NAA post TBI, 
though novel, may not necessarily be as unusual as they appear.  
 In explaining previous decreases in NAA, hypotheses such as a loss of neuronal 
density or a dysfunction in mitochondrial activity have been given. These are based on 
work which shows NAA to firstly only be found in neurons (Bates et al., 1996), and 
secondly to hold a strong relationship with mitochondrial energy production whereby 
NAA levels linearly indicate mitochondrial activity (Moffett et al., 2007). By this logic, a 
decrease in NAA indicates a deficit in the neurophysiology either by loss of cells or loss 
of function. In considering what increased NAA could indicate, it is possible that a 
combination of local events such as the hypothesised astrogliosis and weakening of 
neuronal-axonal membranes via damage to neurofilament (as described in section 
5.5.3) could have caused compaction of neurons, locally increasing the concentration 
of NAA. However when considering the relatively large sizes of the regions sampled in 
this analysis it does not seem entirely reasonable that enough “new” neurons from 
surrounding areas would be forced into the boundary of a MRS voxel without a similar 
number of others also being forced out. On balance, the second hypothesis remains 
more feasible in terms of creating detectably-large effect. 
 While mitochondrial activity could be expected to be compromised in severe 
injury, it is possible that non-severe injury would not be sufficiently destructive to 
disrupt cell energy processes. Responding to the consequences of TBI at a cellular level 
is a very energetic process. As one example, past research has indicated that the brain 
experiences an acute phase of raised glucose metabolism at a similar time-point since 
injury to our acute patients (Bergsneider et al., 1997) as an attempt to correct an ionic 
imbalance that often occurs following TBI so that an appropriate resting membrane 
potential can be restored (Reinert et al., 2000). Undamaged neuronal mitochondria 
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could therefore increase in their activity as a means of achieving this. As NAA levels are 
known to hold a linear relationship with mitochondrial activity (Bates et al., 1996), a 
mirrored increase in NAA would also be expected.  
 Similar explanations may be provided in explaining the increase in Cre; previous 
work (Yeo et al., 2011) has also suggested that a Cre increase is due to a higher local 
energy demand as a consequence of the immune response and on-going cellular repair 
processes. Our results can offer further support to this hypothesis, especially when 
considering that the SWM voxels were chosen having formed the hypothesis in 
Chapter 5 that extensive immune-response processes were ongoing in that location at 
the acute point, although not at the chronic point. Metabolic findings from this 
location showed both NAA and Cre to be increased bilaterally at the acute point, with 
no differences being found at the chronic point, repeating the pattern of DTI findings.  
 While this hypothesis fits with the known physiological processes which occur 
in the acute timeframe, it is more difficult to apply it to the chronic findings. As stated, 
most locations where NAA and Cre were acutely elevated returned to normal at the 
follow-up time-point, although these metabolites did remain raised in a minority of 
locations (or, in the case of NAA, become raised in a voxel where it was acutely 
normal). Descriptively observing the pattern of this, it should be noted that for each 
NAA and Cre, two of the three voxels where chronic increases were recorded were left 
/ right aspects of the same location (the thalamus for NAA and the putamen for Cre), 
possibly indicating these locations to be selectively vulnerable to this. Reasons why 
mitochondria would still be overactive at this point are not forthcoming. Considering 
the time-point, it is likely that these increases are indicative of more permanent / 
severe damage. It could be that cell energy production is still increased as a means for 
compensating other local deficits caused by this long term injury. However, without 
further data it is difficult to satisfactorily conclude on this point, and so it is highlighted 
as a potential avenue for further research.   
 Differences in Cho concentration were also recorded. Similar to NAA and Cre, 
Cho was found to be increased in patients compared to controls in a number of 
locations acutely, but was found to be reduced in some voxels chronically. These 
changes were less widespread than NAA and Cre, with the acute significant findings 
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being recorded in three voxels and chronic findings only in two. Of these locations, the 
PCC voxel held both an acute increase and a chronic decrease.  
Cho has long been speculated to being subject to increases following TBI. It is 
interesting when considering the potential difficult of reconciling ratio and non-ratio 
MRS findings with one another that our non-ratio data still shows a trend for acute 
Cho to increase following injury. The mechanism behind previous Cho increases is 
primarily hypothesised to reside in Cho’s function as a metabolite connected to the 
turnover of cellular membranes, with this in turn being supported by findings showing 
Cho to increase as a response to cellular inflammation (Brenner et al., 1993). Our data 
still supports this hypothesis. Cellular inflammation would be expected to the smallest 
degree in the case of mild / moderate injury, meaning we would only detect Cho 
increases in a minority of locations. Further, while we have hypothesised Cre increases 
to be a phenomenon of non-severe injury, Cho would be expected to increase more 
with severity. In this view, Cho / Cre ratios would still show increases in the case of 
severe injury where Cho is more increased and Cre is less increased. This allows our 
current findings to comfortably with those of the previous literature, regardless of if 
such past papers gave spectra which demonstrated non-ratioed Cho concentration to 
be increased in patients or not.  
However the chronic Cho findings are again more troublesome to explain. 
While sustained increases are sometimes found (Holshouser et al., 2006), chronic 
decreases in Cho have not, to the authors knowledge, been previously reported. As 
previous research has shown that the MRS Cho signal primarily represents both free 
Cho and cellular density (Miller et al., 1996) it is appropriate to consider these findings 
as being potentially indicative of either or both of these. While a long term loss of cells 
may seem reasonable following a TBI this is an unlikely explanation for the Cho 
concentration decrease here, as we would also then expect other metabolite 
concentrations to decrease in a similar manner. In each of the voxels where Cho was 
found to be decreased at the chronic time-point, Cre (which is present in all cells) was 
also found to be increased.  
As with many of our more novel findings, it is instead likely that this chronic 
Cho concentration decrease is due to the non-severe nature of our participant group 
and represents a form on long-term damage which is not found in more severe cases 
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of TBI. The lack of any chronic Cho increases indicates that cellular inflammation no 
longer remains. Although an increase in Cho is an indicator of damage, relatively high 
concentrations of the metabolite are still needed in order to maintain healthy 
functioning in the normal brain. Its release due to inflammation is linked to its more 
primary function of being an essential aspect of maintaining healthy cell membranes, 
while it is also a precursor of the neurotransmitter acetylcholine (Blusztajn and 
Wurtman, 1983). Reservoirs of choline are created for these purposes following a 
synthesis process involving the catabolism of phosphatidylcholine and the degredation 
of lysophosphatidylcholine (Lockman and Allen, 2002). A sustained decrease in Cho 
concentration may therefore reflect deficits in these processes as a consequence of 
long term local damage.  
6.5.2 Cognitive Findings: A number of relationships were found between 
metabolic concentrations and cognitive performance. However, these were found in 
the returning patient data and not replicated in the controls, indicating these 
relationships are due to injury. 
 No correlations were established between metabolic concentration and 
cognitive functioning in the patients at the acute time-point. This perhaps indicates 
that, despite metabolic concentration clearly being affected by injury, these alterations 
are a pure physiological response at the cellular level which do not impact upon 
cognitive processes (at least in predominantly mild patient cohort). However it should 
also not be ruled out that associations do exist in this timeframe. It is possible that the 
stringent criteria for a correlation to be significant resulted in type 2 errors, with the 
same possibility also being true for control data. It is suggested that more research be 
conducted before a full conclusion is reached here.  
 A number of correlations were found with the follow-up patient data. At 1 year 
post-injury, NAA was found to negatively correlate with VLF performance. Cho was 
also found to positively correlate with List Learning (A1-A5 and A6 conditions) 
performance. However all of these metabolite / psychometric test relationships 
appeared in areas where the relevant metabolite was not significantly different in 
concentration compared to controls.  
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While the directions of these correlations superficially support the implications 
of the groupwise findings (that increased NAA / decreased Cho are chronic markers of 
damage at the chronic time-point), this also shows that “healthy” concentrations of 
metabolites may frequently be related to injury-specific cognitive functioning. This 
could either be due to cognitive performance being more delicately linked to local 
metabolic concentrations, so as that a concentration change which is not great enough 
to cause a significant groupwise difference may still affect psychological functioning. In 
this case it may simply remain true that increased NAA / decreased Cho are indeed 
generic markers of chronic damage; it is worth noting on this point that mean NAA / 
Cho values were still descriptively increased / decreased (respectively) in all locations 
where correlations involving that metabolite were found. Alternatively, effective 
cognitive function may form different dependencies with the brains physiology 
following a TBI, which is then reflected by novel relationships with metabolic 
concentrations. This is an interesting idea, but would require more research to 
adequately comment on beyond pure speculation.  
  The disparity between the lack of / presence of cognitive findings in the acute / 
chronic conditions may be a reflection of acute metabolic changes representing 
immune-response processes (e.g. increased NAA as a marker of increased 
mitochondrial activity / increased Cho due to membrane inflammation) in contrast to 
chronic metabolic changes representing lasting cellular damage (e.g. decreased Cho as 
a marker of acquired deficit in acetylcholine production or membrane upkeep).    
6.5.3 Considering Mild / Moderate Differences: While post-hoc analysis of AFu 
vs. AL patient sub-groups was once again largely supportive of the whole acute patient 
sample being representative of the returning patient sample, comparison of acute mild 
and moderate patient sub-groups indicated considering all acute patients as a single 
“non-severe” severity may be problematic. A number of significant findings whereby 
metabolic concentrations of NAA and Cho were increased in the mild patients 
compared to the moderate patients were found in a variety of regions. Combining the 
high number of these findings and the consistency of the direction of change indicates 
that this is a strong effect. This is in contrast with Chapter 5 where mild and moderate 
data presented similar findings, possibly indicating that a disparity between mild and 
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moderate injury may be more pronounced in the physiological changes which MRS, 
but not DTI, detects.  
Comparing Table 6.9 with Table 6.7 shows that three of the five significant mild 
/ moderate differences (bilateral NAA in the SWM and Cho in the PCC lobe) had a 
corresponding patient vs. control difference wherein patient metabolic concentration 
was higher. It is therefore likely that this pattern of increased NAA / Cho in the mild 
group drove these findings. This, and other instances such as increased PCC NAA in the 
mild group, introduces further evidence that many of the novel reported findings may 
be a response more typical of a patient with a GCS of 13 or higher. Testing with the 
returning patients was not able to be conducted due to reduced sample size, so it 
should also not be ruled out that similar effects may persist over time. Similarly, as the 
acute moderate group is substantially fewer than the acute mild group, there may be 
many other cases where a lack of power prevented further mild vs. moderate 
differences from being found. 
However, by considering the abundance of (all) acute patient vs. control 
differences which do not have a corresponding mild vs. moderate difference there is 
also evidence that for a majority of the time both mild and moderate patients 
contribute to the broader reported patient metabolic changes to a comparable degree. 
Indeed, even if the least significant mild vs. moderate comparisons are selected, 
corresponding (all) acute patient vs. control differences are often still found (e.g. NAA 
in the left Putamen, NAA in the right Thalamus, Cho in the left Caudate etc.). This 
suggests that while both mild and moderate patients exhibit these novel groupwise 
changes, the mild group perhaps has an increased propensity to do so. 
6.5.4 Limitations: This work has some limitations. As with Chapter 5, one of the 
main issues is a substantial loss of the patient group between the acute and chronic 
time points. Little more commentary on this issue can be given here than has already 
been covered in section 5.5.5, although it should be noted that appropriate post-hoc 
tests were also conducted using this data (section 6.4). The results from this also 
conformed to the notion that the acute patient sample is representative of the 
returning patient sample, and so making comparisons between the two is not flawed. 
On a similar note, the problem of not all patients being able to complete cognitive 
testing again applies to this testing. However the case still remains that those patients 
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who were unable to partake in cognitive testing would hold the greatest deficits. 
Losing these patients from testing would bias against detecting experimental effects, 
supporting the cognitive findings here as being if anything a reduced example of the 
extent of neuropsychological problems encountered following mild / moderate TBI. 
One additional consideration surrounds the use of water as a stable reference 
point opposed to Cre. Some of the physiological responses to TBI are known to 
increase water concentration, e.g. oedema (Unterberg et al., 2004), or as a result of a 
mass lesion having developed (Go, 1997). Conversely, other than pharmacological 
interventions (which a discussion with Mr. Cowie confirmed was extremely unlikely in 
any of our patient group), a mechanism where water concentration would decrease 
following a TBI would not be as reasonably expected. The possibility of water 
concentration increasing means that diving metabolite values by this may also be an 
imperfect method of correction. However, if water concentration had increased, this 
would lead to lower estimations of metabolic concentrations after referencing to 
water. As the majority of our findings show increased concentrations of a metabolite in 
patients compared to controls this argues against the idea that water concentration 
changes may have impacted upon our results.  
Another potential criticism is that proton density of a location is also an 
estimation rather than a direct measure of water concentration. Deriving water 
concentration by examining the proton density of a location is a common technique, as 
the vast majority of protons in a given location are known to be present in water 
(Tofts, 2003). Therefore, hypothetical error in this would be introduced by 
physiological changes unrelated to water leading to a different proton density value. 
However it is very unlikely that any such events could cause a meaningful change 
relative to the amount of signal which water contributes. Finally, some recent research 
has demonstrated methods that can be used to correct for systematic error in proton 
density mapping by estimating types of error present through examination of other 
MR scan modalities taken at the same time as the proton density map (Volz et al., 
2012). Following these corrections proton density values were shown to be very close 
estimates of literature values of water across various brain regions. Future research 
could consider adopting this approach when estimating water concentration. 
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6.6 Chapter Summary  
This longitudinal work presents evidence of both acute and chronic metabolic 
change following TBI, with the chronic changes also being relevant to cognitive 
outcome. NAA increases were reported in patients both acutely and chronically. 
Though a novel finding, this should not necessarily be considered at odds with previous 
literature due to the use of Cre as a ratio-reference point in past analyses; Cre was also 
found to be subject to increases in this work, supporting other recent research. We 
also therefore present evidence that the use of Cre as a stable reference point for MRS 
analyses is flawed. Further investigation using the mild and moderate patients as 
separate groups also indicates that many of these findings may be due to the 
predominantly mild nature of the tested patient group, offering further support that 
the neurophysiological response to TBI may present in a contradictory manner 
between mild and severe cases. As such, the hypothesis that Cre would increase 
following damage is supported, however cognitive data was not found to hold any 
relationships with this. Additionally, the hypothesis that other metric changes would 
appear as “typical” is only partially supported; while Cho increases were expected 
decreased NAA is a very novel finding. 
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Chapter 7. Thesis Summary 
7.1 Retrospect of Thesis Aims 
MRI techniques have been increasingly used to study TBI in the past two 
decades. “Standard” methods such a T1W imaging are competent in showing areas of 
the visible, focal damage which often occurs. Conversely, “advanced” techniques may 
be used to shed light on microscopic DAI, which previously could only be diagnosed via 
histopathology. Popular among these advanced methods, DTI may be used as a 
method of studying microstructural changes resulting from damage, while MRS is 
capable of characterising changes to the metabolic profile of neural regions. Data 
which is derived from any of these techniques may also be used in seeking 
relationships with the patient’s cognitive outcome. Such findings provide evidence that 
the physiological changes identified by these methods are cognitively relevant. 
 The sum of this past research has arguably produced a consensus on the 
changes expected after someone sustains a TBI. It appears clear that focal injury is 
most often sustained in the anterior aspects of the cortex; the anterior frontal and 
temporal lobes. DTI studies have indicated that neuronal microstructure becomes 
disorganised and torn; something most characteristically implicated by reduced FA and 
increased MD, with relationships to cognitive outcome often supporting that these 
changes mark damage. MRS studies have indicated that in affected areas NAA 
concentration may decrease, while Cho concentrations may increase; suggestive of 
neuronal loss / mitochondrial dysfunction and cellular inflammation, respectively. 
These hypotheses all appear reasonable considering expected outcomes from a TBI, 
but they are based on data which is heavily biased towards studying severe and 
chronic head injury.  
Though accounting for 80-90% of cases, TBI-research has frequently ignored 
mild injury. This is also despite early signs indicating that many patients with mild TBI 
still suffer from lasting and affecting cognitive deficit. Some of the research which has 
examined a mild patient population reported findings of metric and metabolic changes 
contrary to the expected directions (as described above) which began to indicate that 
the conclusions gleaned from severe-focused research may not be applicable to mild 
cases. It also became apparent that the temporal aspect of recovery affected findings, 
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reflecting the differing physiological processes which happen over time. A push to 
isolate mild and acute injury within research began; an approach which this thesis is 
grounded in. Thus, the broader question(s) asked by this project was “Are the 
physiological changes observed following mild TBI separate to those expected 
following a severe injury, how do these change over time, and how do these 
contribute to the patient’s resulting cognitive profile?”.  
To address this question, longitudinal MRI and cognitive data was obtained 
from a predominantly-mild (and non-severe) patient cohort and matched control 
subjects. Cognitive deficit in patients was first assessed (Chapter 3), areas of focal 
damage were identified (Chapter 4), DTI was used to conduct a global investigation 
into microstructural changes and how these affect cognitive deficit (Chapter 5) and 
finally MRS was used to characterise metabolic changes in a number of ROI’s and how 
these affect cognitive deficit (Chapter 6). Findings broadly supported the notion that 
different physiological responses should be expected following a mild injury (compared 
to injury of greater severity) and a number of novel conclusions were made. 
7.2 Characterising the Neurophysiology of Mild TBI 
 Chapter 4’s experimentation was perhaps the only instance here where the 
findings broadly agree with severe-based literature. Images were produced to show 
the probability distribution of visible lesions in our predominantly mild patient cohort. 
These qualitatively demonstrated that visible damage in the brain was most frequently 
found in the anterior, inferior and lateral aspects of the frontal and temporal lobes, 
while a minority of other lesions were isolated in a non-specific pattern around the 
cortex. This a similar pattern to that which is reported in studies focusing on severe 
injury, and this is perhaps not surprising. As primary focal damage is caused directly by 
sites of impact to the skull, this would not be expected to differ between mild and 
severe injury as the main difference between these is instead the force of the impact. 
The finding that total lesion volume increases with GCS further supported this. 
 Although the spatial distribution of focal damage in mild patients appeared to 
conform to the same pattern as in severe patients, DTI and MRS data indicated that 
the presentation of DAI did not. On this point, it should first be made clear that the 
repeated finding of significant metric or metabolic differences in normal-appearing 
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areas of brain shows strong fundamental support of the existence of DAI in non-severe 
TBI. At a glance, the direction and nature of these changes often appeared as a 
complete opposite to what is frequently found when examining severe patients. Most 
notably, DTI and MRS experimentation respectively showed FA and NAA to increase in 
patients. As such alterations first appear almost nonsensical when considered in the 
context of what these markers are purported to indicate (microstructural organisation 
for FA and neuronal density for NAA). Considering them in the context of lesser 
severity and time since injury was required in order to make sense of them.  
Crucially, while findings from past research generally pointed towards changes 
in biomarkers as being direct evidence of physiological damage (e.g. decreased FA to 
indicate a disrupted and disorganised axonal structure), our conclusions were often 
hinged on the principle that while DAI does often result from mild injury, it may not be 
disruptive enough to cause immediate and clear physiological damage. Our data 
supported the hypothesis that an increased survival of neurons and glial cells would 
mean the destruction-based hallmarks of severe injury were not present, while at the 
same time relatively spared cellular functioning would hypothetically result in a 
greater degree of an immune response and repair processes which a more damaged 
brain would not be as capable of. The combination of these creates a substantial 
disparity between the physiology of severe and mild injury. While neuronal 
microstructure may predominantly suffer from tearing, shearing and cell death in 
severe injury (leading to decreased FA), it may remain relatively intact in milder injury. 
This would mean that a response of astrogliosis would instead become the 
predominant physical change, leading instead to increased FA as the processes from 
astrocytes confer greater directionality to local diffusion.  As another example, while a 
loss of neuronal density may lead to a drop in NAA in severe injury, the relative sparing 
of neurons in milder injury may leave neurons more capable of engaging in the 
energetic response to damage, leading instead to an increase in NAA. 
The analyses in this thesis may thus be combined to present a picture of the 
focal, microstructural and metabolic changes expected following non-severe TBI. Focal 
lesions may still be found, in similar patterns to damage following a severe injury albeit 
to a lesser extent. DAI affects many of the brains white matter tracts. At the acute 
stage of injury (approx. 6 days), this causes multi-focal injury to a number of major 
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neuronal pathways which is sufficient to initiate responses such as astrogliosis but not 
severe enough so as to cause cellular destruction. The invasion of astrocytes may 
create an increase in FA when examined by DTI, driven by an increase in AD but 
unchanged RD. Chronically (approx. 1 year), this process has abated and locations of 
lasting damage may now be identified by DTI; the genu of the corpus callosum may 
exhibit decreased FA which is driven by increased RD, now indicative of myelin sheath 
disintegration.  
Metabolically, acute increases in NAA and Cre may be observed in a number of 
locations. These are hypothesised to be due to increased local energy expenditure as a 
response to injury. Concurrently, Cho may also increase as a response to cell 
membrane inflammation. Locations which have suffered chronic damage may also be 
characterised by still-increased NAA and Cre at 1 year post-injury, although reasonable 
hypotheses for these sustained increases cannot currently be made and require more 
research. Conversely, Cho may no longer be expected to be increased but may instead 
now be decreased; hypothesised to be indicative of a departure of healthy functioning 
which seeks to maintain an adequate supply of Cho for various cellular processes. 
7.3 Characterising the Cognitive Profile of Mild TBI 
 Cognitive testing indicated that our cohort of non-severe patients experienced 
a wide range of cognitive deficit at the acute stage of injury. This presented as 
underperformance on psychometric tasks designed to measure aspects of executive 
function, visuospatial and verbal learning, attention, concentration, short-term 
memory and working memory. However by the chronic time point patients were not 
found to perform significantly differently (in groupwise analyses) on any task 
compared to controls, indicating a degree of recovery over time.  
 Examining our data for relationships between cognitive test performance and 
data pertaining to neurophysiological damage revealed a number of relationships at 
both the acute and chronic time-points, allowing inferences about the biological basis 
of these deficits to be made. Focal damage was shown to be related to scores on a 
number of psychometric tasks which patients had been shown to hold a deficit in. The 
manner in which these relationships were established was interesting; total lesion 
volume was an insensitive predictor of this (in terms of correlations with psychometric 
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performance) and it was instead found that patients who had visible lesions 
underperformed on cognitive tasks (in groupwise analyses) compared to those who did 
not. This finding also gave support to the Mayo classification system of head injury 
severity, suggesting it is superior to the GCS with regards to predicting cognitive 
outcome. In this way it is unclear if the lesions themselves contributed to deficit, or if 
the presence of visible damage was instead an indicator of greater overall severity of 
injury which may lead to more cognitive-relevant neurophysiological changes 
elsewhere. As a small number of correlations were found when examining total lesion 
volume, it seems feasible that there is a combination of each of these factors. 
 Examination of DTI and MRS data indicated more direct relationships between 
DAI and cognitive outcome. Our data in Chapter 5 supported the hypothesis that 
subtle damage to axonal neurofilament underpinned deficit in the VLF task by affecting 
the conduction velocity of the neuron. This would also reduce the RD of the axon, but 
not sufficiently enough for a groupwise reduction in RD to be observed. This 
phenomenon was indicated by an RD-driven negative regression between FA and VLF. 
Chronically, FA was still found to regress negatively with VLF although in a different 
location (the genu opposed to the ascending fibres of the corpus callosum, as was 
most strongly implicated in the acute data). This was an interesting point as FA was 
also shown to be reduced in patients compared to controls, often in overlapping 
voxels. The seemingly contradictory implication of these findings is that chronic FA 
reduction (due to myelin sheath disintegration) is indicative of damage, yet patients 
who have lower FA values also tend to perform better on the VLF task. This is 
highlighted as an interesting point for further research. 
 A number of correlations were also found between psychometric task 
performance and various metabolic concentrations in a number of locations in our 
patients. Interestingly however, none of these were found at the acute stage of injury. 
NAA was shown to negatively correlate with VLF and Cho was shown to positively 
correlate with performance on two different conditions of the List Learning task. Each 
of these findings were complementary to counterpart groupwise results, together 
indicating that chronically increased NAA / decreased Cho were indicative of lasting 
damage. This is in contrast to current literature which generally indicates decreased 
NAA and increased Cho to indicate damage. However none of the regions these 
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correlations were found in were the same areas as where that metabolite had also 
been shown to be significantly different compared to controls in groupwise analysis. 
This indicated that injury-specific relationships between metabolite concentrations 
and cognitive functioning may occur in areas where metabolite concentration is 
normal. More work is therefore required regarding the reasons behind these 
concentration changes and their influence on cognitive function in order to produce 
satisfactory conclusions as to the exact physiological mechanisms which are impacting 
upon cognitive outcome.  
 The apparent contradiction between the lack of chronic patient task 
underperformance and the number of findings between physiological data and 
cognitive performance in the chronic phase should be noted. This implies that even if a 
patient outwardly portrays normal levels of cognitive function, this may still be 
underpinned by altered neural physiology. The apparent recovery of cognitive function 
does not therefore indicate a recovered brain on a physiological level. The patient may 
still be experiencing cognitive deficit but to an extent which would not be found in a 
groupwise comparison. It should also be considered that coping mechanisms are likely 
to have developed over time, meaning that some aspects of the observed 
normalisation have a behavioural rather than strictly-biological component. 
7.4 Future Work 
 The investigations here highlights a number of potential avenues for further 
research. Principally, due to the strong evidence that the physiological and cognitive 
profile of non-severe TBI should be considered differently to severe cases, a broad 
indication is made that more research should be conducted into this demographic. 
Specific to the conclusions made here, the mechanisms which underpin VLF 
performance at the chronic phase of injury are of interest and may shed further light 
onto the nature of long term cognitive outcome in non-severe TBI. Equally, reasons 
behind the novel chronic metabolic changes of increased NAA / Cre and decreased Cho 
(each also shown to impact upon cognitive deficit) also remain unclear and present an 
opportunity for further work. Methodological aspects of this project which were 
limited may also be improved upon; higher scan resolution, a greater proportion of 
returning patients and more strict severity criteria would all be of benefit.  
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 Some of the findings in this study also suggest that the analytical techniques 
used in future research should be more carefully considered. In DTI research, AD and 
RD metric values should always be examined. Methods which only consider metrics 
which may be produced through manipulations of these (such as FA) have lower 
sensitivity which may impact upon the ability to make accurate conclusions. Many of 
the novel implications gained from this project’s DTI work would not have been 
possible if AD and RD had not been used in tandem with FA and MD. Further, Cre is 
implicated to be vulnerable to change following TBI. This finding, in conjunction with 
other recent research suggestive of the same thing, means that the technique of 
interpreting NAA and Cho changes through data ratioed to Cre is flawed. Other means 
of correcting the data (such as using water content as a stable reference point) should 
instead be sought so that metabolic changes may more accurately be examined. 
 An effort should also be made to conduct research now with a more direct aim 
of producing findings relevant to the treatment of patients with a TBI. Methods which 
take advantage of the brains ability to compensate for damage could be explored. For 
example, the nature of the focal and diffuse injury sustained in a TBI means that the 
pattern of neural damage is often similar between patients, which would be expected 
to also lead to similar patterns of cognitive deficit. It is feasible that long term deficit 
may therefore be predicted by identification of where acute damage has occurred. On 
this hypothesis, it could be directly examined if methods such as DTI could be used at 
the acute phase of injury in a prognostic manner concerning the patient’s cognitive 
outcome. If this is proved to be the case opportunities are then opened whereby more 
bespoke rehabilitation techniques may be provided to a patient at an earlier point in 
their recovery, potentially aiding the speed and efficiency with which they adapt. 
Related to this would be the use of other study techniques. Combining longitudinal 
fMRI and DTI data would allow for the examination into if locations of tract injury as 
identified by DTI analysis influenced network reorganisation as identified by fMRI 
analysis.  
7.5 Concluding Remarks 
 This project has produced important data which sheds some light onto the 
neuro-psychological consequences of non-severe TBI. Strong evidence is presented 
that the physiological outcome of non-severe TBI are not comparable to severe cases. 
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These differing injury mechanisms may be identified by novel-appearing metric and 
metabolic changes such as increases in FA, NAA and Cre. Many of these changes also 
appear to affect the cognitive outcome of the patient. Therefore, future research 
should rightly consider non-severe injury as unique and investigate it as such.  
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Appendix A 
Detailed Injury Characteristics of our Patient Group 
Table A.1 (continued over the next three pages) gives individual injury characteristics 
for all of the patient group who took part in this study. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
204 
 
Number 
Sex 
Age at acute 
scan 
Severity 
GCS on 
admission 
Headache Vomiting Seizure 
LOC 
(minutes) 
PTA 
(hours) 
CT findings / T1W MRI scan 
findings 
1 Male 48 Mild 14 + - - Unknown - Contusions 
2 Male 65 Mild 14 + - - 5 2 Subdural Haematoma 
3 Male 18 Mild 14 + - - 5 - 
Extradural haematoma, fracture in 
base of skull 
4 Male 22 Mild 15 + + - - - 
Intracerebral haematoma, 
contusions, skull fractures 
5 Male 64 Mild 14 + + - 10 - Contusions 
6 Female 40 Mild 14 + - - - 2 Normal Appearing Scan 
7 Male 47 Mild 15 + - - 3 - Normal Appearing Scan 
8 Female 26 Mild 15 + - - - - Normal Appearing Scan 
9 Male 26 Mild 15 + - - 2 3 
Contusion, subdural haematoma, 
sub-arachnoid haemorrhage, 
fracture in base of skull 
10 Male 68 Mild 14 + - - 2 0.5 
Contusion and sub-arachnoid 
haemorrhage 
11 Male 36 Mild 14 + + - 5 - Contusion 
12 Female 40 Mild 14 + - + 10 - Sub-arachnoid haemorrhage 
13 Male 23 Mild 15 - + + 1 0 Normal Appearing Scan 
14 Male 17 Mild 15 + + - 2 1 Normal Appearing Scan 
15 Male 17 Mild 15 + + + 5 Unknown Contusion 
16 Female 34 Mild 13 + - - 5 30 Vault fracture 
17 Male 44 Mild 14 + - - - 4 Normal Appearing Scan 
18 Female 32 Mild 15 + + - 1 0.5 
Contusion, sub-arachnoid 
haemorrhage, fracture in base of 
skull 
19 Male 21 Mild 14 + - - - 1 
Intracerebral haematoma, skull 
fractures 
20 Male 65 Mild 15 + - - - - Vault fracture 
21 Male 45 Mild 15 + + - 1 - Normal Appearing Scan 
Table A.1: Full injury characteristics of the patient group. Cells with a yellow shading denote that the patient returned for follow-up testing. 
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Number Sex 
Age at acute 
scan 
Severity 
GCS on 
admission 
Headache Vomiting Seizure 
LOC 
(minutes) 
PTA 
(hours) 
CT findings / T1W MRI scan 
findings 
22 Female 51 Mild 15 + + - - - Vault fracture 
23 Male 27 Mild 15 + + - - - Contusions 
24 Male 23 Mild 14 + - - 2 12 Normal Appearing Scan 
25 Male 33 Mild 15 + + - 1 - 
Contusions, subdural haematoma, 
vault fracture 
26 Male 28 Mild 15 + - - - - 
Intracerebral haematoma, vault 
fracture 
27 Male 35 Mild 15 - + - - - Vault fracture 
28 Female 28 Mild 14 + - - 1 2 
Contusion, subdural haematoma, 
vault fracture 
29 Male 25 Mild 14 + + - - 7 Contusions 
30 Male 48 Mild 15 + + - - - Extradural haematoma 
31 Male 57 Mild 14 + + - 1 1 Contusion, vault fracture 
32 Male 20 Mild 15 + + - - - Contusion 
33 Male 22 Mild 13 + + - - 4 Contusion 
34 Male 26 Mild 13 + - - - 12 
Intracerebral haematoma, 
contusion 
35 Male 20 Mild 15 + + - 1 1 Contusion 
36 Male 28 Mild 14 + + - 0.5 6 
Contusion, sub-arachnoid 
haemorrhage 
37 Male 51 Mild 14 + + + 10 2 Normal Appearing Scan 
38 Male 28 Mild 14 + - - 15 - 
Contusion, sub-arachnoid 
haemorrhage, subdural 
haematoma, vault fracture 
39 Male 21 Mild 14 + - - - 3 
Sub-arachnoid haemorrhage, vault 
fracture 
40 Male 19 Mild 15 + + - 20 6 
Contusion, subdural haematoma, 
vault fracture 
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Number Sex 
Age at acute 
scan 
Severity 
GCS on 
admission 
Headache Vomiting Seizure 
LOC 
(minutes) 
PTA 
(hours) 
CT findings / T1W MRI scan 
findings 
41 Male 19 Mild 13 + + - 1 2 
Sub-arachnoid haemorrhage, 
subdural haematoma, contusion, 
vault fracture 
42 Male 44 Mild 15 + + - - 0.5 
Extradural haematoma, vault 
fracture 
43 Male 25 Mild 14 + + - 1 5 
Contusions, sub-arachnoid 
haemorrhage, vault fracture 
44 Male 16 Mild 15 + + - 2 18 Contusion, vault fracture 
45 Male 26 Moderate 10 + + - 1 1 
Subdural haematoma, vault 
fracture 
46 Male 25 Moderate 10 + + - 1 7 
Subdural haematoma, contusions, 
vault fracture 
47 Male 29 Moderate 12 - + - - 2 
Contusions, fracture on base of 
skull 
48 Male 52 Moderate 12 + + - 15 4 
Subdural haematoma, contusions, 
vault fracture 
49 Male 25 Moderate 12 + + - 10 6 Contusions, vault fracture 
50 Female 22 Moderate 12 + - - - 0.5 Contusions 
51 Male 37 Moderate 12 + + - 3 336 
Contusions, fracture on base of 
skull 
52 Male 27 Moderate 7 + - - 5 1 
Extradural haematoma, fracture in 
base of skull 
53 Female 63 Moderate 9 + - - 10 240 
Sub-arachnoid haemorrhage, 
contusion 
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Appendix B 
Comparing the DTI Data of those Patients who did and did not return for 
Follow-up Testing 
Aims: A further potential confound to the findings is the possibility of how 
effectively a patient recovered being an influencing factor to them when deciding 
whether or not to return for follow-up testing. In this way it’s feasible that those 
patients who did not return were the most mildly injured, therefore introducing bias 
into the data whereby the follow-up group could not be validly comparable to the 
acute group. To investigate this bias, the acute patient data was split into two groups 
defined by if that patient did or did not return for follow-up testing. These acute data 
were then subject to groupwise statistical comparisons against one another.  
 Preliminary Methods: TBSS was once again used to examine if there were any 
differences in the acute data between those patients who returned for the follow-up 
testing (here referred to as AFu, N=23) and those who were lost to follow-up (here 
referred to as AL, N=30). A comparison was also made between the AFu group and 
control data in as a means of testing if the main findings of this experiment (section) 
would be different if only those patients who returned at follow-up were used acutely. 
The same methods as before for the main analysis were used again for groupwise 
comparisons. 
 Preliminary Results: TBSS analysis revealed that AFu data is not representative 
of all patients when considered together. Figure B.1, below, shows AFu metric changes 
compared to controls. MD and AD still exhibit an increase however in contrast to the 
results concerning all patients, FA shows no change. 
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TBSS analysis comparing AFu to AL also revealed that FA was increased in select 
locations in the AL group (Figure B.2, below).  
 
 
 
 
 
 
 
 
Preliminary Summary: These findings are suggestive that there may be an 
inherent physiological difference between those patients who did and who did not 
return for the follow-up examinations whereby the phenomenon of increased FA may 
be attributed to the AL group but not the AFu group. It is possible however that the 
-20 0 20 40 Z = 
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Figure B.2. TBSS outputs showing FA differences between AFu and AL. FA is shown to be increased in the AL 
group. Z co-ordinates were chosen both for comparison with other data and to best emphasise the locations 
of the increase. AD, RD and MD are not sown as no differences were found for these. 
Figure B.1. TBSS outputs showing metric differences in AFu compared to controls. All cases show an increase 
in the AFu group. FA and RD are not shown as no differences were found for these. 
AD 
MD 
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reduction in statistical power from splitting the acute group into two sub-groups has 
affected this analysis. It would also be beneficial to examine the exact spread of data in 
these patients groups at these locations. For these reasons, further testing was 
conducted. 
Follow-up Methods: Although the TBSS findings show locations of significant 
change they do not allow for the magnitude of this change or the spread within this 
data to be examined. Therefore, an additional ROI analysis was conducted on the TBSS 
images to extract exact metric values from specific tract locations, allowing this 
information to be more closely examined and further statistical tests to be made. Two 
regions were chosen for this; the ascending fibres of the corpus callosum in the left 
hemisphere (as this was the location where the strongest FA changes had been 
observed at the acute time point in the main analysis), and the anterior forceps (as this 
was the location where the greatest FA difference between the AFu and AL groups had 
been observed). 
MRIcro was used to draw a ROI on each tract (axially) in the 
“mean_FA_skeleton” file that was produced by TBSS for the acute patient vs. control 
analysis. This was done at z co-ordinate 36 for the left corpus callosal fibres and z co-
ordinate 9 for the anterior forceps after visual inspection ascertained that these slices 
were the most relevant with respect to the findings. It was decided that it would be 
advantageous for the ROI’s to also be applicable to the follow-up data so that the 
chronic data may potentially be investigated in the event of further developments 
deeming this necessary, although this did not occur. To accommodate this goal, the 
ROI was then loaded onto the “mean_FA_skeleton” file that was produced by TBSS for 
the chronic patient vs. control analysis and any redundant voxels, which were part of 
the underlying tract in the acute sample but outside the tract boundary at follow-up, 
were removed. This left an ROI of the tract in question which was applicable to both 
acute and chronic samples. These ROI’s are shown in Figure B.3, below. Average metric 
values were extracted from acute patient and control scans. 
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To further examine for differences between the AFu and AL sub-groups, all key 
cognitive test scores (Table 3.6) were first compared between these two groups to 
examine any difference in psychometric performance at baseline. These were done 
either by t-test or Mann-Whittney depending on if the control data for that test had 
previously found to be normal or not-normal, respectively (sections 3.6.2.1-3.6.2.9). 
Acute patient FA for each ROI was then split into these sub-groups and compared 
against one another, and against control data; comparisons with one another would 
reveal potential metric differences between these sub-groups, while comparisons with 
the control group would reveal if the significant findings of the experiment would 
differ when considering these sub-groups separately. Any discrepancies found in these 
analyses was be further explored by appropriate groupwise testing with AD and RD 
values to determine the underlying effect driving the change. For any groupwise test 
involving a metric, control distribution was examined first by the Anderson-Darling test 
for normality. If data was normal t-tests were used for these analyses while if it was 
not then the Mann Whitney test were used instead.  Regression analysis with VLF as 
the dependant variable and FA / NART as predictor variables was also repeated in each 
ROI for each sub-group, and scatterplots were produced so that the spread of data in 
each sub-group may be examined. 
Results – Cognitive Test Comparisons: Groupwise comparison of cognitive 
performance between AFu and AL sub-groups showed one significant difference in 
Z = 9 36 
A B 
Figure B.3. TBSS outputs to demonstrate the regions chosen for post-hoc ROI investigation. The ROI’s 
are shown in pink and are projected onto their relevant TBSS output. Part A shows raised acute FA in 
the left ascending fibres of the corpus callosum. Part B shows lowered chronic FA on the AF.  
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VLF, whereby the AFu group outperformed the AL group. All findings are shown in 
Table B.1 while the VLF finding is further visualised in Figure B.4. 
 
 
 
 
Psychometric Test AFu Descriptive Data AL Descriptive Data p-value 
SOIP 
Mean=60.9 
SD=18.3 
Mean=55.2 
SD=20.4 
0.294 
Design Learning (A1-A5) 
Mean=35.45 
SD=8.5 
Mean=35.86 
SD=8.24 
0.867 
Design Learning (B1) Median=6 Median=6 0.678 
Design Learning (A6) Median=9 Median=8.5 0.4972 
List Learning (A1-A5) 
Mean=42.4 
SD=15.2 
Mean=43.4 
SD=12.5 
0.811 
List Learning (B1) Median=6 Median=6 0.444 
List Learning (A6) 
Mean=8.48 
SD=4.31 
Mean=8.1 
SD=3.87 
0.746 
PASAT (2 second intervals) 
Mean=38.5 
SD=29.8 
Mean=35.5 
SD=26.7 
0.725 
PASAT (3 second intervals) 
Mean=56.6 
SD=33 
Mean=60.5 
SD=27.6 
0.674 
Backwards Digitspan Median=6 Median=5 0.106 
Backwards Spatialspan Median=7 Median=7 0.453 
VLF 
Mean=36 
SD=15 
Mean=27.5 
SD=10.2 
0.028 
Category Fluency 
Mean=38.1 
SD=12.6 
Mean=33.4 
SD=9.15 
0.147 
CWIT (colour naming condition) 
Mean=23.9 
SD=16.9 
Mean=28 
SD=15.4 
0.376 
CWIT (switching condition) 
Mean=19.2 
SD=30.8 
Mean=23.7 
SD=22.2 
0.5675 
Table B.1: Findings from groupwise comparison of psychometric performance between AFu and AL 
patient sub-groups. Only VLF is significantly different. 
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In light of this finding, post-hoc analysis which compared AFu / AL VLF 
performance against Control data was conducted in order to see if both groups 
remained significantly different compared to controls, or if the initial finding of the 
acute patient group underperforming on the task was due to a disproportionate effect 
in only one of these subgroups. t-test analysis showed while the difference between AL 
VLF (Mean=27.5, SD=10.2) and Control VLF (Mean=41.63, SD=9.38) was significant 
(t(49)=-5.37, p=<0.001), the difference between AFu VLF (Mean=36, SD=15) and 
Control VLF was not (t(34)=-1.58, p=0.125). 
Results - AFu / AL differences in the left corpus callosal fibres: Statistical 
examination of the patient sub-groups by t-test demonstrated that the difference 
between AFu FA (Mean = 0.42, SD = 0.057) and control FA (Mean = 0.4, SD = 0.04) was 
not significant (t(36) = 1.47, p = 0.149), although t-test comparison between AL FA 
(Mean = 0.44, SD = 0.043) and control FA showed that AL FA was significantly increased 
(t(59) = 3.81, p = <0.001). Further testing indicated that this increase was due to a 
change in RD, which was found to be significantly decreased in both the AFu 
(Mean=0.00063, SD=0.00007, t(52)=-2.36, p=0.022) and AL 
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Figure B.4: Boxplot to show the difference in VLF between AFu and AL patient sub-groups. The AFu 
group was found to significantly outperform the AL group. 
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(Mean=0.00063,SD=0.00007, t(59)=-2.79, p=0.007) sub-groups compared to controls 
(Mean=0.00068, SD=0.00009). t-test comparison showed that FA in the AFu and AL 
sub-groups were not significantly different from one another (t(39) = -1.37, p=0.178).  
Regression analysis indicated that neither FA of the AFu sub-group (R2 = 
22.92%, T=-2.02, p = 0.057) or the AL sub-group (R2 = 17.52%, T=-0.56, p=0.584) held a 
significant relationship with VLF scores. These data are visualised in Figure B.5. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results - AFu / AL differences in the anterior forceps: Statistical examination of 
the patient sub-groups by t-test demonstrated no significant difference between AFu / 
control data (AFu Mean/SD = 0.606/0.047, Control Mean/SD = 0.625/0.375, t(40)=-
1.64, p=0.11), AL / control data (AL Mean/SD = 0.629/0.041, t(58)=0.44, p=0.665) or 
AFu / AL data (t(43)=1.91, p=0.063).  
Figure B.5. A Scatterplot with regression showing the distribution of FA in the AFu (green) and AL (red) 
patient groups, and their relation to VLF score. Note that neither of these relationships form 
significant regressions. The black line is indicates the line of best fit for all acute patients as a single 
group for visual comparison.  
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Regression analysis also showed that neither FA of the AFu sub-group 
(R2=12.24, T=-1.07, p=0.297) or of the AL sub-group (R2=16.25, T=-0.04, p=0.97) held a 
significant relationship with VLF scores. A scatterplot combining this information is 
included below (Figure B.6) nevertheless so that the spread of the data may be visually 
inspected.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Summary: The significant difference in task performance on VLF is interesting. 
As this indicated that the AFu group outperformed the AL group, the direction of this is 
the opposite of what would be expected by the hypotheses of those patients declining 
to return being less impaired. The lack of significant differences being found in any 
other task also suggests that if there is a disparity in cognitive ability between these 
sub-groups, it does not represent a broad deficit. On balance, the idea that the 
returning patient sample may hold relatively cognitively superior abilities should not 
impact upon the findings of the study as a) there is a minority of cognitive facets 
Figure B.6. A Scatterplot with regression showing the distribution of FA in the AFu (green) and AL (red) 
patient groups, and their relation to VLF score. The black line shows the line of best fit for all acute 
patients as a single group. No regressions here are significant; the graph is included so that the spread 
of this data can be examined. 
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affected by this and b) as it is the sub-group which returned for further testing who 
appear to have superior functioning this implies that any evidence of injury found 
would be an underestimation of the damage incurred in mild TBI. 
The majority of the ROI findings are fully supportive of there being no 
difference either between the sub-groups themselves, or the findings that 
comparisons between them and the control data produce. The only inconsistency lies 
with the AFu / control comparison in the corpus callosal fibres not reaching 
significance while the corresponding comparison with the AL group showed a true 
significant difference. However further testing indicated that the driving factor in this 
change (decreased RD) was similarly altered to a significant extent in both the AFu and 
AL groups. This implies that the same fundamental effect is present in each sub-group 
but may simply be more exaggerated in one. Again, as the patients who appear the 
most affected are those who did not return for further testing it also still stands to 
reason that the patients retained at the chronic time-point would give an 
underestimation of the effects of TBI. Finally, the TBSS finding of an FA difference 
between the AFu and AL groups in the anterior forceps (Figure B.2) was not repeated 
when examining the ROI data which also showed no difference. Examination of the 
spread of data between the sub-groups (Figures B.5 and B.6) also show no major 
differences. Each plot shows a very even distribution of values and similar relationships 
with VLF.  
Concerning the corpus callosal fibre data here, it is interesting to note that AD 
was not found to be increased but RD was again found to be decreased, in 
contradiction with the main TBSS findings but in support of the tractography analysis 
of the same region (section 3.4.1.3). However, unlike that tractography analysis, data 
used here is directly derived from the values in the main TBSS experiment. As the main 
TBSS findings utilised the TFCE clustering technique, this disparity perhaps indicates 
that a very local effect of decreased RD exists in the region of the ascending corpus 
callosal fibres but that this is eliminated when also taking into account the changes in 
the surrounding areas. 
 ROI analysis of locations indicated by TBSS (Figure B.2) to contain differing FA 
results between AFu / AL therefore does not support that these groups are 
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significantly different from one another. The notion of reduced sample size causing the 
inconsistencies is further supported by clusters of MD and AD changes in the AFu 
group compared to controls (Figure A.1) to be reduced in size and number when 
compared with all patients. Further, examination of scatterplots does not show any 
skew in the FA distribution between AFu and AL groups. Finally, the only notable 
observation from these plots is a differing line of regression between FA and VLF in the 
AF, although regression analysis between these measures in this location have never 
formed a statistically significant result throughout the study. This still remains the case 
even when considering the AFu and AL groups separately. These analyses indicate that 
while some TBSS analysis suggests the AFu and AL groups are not entirely 
representative of one another, these non-conformities are most likely due to a lack of 
statistical power rather than an inherent difference between these patients. As such 
the validity of comparing the follow-up patient group against the acute patient group 
is not compromised. 
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Appendix C 
The following pages include a joint first-author publication which was based on the DTI 
portion of this thesis 
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